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Title of Study: DEVELOPING AND DEPLOYING DATA MINING TECHNIQUES IN 
HEALTHCARE 
 
Major Field: INDUSTRIAL ENGINEERING AND MANAGEMENT 
 
Abstract: Improving healthcare is a top priority for all nations. US healthcare expenditure 
was $3 trillion in 2014. In the same year, the share of GDP assigned to healthcare 
expenditure was 17.5%. These statistics shows the importance of making improvement in 
healthcare delivery system. In this research, we developed several data mining methods 
and algorithms to address healthcare problems. These methods can also be applied to the 
problems in other domains.  
The first part of this dissertation is about rare item problem in association analysis. This 
problem deals with the discovering rare rules, which include rare items. In this study, we 
introduced a novel assessment metric, called adjusted_support to address this problem. 
By applying this metric, we can retrieve rare rules without over-generating association 
rules. We applied this method to perform association analysis on complications of 
diabetes. 
The second part of this dissertation is developing a clinical decision support system for 
predicting retinopathy. Retinopathy is the leading cause of vision loss among American 
adults. In this research, we analyzed data from more than 1.4 million diabetic patients and 
developed four sets of predictive models: basic, comorbid, over-sampled, and ensemble 
models. The results show that incorporating comorbidity data and oversampling 
improved the accuracy of prediction. In addition, we developed a novel “confidence 
margin” ensemble approach that outperformed the existing ensemble models. In 
ensemble models, we also addressed the issue of tie in voting-based ensemble models by 
comparing the confidence margins of the base predictors.  
The third part of this dissertation addresses the problem of imbalanced data learning, 
which is a major challenge in machine learning. While a standard machine learning 
technique could have a good performance on balanced datasets, when applied to 
imbalanced datasets its performance deteriorates dramatically. This poor performance is 
rather troublesome especially in detecting the minority class that usually is the class of 
interest. In this study, we proposed a synthetic informative minority over-sampling 
(SIMO) algorithm embedded into support vector machine. We applied SIMO to 15 
publicly available benchmark datasets and assessed its performance in comparison with 
seven existing approaches. The results showed that SIMO outperformed all existing 
approaches. 
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CHAPTER I 
 
 
INTRODUCTION 
 
 
 
1.1. Introduction and Motivation 
Improving healthcare is a top priority for all nations. In 2014, US healthcare expenditure was $3 
trillion, or $9,523 per person. In the same year, the share of GDP assigned to healthcare 
expenditure was 17.5% [1]. These statistics shows the importance of improving the healthcare 
delivery system. 
Diabetes is one of the most serious and prevalent chronic conditions affecting approximately 415 
million people worldwide, with this number is expected to grow to 642 million by 2040 [2]. The 
situation is particularly dire in the U.S., which has the highest prevalence of diabetes of all 
developed nations. Approximately 86 million adults aged 20 years and older (37%) were 
diagnosed as pre-diabetic between 2009 and 2012. By 2014, the estimated number of adults with 
diagnosed or undiagnosed diabetes topped 29 million, representing about 9% of the U.S. adult 
population (National Diabetes Statistics Report, 2014). Minority racial/ethnic groups have higher 
rates of diabetes than non-Hispanic whites, with Native Americans having the highest rate at 
nearly 16%, followed by African American (13.2%), Hispanics (12.8%), Asian Americans (9%) 
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and Caucasians (7.6%). Each year, approximately 1.4 million people are diagnosed with either 
type 1 or type 2 diabetes, making it the nation’s seventh leading cause of death in 2010. The cost 
of diabetes in America in 2012 was approximately $245 billion, which included about $69 billion 
in indirect costs related to impairment, job loss, and premature death. 
In recent years, due to modern healthcare technology, a large amount of data from various 
sources, such as patient care, as well as compliance and regulatory requirements has become 
available [4]. The digitization of this data has been happening rapidly in the recent years [5]. The 
extensive availability of healthcare data, as well as advances in the area of data mining and 
machine learning, has generated the interesting field of healthcare analytics. The development of 
decision support systems by data analysts with the aid of clinical experts’ knowledge has eased 
the burden on physicians and clinicians and smoothed clinical procedures. Analyzing healthcare 
data and applying machine learning techniques in this area have several benefits: patients can be 
stratified based on the severity of a particular disease or condition and, consequently, suitable 
treatments can be provided for each group; risk factors of different diseases can be identified, 
leading potentially to better health management; and diseases can be detected at early stages, 
allowing for appropriate interventions and treatments. For a comprehensive discussion about 
healthcare analytics, its promises and its potentials we refer readers to [5]. 
Similar to other domains, three types of analytics can be conducted in healthcare: descriptive, 
predictive, and prescriptive. Most of the analytics projects start with descriptive analytics [6]. 
Descriptive analytics tells us what has happened in the past and what is going on at the present. In 
descriptive analytics, hypotheses are tested, and trends are identified. Descriptive analytics could 
lead to discovering interesting patterns in the data. The next step in analytics is predictive 
analytics. Predictive analytics tells us what is going to happen in the future. In predictive 
analytics, by using statistical and machine learning models to analyze historical data, the 
relationship between the target and predictors can be detected [7]. The final step in an analytics 
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project is prescriptive analytics. In this step, analysts use optimization techniques to identify the 
best course of action. In Figure 1.1, different levels of analytics can be seen [8]. 
 
Figure 1.1- Three analytics levels-descriptive, predictive, and prescriptive. Adopted from Real-World Data 
Mining: Applied Business Analytics and Decision Making, by D. Delen, 2015: FT Press (a Pearson Publishing 
Company). Adapted with permission 
Discovering the affinities and associations among various items has long been of interest to 
managers and data analysts. Association rule mining (or market basket analysis in the marketing 
and business literature) is a data mining method that aims to reveal the association/affinity 
patterns/rules among various items (objects or events) that occur together. We can enumerate 
several implications for association rule mining. In the retail industry, it facilitates finding 
solutions for assortment planning, coupon design, and product discounting [9]. In health care 
settings, association rule mining may help answer questions such as whether the presence of a 
particular health condition increases the probability of developing other conditions and which 
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preventive measures could best reduce risk of complications. These questions can be addressed 
through an understanding of the associations among different complications. 
One critical challenge in healthcare domain is detecting the disease in early stages. One of the 
major complications of diabetes that has not received enough attention is diabetic retinopathy. 
This complication is the most common cause of vision loss among people with diabetes and a 
leading cause of blindness for American adults. According to the 2014 National Diabetes 
Statistics Report, between the years 2005 and 2008, 4.2 million of American diabetics aged 40 or 
older suffered from diabetic retinopathy. Among patients who have had diabetes for up to 20 
years, almost all type І and more than 60% of type ІІ diabetics develop retinopathy [10]. This 
complication is caused by damage to the blood vessels of retina, the light-sensitive tissue at the 
back of the eye. At its early stages, diabetic retinopathy may be asymptomatic or only show mild 
vision problems, but if it is not diagnosed and treated in time, it can eventually cause blindness. 
Another challenge that data analysts face in the healthcare domain as in many other domains is 
dealing with imbalanced datasets. A dataset is called imbalanced when the distribution of 
different classes in the data is not similar. For instance, in the case of two-class data, there are 
many more examples of one class (negative examples) compared to the other class (positive 
examples). Let us call the class with fewer examples the minority class, and the class with more 
examples the majority class. The imbalanced datasets are very common in real-life problems, 
especially in pattern recognition problems. For example, if a sample of people were tested for a 
specific disease, only a small portion of them would actually have the disease. Another example 
is credit card fraud detection where only a few numbers of transactions in the whole sample of 
transactions are actually fraud [11].   
In imbalanced datasets, the prediction accuracy, especially for the minority class, is a critical 
challenge. When the standard machine learning techniques are applied to the imbalanced data, the 
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result will be in favor of the majority class, i.e. a big portion of the minority class examples will 
be classified as the majority. In real world applications, the detection accuracy of the minority 
class is critically important because the minority class usually is the class of interest. Thus, 
misclassifying the minority class has much higher cost compared to misclassifying a majority 
class example. To make it clearer, compare the cost of misclassifying a cancerous patient as non-
cancerous to the cost of misclassifying a non-cancerous as cancerous; in the former case, the 
misclassification may lead to death of a person but in the latter case, there will be some more tests 
and screenings. 
1.2. Problem Statements 
One of the most critical problems in association rule mining is the rare item problem. This 
problem emerges when there are items that occur rarely compared to items that are more frequent. 
For instance, in retail, purchases of items such as electronics or jewelry are likely rarer than 
grocery purchases. Rare items, however, may be equally as important as frequent items or even 
more so. In health care, some complications may not be as frequent as other complications, but 
they may be more critical or even fatal. Therefore, it is important to recognize and discover the 
association patterns among rare items as well as the association patterns between rare and 
frequent items. Any association rule that includes a rare item is called a rare rule. Discovering 
rare rules is a critical challenge in association analysis. In classical association rule mining, a 
minimum support is specified to extract the association rules. Support of a rule specifies the 
fraction of a population for which the rule is true. Setting a high threshold for support may lead to 
losing rare association rules. On the other hand, specifying a low threshold for support will lead 
to over generating association rules. Therefore, the problem statement is “how to retrieve and 
discover rare association rules without over-generating association rules?” 
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Diabetes typically leads to several complications, often presenting simultaneously. The American 
Diabetes Association (ADA) classifies these conditions as: skin complications, eye complications 
(retinopathy), neurological manifestations (neuropathy), foot complications, diabetic ketoacidosis 
(DKA) and ketones, renal manifestations (nephropathy), high blood pressure (hypertension), 
stroke, hyperosmolar hyperglycemic nonketotic syndrome (HHNS), gastroparesis, heart disease, 
stroke, and mental health. The existence of more than one distinct condition in a patient is defined 
as comorbidity [12]. Comorbidity is highly prevalent in diabetics. Research shows that between 
1999 and 2004, only 14% of type 2 diabetic patients were not diagnosed with any additional 
comorbid conditions [13]. The benefit of considering comorbidities as opposed to studying 
different diseases in isolation has been showed by many researchers ([14], [15], [16], [17], and 
[18]). The high prevalence of comorbid conditions among diabetics and the benefits of studying 
comorbidities shown by other researchers motivated us to study the comorbidity in diabetes and 
conduct association analysis among its complications. The problem statement here is “is there any 
strong and interesting association among complications of diabetes?” 
Although retinopathy is preventable and existing treatments can slow down the disease progress, 
vision loss that happens in the late stages of retinopathy cannot be restored. Thus, it is critical to 
diagnose this complication as early as possible. The current method for diagnosing diabetic 
retinopathy is a comprehensive eye examination in which after a patient’s eye is dilated, an 
ophthalmologist examines the retina with an indirect ophthalmoscope and a special lens. 
Unfortunately, and despite the high prevalence of retinopathy, the annual diabetic retinopathy 
evaluation has one of the lowest rates of patient compliance for several reasons. First, many 
patients do not seek proper medical attention because this disease is asymptomatic at the early 
stages; second, availability of ophthalmologists is low or even nonexistent in many areas, 
especially in rural communities; and third, many patients find the necessary eye dilation 
unpleasant. Because of this low compliance rate, about 50% of patients with diabetic retinopathy 
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are undiagnosed (National Eye Institute report, 2015). Therefore, the rising prevalence of 
diabetes, coupled with barriers to ophthalmological screenings that lead to a high rate of 
undiagnosed diabetic retinopathy patients, create an urgent need for a tool to detect this 
complication. To be useful, this tool should be non-invasive, readily available to diabetic patients, 
validated on a large number of cases, and eliminate the need for specialized equipment that is not 
universally available. This study sets out to employ an analytics approach on data collected 
during routine primary care visits to fills this gap. Specifically, we build a clinical decision 
support system (CDSS) for prediction of diabetic retinopathy that satisfies the aforementioned 
requirements for diagnostic tools. Our problem statement in this research topic is “How to detect 
diabetic retinopathy at early stages when retina images are not available?” 
To develop the CDSS for diabetic retinopathy, we have applied several machine learning 
techniques such as neural networks, logistic regression, decision tree and random forest. 
Ensemble models are learning approaches that combine multiple single classifiers and then make 
the final classification decision by an averaging or voting mechanism [19]. Use of ensemble 
models in several studies in the literature, including the studies that used lab and demographic 
data to predict diabetic retinopathy, points out to the complexity of this problem domain. 
Ensemble models have the benefit of being more robust than single models [20], and therefore, 
improve prediction accuracy. For this reason, we also employ an ensemble modeling approach in 
developing our CDSS. Specifically, we develop a heterogeneous confidence margin ensemble 
and illustrate how it outperforms the existing ensemble techniques. In this research topic, the 
problem statement is “how to improve the prediction accuracy of single classifiers through 
developing an efficient ensemble approach?” 
There are various remedies for the imbalanced data learning problem. One of these remedies is to 
modify the imbalance ratio in the dataset. Decreasing the imbalanced ratio can be achieved 
through either under-sampling the majority class, i.e. removing some portion of data that belong 
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to the majority class; or over-sampling the minority class, i.e. generating synthetic data points that 
belong to the minority class. In this research topic, the problem statement is “how to address the 
problem of learning from imbalanced data, by developing an efficient over-sampling algorithm?” 
1.3. Research Objectives 
Our research objectives in this dissertation are as follows, 
 Developing a new assessment metric to discover rare rules in association analysis 
 Discovering the potential existing associations among complications of diabetes by 
applying association analysis 
 Developing a CDSS to detect diabetic retinopathy using lab data collected during a routine 
diabetic primary care visit 
 Developing a novel ensemble approach to further improve the prediction accuracy of single 
classifiers 
 Developing an over-sampling algorithm embedded into support vector machine to enhance 
the performance of machine learning techniques when applied to imbalanced datasets 
 
1.4. Contributions 
In this research, we have three topics. First topic is “developing a new metric to identify rare 
patterns in association analysis: the case of analyzing diabetic complications”. Second topic in 
this dissertation is “a data mining approach to build a clinical decision support system for diabetic 
retinopathy: developing and deploying a model ensemble”. Finally, the third topic is “developing 
a synthetic informative minority over-sampling (SIMO) algorithm embedded into support vector 
machine to learn from imbalanced datasets.” 
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In the first research topic, our contributions to the fields of decision support systems and medical 
informatics are twofold. At the methodological level, we introduced adjusted_support, a new 
assessment metric for association rule mining that addresses the rare item problem. By using 
adjusted_support, we will be able to address the problem of rare items by extracting rare rules 
without over-generating association rules. At the application level, we performed association rule 
mining on the complications of diabetes by applying the adjusted_support metric. Our findings in 
this research shed light on the association patterns among diabetes complications, which has not 
received enough attention in the literature. 
Second research study contributes to the data mining and medical decision support literatures 
from three perspectives: methodology, data management, and application. In the methodological 
aspect, we develop and evaluate a novel approach in building ensemble models. This approach 
aggregates the predictions of individual models by calculating a weighted confidence margin 
across all models. However, in contrast to the existing weighted averaging ensembles that assign 
weights to individual models based on their overall prediction performance, our confidence 
margin ensemble assigns varying weights to the constituting models. These weights are 
calculated for each observation in the data and are based on the distance between the estimated 
probabilities of records and the decision cut off point. We show how this approach improves the 
accuracy of decisions made by our CDSS. From the data management perspective, we processed 
a very large transactional database of clinical encounters and aggregated the observations at the 
patient level. This enabled us to create a single data set containing comorbid conditions of 
patients to develop an accurate picture of their health status. Consequently, our CDSS is able to 
consider a larger number of risk factors and provides a more realistic depiction of the coexistence 
of chronic diseases. Finally, in the application aspect, we develop an accessible, easy-to-
implement, and inexpensive solution to the currently high proportion of undiagnosed retinopahty 
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among diabetics. This CDSS reduces direct and indirect medical costs of the healthcare system in 
the US and more importantly, saves eyesight for a large number of citizens. 
In the third research topic, we propose a novel over-sampling algorithm integrated with support 
vector machine (SVM). We can numerate several advantages for our proposed algorithm. First, it 
is embedded into a powerful classifier, i.e. SVM, and therefore better results are expected 
compared to other pre-processing approaches. Second, we conduct over-sampling rather than 
under-sampling that may lead to information loss due to discarding a fraction of data. Finally, we 
perform the over-sampling only on the informative minority examples. In this way, we generate 
the least amount of synthetic data points; therefore, the distribution of the training data will not 
change dramatically. In addition, because the amount of synthetic generated data is much less 
compared to other existing methods such as SMOTE, Borderline SMOTE, Safe-Level SMOTE, 
and Cluster-SMOTE, the computational cost of training machine learning techniques will be 
lower. 
1.5. Organization of the Dissertation 
The remainder of this dissertation is organized as follows. The second chapter contains the 
literature review on the three topics that are covered in this research. The third chapter presents 
the association analysis method and its implementation on diabetes complication. In Chapter 4, 
different stages of developing a CDSS for diabetic retinopathy is described and the results of the 
developed predictive and ensemble models are provided. Chapter 5 presents our developed over-
sampling algorithm, SIMO. This algorithm is evaluated compared to other existing approaches 
and the results are provided in Chapter 5. Finally, in Chapter 6, we summarize and conclude the 
dissertation.
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CHAPTER II 
 
 
LITERATURE REVIEW 
 
 
 
In this chapter, we review the related literatures for the research topics in this study. First, we 
provide the literature review for association analysis and the rare rule problem. We also review 
the studies related to the application of association analysis on diabetes complications. Then, we 
discuss the related studies to the diabetic retinopathy CDSSs and ensemble models. Finally, we 
review the studies in the domain of imbalanced data learning. 
2.1. Rare Rules Association Analysis: The Case of Diabetes Complications 
In recent years, the application of analytics and data mining in health care has received much 
attention. Although association analysis has been one of the popular data mining methods applied 
to health care data, its application to studies of diabetes complications, especially rare 
complications, is still limited. Agrawal, et al. [9] introduced association analysis for the first time. 
They studied associations among items in a large customer transaction dataset. Following their 
work, association analysis has been applied to many domains, such as bioinformatics ([21], [22], 
[23]), social domain ([24], [25], [26]), and earth science ([27], [28]).
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One of the components of association analysis is assessing rules such that only the most useful 
ones are retained. Several assessment measures, termed interestingness metrics, exist for 
evaluating rules and filtering out the least useful. Two traditional measures, support and 
confidence, will be described in detail in Chapter 3. Several other interestingness metrics for 
association rules were introduced by researchers, such as h-confidence by Xiong, et al. [29],  
NConf by Liu, et al. [30] and relative-confidence by Yan, et al. [31]. Tan, et al. [32] extensively 
reviewed 21 metrics for association patterns and described their usefulness in different 
application areas. Various association analysis techniques and their properties were reviewed by 
Kotsiantis and Kanellopoulos [33]. 
Rare item problem is one of the important challenges in association analysis. Theoretically 
studying the rare item problem in association analysis started by Liu, et al. [34]. They proposed a 
multiple min-support approach in which every item in the data has its own min item support 
(MIS). MIS is specified by comparing a lowest allowable support and the support of the item 
times a parameter, 𝛽. In this way, rare items have lower min-support compared to frequent items, 
thus they will not be ignored in the rule generation procedure. There are two are main downsides 
of this approach. First, specifying MIS when the number of items in the dataset is large is a 
tedious job, and second, determining the optimal value of 𝛽 is not easy. To address these issues, 
Yun, et al. [35] introduced relative support. Their formula does not include the parameter 𝛽, 
therefore they did not have the challenge of determining the optimal value for 𝛽. Nevertheless, 
their approach still requires specifying multiple suitable min-support for various itemsets. 
Wang, et al. [36] also introduced a framework to address the rare item problem. Similar to the 
two previously mentioned studies, they assigned different min-support to various itemsets by 
tracking the dependency chain of itemsets in generating the itemset. While other multi min-
support approaches focus on the frequency of items, the approach developed by Seno and Karypis 
[37] focuses on the length of the itemset, i.e., the itemsets with more items have lower min-
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support while itemsets with fewer items have higher min-support. Any-confidence, all-
confidence, and bond were introduced by Omiecinski [38] as alternatives for supports in rare item 
association analysis. Adjusted_support is similar to any-confidence in 2-item rules. These metrics 
are effective for rules that all items are rare, but they are not effective for rules containing both 
rare and frequent items. Kiran and Re [39] proposed an improved multiple min-support approach 
for extracting the rare association rules. Their approach requires specifying multiple minimum 
support, which is inconvenient compared to a single minimum adjusted_support in real-world 
application. For a comprehensive review of existing methods and metrics for rare item association 
analysis, we refer readers to [40].  
Several researchers have applied association analysis to diabetes. Simon, et al. [41], Simon, et al. 
[42], Ramezankhani, et al. [43], and Kamalesh, et al. [44] applied association analysis to assess 
the risk of developing diabetes. Shin, et al. [45] analyzed the data of 5,022 patients diagnosed 
with essential hypertension and Valent, et al. [46] analyzed the data of 9,358 diabetic patients. By 
applying association analysis, they showed that essential hypertension and diabetes mellitus were 
strongly associated. This result is not surprising since about 71% of diabetic patients have 
hypertension [3]; thus, this association pattern cannot be considered very useful or interesting. 
Kim, et al. [47] analyzed the data of 20,314 diabetic patients in South Korea and assessed the 
associations among various diseases and type 2 diabetes. They found strong associations between 
diabetes and hypertension; diabetes, hypertension, and stroke; and diabetes, hypertension, and 
dyslipidemia. However, the relatively small number of patients as well as the limitation of race to 
Asians diminishes the reliability and generalizability of their results. Therefore, there is an urgent 
need for a comprehensive study of the associations among diabetes complications using a large 
dataset that represents the diversity of diabetic patients. Our study fills this gap in the literature by 
performing association analysis on complications associated with diabetes and introducing a new 
interestingness assessment metric that captures both rare and frequent association patterns.  
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2.2. CDSS for Diabetic Retinopathy 
Even though CDSSs based on EMR data have been broadly used by practitioners in recent years, 
its implementation in the field of ophthalmology is still limited [48]. This dearth exists while 
several researchers have studied the relationship between diabetic retinopathy and different 
potential risk factors. For instance, Karma, et al. [49] studied the existence of diabetic retinopathy 
in 328 diabetic patients using ophthalmoscopy and wide field fundus photography and tried to 
identify the association between diabetes duration and other risk factors, such as nephropathy and 
coronary disease. In another study, Klein, et al. [50] measured the relationship between 
retinopathy and hyperglycemia by studying 1878 diabetics. 
Most of the existing CDSSs for diabetic retinopathy use image processing algorithms. While 
these algorithms facilitate early detection of diabetic retinopathy, they require an image of the 
retina. Therefore, although they ease the burden of assessing the images of retina, they fail to 
address the evident barrier of patients’ access to specialists. Examples of studies that belong to 
this category are (Kahai, et al. [51], Paunksnis, et al. [52], Marsolo, et al. [53], Tsai, et al. [54], 
Noronha, et al. [55] Bursell, et al. [56], Kumar and Madheswaran [57], and Xiao, et al. [58]). We 
refer the readers to Mookiah, et al. [59] for a comprehensive review of research in this category.  
The other category of CDSSs for diabetic retinopathy includes those matched with lenses or an 
ophthalmoscope that can be used on a smartphone. Prasanna, et al. [60] proposed a portable 
smartphone-based CDSS that requires attaching an ophthalmoscope to a smartphone to capture 
fundus images, and captured images will be processed by the algorithm installed on the 
smartphone. Bourouis, et al. [61] also proposed a smartphone-based algorithm integrated with 
microscopic lenses used to capture retinal images. Their CDSS uses a neural network model to 
analyze such images and provide the results. Despite all the benefits of these algorithms, 
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additional equipment is still required for retinal imaging, which, for many diabetics and primary 
care providers, may be cost-prohibitive or unavailable.  
Many research projects have studied the association of retinopathy and different lab tests. For 
instance, the association of retinopathy and hemoglobin A1c has been shown in several studies 
([62], [63], [64]). Researchers have also studied the relationship between cholesterol and 
retinopathy and have found the two to be related ([65], [66]). The Diabetes Control and 
Complications Trial (DCCT) and the U.K. Prospective Diabetes Study (UKPDS) have shown that 
controlling the glucose level could reduce the risk of retinopathy [67]. Other studies have shown 
that retinopathy and hypertension are associated [68]. Besides blood tests, some urine tests such 
as proteinuria are shown to be associated with retinopathy [69]. 
While these studies show the potential for developing tools that can detect or predict retinopathy 
using lab results, only a few studies have used lab and demographic data to detect diabetic 
retinopathy without requiring retinal imaging. Skevofilakas, et al. [70] developed a CDSS using 
data from 55 type І diabetic patients to predict the risk of diabetic retinopathy. They applied 
classification-based Rule Induction with C5.0, Hybrid Wavelet Neural Network (HWNN), 
Classification and Regression Tree (CART), and neural network, and merged their results using a 
voting mechanism. In another work, Balakrishnan, et al. [71] used data from 140 diabetic patients 
in Malaysia to build a diabetic retinopathy predictive system, which employed a voting 
mechanism to select the final outcome from the results of decision tree and case-based reasoning 
(CBR).  
Although these two research projects did not use any retinal images to predict the risk of diabetic 
retinopathy, they are limited in a number of ways. First, they are based on small samples (55 in 
the first and 140 patients in the second study). Second, they consider a limited number of risk 
factors. These charactreistics not only contribute to lack of a comprehensive image of the 
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patients’ health status, but also make the final results less generalizable. Additionally, while 
according to the NIH statistics, 95% of the diabetics are type ІІ, the first study has only focused 
on type I diabetic patients. Research shows between 74.9% to 82.3% of type I diabetics have 
retinopathy [72]. Therefore, the baseline model for predicting retinopathy among type I diabetics 
will have an accuracy of about 80%. Moreover, almost all type І diabetic patients who have had 
the disease for 20 years develop this vision complication. Thus, despite the first study’s high 
accuracy (98%) in predicting retinopathy among type I diabetic patients, it does not address the 
more important problem of detecting retinopathy in type II diabetics. This limitation is addressed 
in the second study, but with an overall accuracy of 85%, it leaves room for improvement. 
Therefore, another promise of the current effort is to develop a model that addresses the 
limitations of the extant literature, while improving upon their results.  
Ensemble models for supervised learning were first introduced by Tukey [73] and have since 
been studied by many researchers. At a high level, there are two categories of ensemble models: 
homogeneous and heterogeneous ensembles. Homogeneous ensembles combine multiple 
variations of a single classifier technique. Ensembles in this category use such algorithms as 
Bagging and AdaBoost to manipulate the training dataset and to develop multiple training 
datasets. These training datasets will be used by a data mining technique such as decision tree, 
and at the end, a voting or averaging mechanism will be used to make the final prediction using 
the outputs of single classifiers [19]. One of the most famous ensemble models in this category is 
random forest. Heterogeneous ensembles, on the other hand, combine various single classifiers 
(that are built using different data mining techniques) on the same training dataset. Simple 
average, weighted average, and voting based ensembles belong to this category [74]. A 
comprehensive review of ensemble techniques can be found in Rokach [75]. In this study, we 
developed a novel heterogeneous ensemble approach that will be explained in Chapter 4. 
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2.3. Imbalanced Data Learning Algorithms 
Studying the imbalanced data classification has received a considerable amount of attention in 
recent years. He and Garcia [76] classified the different approaches of analyzing imbalanced data 
into four main classes, 
- Sampling methods 
- Cost-sensitive methods 
- Kernel-based methods and active learning methods 
- Other methods such as, one-class learning, novelty detection, etc. 
Sampling methods: The aim of the sampling methods is to reach some degree of balanced 
distribution in the dataset. These methods can be categorized into two major streams, those that 
under-sample the majority class and those that over-sample the minority class. In under-sampling 
methods, some parts of the majority examples are removed. As a result, the distribution of the 
classes will be more balanced. The simplest method in this category is the random under-
sampling. There is not any specific mechanism for under-sampling in this approach and it 
functions merely randomly. Other under-sampling approaches such as BalancedCascade and 
EasyEnsemble presented by Liu, et al. [77] are called informed under-sampling. In 
EasyEnsemble, several samples of the majority class data are taken and combined with minority 
class data. Multiple models are built based on these datasets, and at the end an ensemble model 
makes the final decision. The main criticism of the under-sampling methods is that by removing 
some parts of the data, potential important information in the data can be lost.  
Over-sampling on the other hand, is to re-sample or generate extra examples of the minority 
class. The most basic over-sampling method is random over-sampling in which minority 
examples in the data are randomly duplicated. The main downside of random over-sampling is 
over-fitting. Another major approach in over-sampling is synthetic data generation. SMOTE 
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(Synthetic Minority Over-Sampling Technique) is one of the most well-known methods in 
synthetic data generation. In this method, synthetic data points are generated on the line 
connecting the minority samples to their k nearest minority class neighbors [78]. The major 
drawback in SMOTE is that it may lead to over-generalization.  
There are extensions to the SMOTE that tried to improve the performance of this technique. Han, 
et al. [79] proposed a synthetic over-sampling method named Borderline-SMOTE. In this 
method, only a subset of minority data points is over-sampled by SMOTE technique. Those 
minority data points are located near the border of two classes. Borderline minority data points 
are identified as minority examples that most of their nearest neighbors belong to the majority 
class. On the other hand, Bunkhumpornpat, et al. [80] introduced a method named Safe-Level 
SMOTE. This method calculates a parameter called safe-level. The greater that a safe-level is for 
a minority example shows that example is farther away from the borderline. After identifying the 
minority examples in safe regions, those data points will be over-sampled using SMOTE. Cieslak, 
et al. [81] introduced the cluster SMOTE method. This method first clusters the minority 
examples, and then over-samples data points within each cluster by applying SMOTE. 
Barua, et al. [82] proposed a majority weighted minority oversampling technique that first 
identifies hard to learn minority examples by considering their distance from the majority 
neighbors, and then it over-samples those examples using a clustering approach. There are other 
studies in the area of synthetic data generation  ([79], [83], and [84]). Generally speaking, 
synthetic oversampling significantly improves the classification accuracy, especially for the 
minority class. Another advantage is that by generating the synthetic minority data (not simply 
replicating existing minority data), the minority region is generalized and overfitting can be 
avoided [85]. For a more comprehensive review of the sampling methods, we refer readers to He 
and Garcia [76]. 
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Cost-sensitive methods: Unlike sampling methods that alter the distribution of the data through 
either generating synthetic minority data points or removing some portion of majority data points, 
the idea of cost-sensitive methods is based on the different misclassification costs for different 
classes in the dataset. Usually the cost of misclassifying the minority class is much higher than 
the majority class misclassification [86]. To perform cost-sensitive methods, a matrix, called cost 
matrix is required. This matrix shows the misclassification cost for different classes in the dataset 
[87]. The main concern about cost-sensitive methods is that in most of the situations the exact 
misclassification cost related to various classes is unknown [88]. 
There are three major categories in cost sensitive approaches [76]. The first category includes 
techniques that assign various weights to the examples in the dataspace. Methods in this category 
are motivated by the AdaBoost algorithm [89]. AdaBoost is a meta-algorithm that begins with the 
original dataset and trains a model on this dataset. Incorrectly classified examples are identified, 
and in the next iteration more weight (higher error cost) will be assigned to them. In this way, 
more focus will be on the examples that are misclassified. This process repeats and the classifier 
performance improves. The second group encompasses approaches are those that use ensemble 
schemes integrated with cost-sensitive approaches. Many of the research studies in these two 
categories have combined various weighting and adaptive boosting techniques. For instance Sun, 
et al. [90] and Fan, et al. [91] proposed algorithms for updating the weights in AdaBoost in 
imbalanced data learning. Lee, et al. [92] used SVM to adjust the weights of the examples in 
AdaBoost to learn from imbalanced data. In the third category, cost-sensitive methods incorporate 
the misclassification costs directly into the classifiers. Cost-sensitive decision tree [93], cost-
sensitive neural networks [94], and cost-sensitive SVM [95] are in this category. 
Kernel-based methods: Kernel-based methods are mostly integrated with SVM. Many researchers 
have studied imbalanced data learning through support vector machine. Wu and Chang [96] 
developed a boundary-alignment algorithm, which makes a change in the kernel function to move 
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the boundary toward the negative instances. Akbani, et al. [97] proposed an algorithm by 
integrating the different error cost method [95] and the SMOTE over-sampling method, however 
they performed the SMOTE over-sampling independent from the SVM model. Wang and 
Japkowicz [98] applied boosting and asymmetric error cost for minority and majority classes. 
Mathew, et al. [99] proposed a kernel-based SMOTE for SVM. In their approach, the over-
sampling through the SMOTE technique happens in kernel feature space. Yu, et al. [100] 
developed the SVM-OTHR algorithm. In this algorithm, they adjusted the decision threshold by 
moving the decision hyperplane toward the majority class data. 
Tang and Zhang [101] proposed a granular SVM with repetitive under-sampling. They utilized 
SVM for under-sampling in a way that they repeatedly developed SVM models and each time 
discarded the negative (majority class) support vectors from the data. Even though they 
performed the under-sampling integrated with the SVM, the problem of losing potential 
important information by under-sampling still exists. As Akbani, et al. [97] showed in their paper, 
under-sampling the majority class may decrease the total error, but it usually deteriorates the 
performance of the SVM on the test data, because it fails to approximate the orientation of the 
ideal hyperplane. Batuwita and Palade [102] suggested an over-sampling method in which they 
selected the majority examples near the boundary as the informative negative data points, and 
then they randomly over-sampled the minority examples to have relatively balanced data. This 
work can be critiqued in two ways. First, they focused on the informative majority examples, 
while the primary interest in imbalanced datasets is on the minority examples, therefore the focus 
on the informative majority examples may lead to even more bias toward the majority class. 
Second, they simply applied random over-sampling that is not as powerful as synthetic data 
generation methods and may lead to over-fitting. The two former studies did not compare their 
model’s performance with other exiting methods; therefore, it is not easy to comment on 
generalizability and efficiency of their model. [103] proposed a preprocessing approach using 
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SVM for imbalanced data. In their approach, they first trained SVM on the original data, and then 
replaced the actual target variable value by the SVM predicted value. They claimed that SVM 
will classify a portion of the majority examples as minority, and therefore the processed data will 
have a more balanced distribution. Their claim is questionable, because in imbalanced data 
learning most of the time there is poor accuracy on minority class and good accuracy on majority. 
This means that most of the minority examples are misclassified as majority not the other way 
around. They tested their approach only on one dataset; therefore, their results could be because 
of the characteristics of that special dataset. 
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CHAPTER III 
 
 
DEVELOPMENT OF A NEW METRIC TO IDENTIFY RARE PATTERNS IN 
ASSOCIATION ANALYSIS: THE CASE OF ANALYZING DIABETES COMPLICATIONS 
 
 
 
In this chapter, we present the methodology of association analysis and our developed metric, 
adjusted_support. Following that we provide the results of applying adjusted_support and 
association analysis to complications of diabetes. The number of co-existing complications 
among diabetic patients could be a meaningful index to evaluate their health status. In this study, 
we defined comorbidity index as the mean number of co-exiting complications in a diabetic 
patient. Besides association analysis, we also performed a comorbidity analysis on diabetic 
patients by calculating their comorbidity index and compared the comorbidity index of patients in 
different demographic groups. This analysis will provide insight on the comorbidity status of 
diabetics at a more granular level and can lead to better decision making by healthcare 
administrative professionals and clinicians. In addition, we studied the prevalence of diabetes 
complications among various demographic groups.
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3.1. Methodology 
In this section, we start with briefly describing association analysis, define its common 
parameters and metrics, and explain the algorithmic extent of our proposed rare item/patterns 
identification metric.  
Let 𝐼 = {𝑖1, 𝑖2, … , 𝑖𝑛} be the set of all items (in our study, items are various diabetes 
complications), and 𝑅 = {𝑟1, 𝑟2, … , 𝑟𝑁} be the set of all records in our data (each record 
corresponds to each patient and contains the patient’s complications). Let 𝑋 be a subset of 𝐼, i.e., 
a subset of items (diabetes complications), then 𝑋 is called an itemset (𝑋 = {𝑖1, 𝑖2, … , 𝑖𝑘). An 
itemset with 𝑘 items is called k-itemset. Every record, 𝑟𝑖, includes a subset of items 
(complications) in 𝐼, thus each 𝑟𝑖 is an itemset (𝑟𝑖 ⊆ 𝐼). Suppose itemset 𝑋 contains the following 
complications: retinopathy, nephropathy, and neuropathy. The support count for 𝑋 is the number 
of records that include items in 𝑋. The support count for 𝑋 is denoted by 𝑠𝑢𝑝𝑝𝑜𝑟𝑡_𝑐𝑜𝑢𝑛𝑡(𝑋), and 
is calculated as in Equation 3.1. 
𝑠𝑢𝑝𝑝𝑜𝑟𝑡_𝑐𝑜𝑢𝑛𝑡(𝑋) = |{𝑟𝑖|𝑋 ⊆ 𝑟𝑖, 𝑟𝑖 ∈ 𝑅}| (3.1) 
 Where |.|, denotes the cardinality of a set. 
An association rule is defined as 𝑋 ⟶ 𝑌, where 𝑋 and 𝑌 are itemsets and their intersection is ∅. 
When the number of items (in our case, the number of complications) increases, the number of 
generated rules grows exponentially. As a result, generated association rules should be evaluated 
and useful rules identified. Two sets of assessment measures, objective and subjective, can be 
applied to selecting beneficial and interesting rules [104]. We describe these measures in the 
following sections. 
Objective Measures 
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In this category, there are two major classical assessment metrics to evaluate an association rule’s 
strength: support and confidence. The support of an association rule is the occurrence probability 
of the rule among all records, or, in our study, the proportion of patients for which the rule is true. 
It is calculated as in Equation 3.2. 
 𝑆𝑢𝑝𝑝𝑜𝑟𝑡 (𝑋 ⟶ 𝑌) =
𝑠𝑢𝑝𝑝𝑜𝑟𝑡_𝑐𝑜𝑢𝑛𝑡(𝑋∪𝑌)
𝑁
 (3.2) 
In traditional association analysis, a minimum support is specified before generating rules. When 
rare (infrequent) items exist in the data, this approach is inefficient. A high min-support will lead 
to elimination of all rules containing any rare item, and a low min-support will lead to over-
generating rules that may not be interesting enough. Therefore, a new assessment metric is 
required that can simultaneously solve the problem of eliminating rare items and over-generating 
uninteresting rules. In this study, we introduce a new assessment metric termed adjusted_support. 
It is calculated as shown in Equation 3.3. 
𝐴𝑑𝑗𝑢𝑠𝑡𝑒𝑑_𝑆𝑢𝑝𝑝𝑜𝑟𝑡 (𝑋 ⟶ 𝑌) =
𝑠𝑢𝑝𝑝𝑜𝑟𝑡_𝑐𝑜𝑢𝑛𝑡(𝑋∪𝑌)
𝑀𝑖𝑛 {𝑠𝑢𝑝𝑝𝑜𝑟𝑡_𝑐𝑜𝑢𝑛𝑡(𝑋),   𝑠𝑢𝑝𝑝𝑜𝑟𝑡_𝑐𝑜𝑢𝑛𝑡(𝑌)}
 (3.3) 
The calculation of adjusted_support begins by comparing the number of records with items in X 
(left hand side of rule) to the number of records with items in Y (right hand side of rule) and 
selecting the smallest group. Using the selected group, the proportion of records with items in 
both X and Y (patients that are diagnosed with the complications in both X and Y) is calculated. 
To calculate the adjusted_support, instead of considering the entirety of patients’ records, we 
focus on a subset of records in order to capture the rare association rules. When a rare item 
(complication) exists in a rule, the denominator of the adjusted_support will be a small number, 
and, as a result, adjusted_support will be large enough to satisfy the minimum adjusted_support 
condition. For the frequent rules, the adjusted_support still will be large enough because these 
rules will have a large numerator. Therefore, by considering a single pre-specified minimum 
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adjusted_support, both rare and frequent association rules can be discovered and extracted from 
the data. Here we provide a simple example to describe the adjusted_support more clearly. 
Suppose we have a hypothetical dataset with the following characteristics (Table 3.1): 
Table 3.1-Hypothetical Dataset H (Total number of the records=5000) 
Itemset Support count of the itemset 
Retinopathy (𝑿𝟏) 1800 
Nephropathy (𝑿𝟐) 2000 
Gastroparesis (𝑿𝟑) 200 
Retinopathy, Nephropathy 500 
Retinopathy, Gastroparesis 80 
Nephropathy, Gastroparesis 5 
Consider the following association rules and their calculated support and adjusted_support in Table 
3.2: 
Table 3.2- Generated rules from dataset H 
No. Rule Support  Adjusted_support 
1 𝑋1 ⟶ 𝑋2 500 5000⁄ = 0.10 500 𝑀𝑖𝑛(1800, 2000)⁄ = 0.28 
2 𝑋1 ⟶ 𝑋3 80 5000⁄ = 0.016 80 𝑀𝑖𝑛(1800,200)⁄ = 0.40 
3 𝑋2 ⟶ 𝑋3 5 5000⁄ = 0.001 5 𝑀𝑖𝑛(2000,200)⁄ = 0.025 
Suppose both minimum support and adjusted_support are specified as 5%. In this case, rule 
number 1 passes both criteria and rule number 3 passes neither of them. However, without 
considering adjusted_support, rule number 2 will not be selected, but obviously there is a strong 
association between 𝑋1 and 𝑋3. By considering adjusted_support as the assessment metric, this 
rule will be selected as a strong and interesting rule. Therefore, we can see that adjusted_support 
is effective in all cases, i.e., capturing both strong rare and frequent rules (rules 2 and 1) and 
removing weak rules (rule 3). 
The next measure that we used is confidence. The confidence of a rule measures how often 
records include items in Y, given they include items in X (in our case, how often patients have the 
complications in 𝑌 (right hand side of rule) when they are diagnosed with complications in 𝑋 (left 
hand side of rule)). For instance, a confidence of 60% means that 60% of the patients with 
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complications in X also have complications in Y. Thus, a rule with higher confidence is more 
dependable. The calculation of confidence is shown in Equation 3.4. 
 𝐶𝑜𝑛𝑓𝑖𝑑𝑒𝑛𝑐𝑒 (𝑋 ⟶ 𝑌) =
𝑠𝑢𝑝𝑝𝑜𝑟𝑡_𝑐𝑜𝑢𝑛𝑡(𝑋∪𝑌)
𝑠𝑢𝑝𝑝𝑜𝑟𝑡_𝑐𝑜𝑢𝑛𝑡(𝑋)
 (3.4) 
As can be seen in Equations 3.2 and 3.3, support and adjusted_support are commutative 
operations, i.e., 𝑆𝑢𝑝𝑝𝑜𝑟𝑡 (𝑋 ⟶ 𝑌) = 𝑆𝑢𝑝𝑝𝑜𝑟𝑡 (𝑌 ⟶ 𝑋) and 𝐴𝑑𝑗𝑢𝑠𝑡𝑒𝑑_𝑆𝑢𝑝𝑝𝑜𝑟𝑡 (𝑋 ⟶ 𝑌) =
𝐴𝑑𝑗𝑢𝑠𝑡𝑒𝑑_𝑆𝑢𝑝𝑝𝑜𝑟𝑡 (𝑌 ⟶ 𝑋). However, confidence is not a commutative operation, i.e., if the 
direction of a rule changes, its confidence will also change. 
Only considering support, adjusted_support, and confidence for evaluating an association rule 
might be misleading. Lift is a metric that considers both confidence and support concepts at the 
same time. Lift, also called improvement, is calculated as in Equation 3.5. 
 𝐿𝑖𝑓𝑡 (𝑋 ⟶ 𝑌) =
𝐶𝑜𝑛𝑓𝑖𝑑𝑒𝑛𝑐𝑒 (𝑋⟶𝑌)
𝑆𝑢𝑝𝑝𝑜𝑟𝑡(𝑌)
 (3.5) 
Lift measures the usefulness of a rule compared to a random guess. Suppose we have a rule such 
as 𝑑𝑖𝑎𝑏𝑒𝑡𝑖𝑐 𝑛𝑒𝑢𝑟𝑜𝑝𝑎𝑡ℎ𝑦 ⟶ 𝑑𝑖𝑎𝑏𝑒𝑡𝑖𝑐 𝑟𝑒𝑡𝑖𝑛𝑜𝑝𝑎𝑡ℎ𝑦. If the lift of this rule is 3, it means that the 
chance of a diabetic neuropathy patient having diabetic retinopathy is 3 times higher than a 
random diabetic patient. Rules with lift higher than 1 are considered as useful rules. Lift is also a 
commutative operation; we can mathematically show this property of the lift as follows, 
 
𝐿𝑖𝑓𝑡 (𝑋 ⟶ 𝑌) =
𝐶𝑜𝑛𝑓𝑖𝑑𝑒𝑛𝑐𝑒 (𝑋⟶𝑌)
𝑆𝑢𝑝𝑝𝑜𝑟𝑡(𝑌)
=
𝑠𝑢𝑝𝑝𝑜𝑟𝑡_𝑐𝑜𝑢𝑛𝑡(𝑋∪𝑌)
𝑠𝑢𝑝𝑝𝑜𝑟𝑡_𝑐𝑜𝑢𝑛𝑡(𝑋)
𝑠𝑢𝑝𝑝𝑜𝑟𝑡_𝑐𝑜𝑢𝑛𝑡(𝑌)
𝑁
=
𝑠𝑢𝑝𝑝𝑜𝑟𝑡_𝑐𝑜𝑢𝑛𝑡(𝑋∪𝑌)𝑁
𝑠𝑢𝑝𝑝𝑜𝑟𝑡_𝑐𝑜𝑢𝑛𝑡(𝑋)𝑠𝑢𝑝𝑝𝑜𝑟𝑡_𝑐𝑜𝑢𝑛𝑡(𝑌)
 (3.6) 
𝐿𝑖𝑓𝑡 (𝑌 ⟶ 𝑋) =
𝐶𝑜𝑛𝑓𝑖𝑑𝑒𝑛𝑐𝑒 (𝑌⟶𝑋)
𝑆𝑢𝑝𝑝𝑜𝑟𝑡(𝑋)
=
𝑠𝑢𝑝𝑝𝑜𝑟𝑡_𝑐𝑜𝑢𝑛𝑡(𝑌∪𝑋)
𝑠𝑢𝑝𝑝𝑜𝑟𝑡_𝑐𝑜𝑢𝑛𝑡(𝑌)
𝑠𝑢𝑝𝑝𝑜𝑟𝑡_𝑐𝑜𝑢𝑛𝑡(𝑋)
𝑁
=
𝑠𝑢𝑝𝑝𝑜𝑟𝑡_𝑐𝑜𝑢𝑛𝑡(𝑌∪𝑋)𝑁
𝑠𝑢𝑝𝑝𝑜𝑟𝑡_𝑐𝑜𝑢𝑛𝑡(𝑋)𝑠𝑢𝑝𝑝𝑜𝑟𝑡_𝑐𝑜𝑢𝑛𝑡(𝑌)
 (3.7) 
from (3.6), (3.7), and 𝑠𝑢𝑝𝑝𝑜𝑟𝑡_𝑐𝑜𝑢𝑛𝑡(𝑋 ∪ 𝑌) = 𝑠𝑢𝑝𝑝𝑜𝑟𝑡_𝑐𝑜𝑢𝑛𝑡(𝑌 ∪ 𝑋) 
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⇒ 𝐿𝑖𝑓𝑡 (𝑋 ⟶ 𝑌) = 𝐿𝑖𝑓𝑡 (𝑌 ⟶ 𝑋)  (3.8) 
Subjective Measures 
Subjective measures are based on subjective reasoning. We call an association rule subjectively 
interesting, if it unveils interesting and unexpected patterns in the data. For instance, discovering 
the strong association between diabetic retinopathy and ophthalmic complications of diabetes is 
expected because they are both eye-related diseases. An association rule such as 
"𝑑𝑖𝑎𝑏𝑒𝑡𝑖𝑐 𝑟𝑒𝑡𝑖𝑛𝑜𝑝𝑎𝑡ℎ𝑦 ⟶ 𝑜𝑝ℎ𝑡ℎ𝑎𝑙𝑚𝑖𝑐 𝑐𝑜𝑚𝑝𝑙𝑖𝑐𝑎𝑡𝑖𝑜𝑛" may have high support, 
adjusted_support, confidence, and lift, but this rule does not uncover any interesting and 
unexpected pattern in the data and therefore, does not help physicians in diagnosis and treatment. 
Evaluating an association rule via subjective measures requires domain knowledge, and a data 
analyst cannot assess an association rule subjectively by herself without consulting domain 
experts. 
It is important to note that association rules should not be interpreted as cause and effect. These 
rules only illustrate associations, not causality [47]. For example, in this study associations 
represent the co-existence of different complications. Therefore, a strong association between two 
complications in a rule does not in and of itself indicate any causality, but it can point to the need 
for future research on the causal nature of related complications. 
Data Preparation 
Data for this study came from the Cerner Health Facts data warehouse, one of the largest 
commercial databases of electronic medical records (EMR) in the U.S. For research purposes, 
data are de-identified in accordance with HIPAA requirements and are linked through unique 
identifiers. Each admission has information recorded for patient demographics, admission source, 
diagnoses, procedures, drugs dispensed, laboratory test results, and billing and primary payer. At 
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the time of this study, Health Facts contained data for more than 58 million unique patients, about 
84 million patient visits, over 320 million prescriptions, and about 2.4 billion clinical lab results 
that were collected since 2000 from 480 affiliated hospitals and hospital systems across the 
nation. 
For this study, we extracted admission and diagnosis data for diabetes and its complications for 
patient visits between September 1999 and January 2016. The first dataset included 2,317,259 
unique diabetic patients with various complications. Among them, 624,810 were only diagnosed 
with diabetes, and 1,086,005 had only essential hypertension co-existing with diabetes (here we 
need to note that all of the patients in our study were diagnosed with diabetes or one of its 
complications, and among them 1,502,946 patients had hypertension that could be co-existing 
with other diabetes complications). Because the number of these two conditions were extremely 
large compared to the other diabetes complications, and also more than 70% of diabetics are 
known to have hypertension, patients diagnosed with only diabetes and/or hypertension i.e., the 
diabetic patients without other diabetes complications were excluded from the association 
analysis. Diabetes and related complications were defined by International Classification of 
Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) and by the ICD, Tenth Revision 
(ICD-10-CM). In the data, among various diagnosis for diabetic patients, there were two 
diagnoses as “Other specified manifestations” and “Unspecified complication”. Since these two 
diagnosis (complications) did not have any specific and clear meaning, we removed the records 
for them for the data. The final dataset included 492,025 unique patients with diabetes and 
associated complications. The number of unique patient/complication in the dataset was 753,733. 
The size of our dataset compared to the existing literature in the field is much larger, thus the 
output of our analysis is expected to be more dependable. Table 3.3 illustrates the distribution of 
diabetes complications in our data. The complications used in this study were selected based on 
the ICD 9 and ICD 10 classification for diabetes complications. Although diabetic patients may 
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have other complications, these conditions were outside the scope of this study and therefore not 
included in the analysis. 
Table 3.3-Diabetes complications count and percentage in the data 
Complication Frequency Count Frequency Percentage 
Neurological manifestations (Neuro) 202634 26.88 
Renal manifestations (Renal) 122882 16.30 
Stroke 79985 10.61 
Ophthalmic manifestations (Ophthal) 74198 9.84 
Retinopathy (Retino) 61046 8.10 
Peripheral circulatory disorder (PCD) 53804 7.14 
Ketoacidosis (Keto) 49661 6.59 
Heart Disease (Heart) 43007 5.71 
Gastroparesis (Gastro) 30032 3.98 
Diabetes with hyperglycemia (Hyper-g) 14886 1.97 
Hyperosmolarity (Hyperos) 14530 1.93 
Other coma (Coma) 3213 0.43 
Skin complications (Skin) 2154 0.29 
Diabetes with hypoglycemia (Hypo-g) 1427 0.19 
Diabetic Arthropathy (Arthro) 264 0.04 
Oral complications (Oral) 10 0.00 
ICD-10 diagnosis codes, which went into effect October 1, 2015, are more granular than ICD 9 
codes. Because ICD-10 has been implemented for a relatively short time, there are limited 
numbers of records for the more granulated diagnosis. For instance, in ICD 9 the code 250.8 is 
described as “diabetes with other specified manifestations”; while in ICD 10, under the E10.6 (or 
E11.6) which is for diabetes with other specified manifestations, there are diabetic arthropathy, 
skin complications, oral complications, diabetes with hypoglycemia, and diabetes with 
hyperglycemia. Thus, as can be seen in Table 3.3, the number of patients diagnosed with diabetic 
arthropathy, skin complications, oral complications, diabetes with hypoglycemia, and diabetes 
with hyperglycemia are too small.  
To prepare the data, we needed to perform several steps such as merging tables, creating new 
variables, and changing the structure of the data tables. In the final dataset, we needed a patient 
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identifier and a complication in each row. Therefore, patients with multiple co-existing 
complications had multiple records in the final dataset. Figure 3.1 shows the structure of the final 
dataset used for the association analysis. 
 
Figure 3.1- Final dataset structure 
3.2. Results 
In this section, we first present the results of the comorbidity index analysis in different 
demographic groups of patients. Following that, we compare the prevalence of major diabetes 
complications in different demographic groups. Finally, we represent the results of the association 
analysis among diabetes complications. 
Comorbidity Index Analysis 
In this study, we calculated what we have termed comorbidity index, which is the mean number 
of complications. The overall index value for the study population was 1.53. Because of the large 
proportion of diabetic patients with hypertension, we excluded it from our analysis, therefore, the 
inclusion of hypertension and diabetes itself increases the index value by 2 points to 3.53. Table 
3.4 shows index values and descriptive statistics for the racial/ethnic groups examined in this 
study. 
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Table 3.4-Comorbidity index value by race/ethnicity   
Race/Ethnicity 
Num. of 
Observations 
Percentage Mean Maximum 
Lower 
95% CI  
Upper 
95% CI 
Whole Population 492025 100% 1.53 11 1.529 1.535 
Biracial 557 0.11% 1.76 9 1.667 1.859 
African American 101582 20.65% 1.66 10 1.650 1.663 
Hispanic 7434 1.51% 1.62 8 1.598 1.646 
Native American 5394 1.10% 1.59 8 1.567 1.621 
Caucasian 302801 61.54% 1.51 11 1.502 1.509 
Asian 7145 1.45% 1.50 7 1.482 1.525 
Other 14207 2.89% 1.47 9 1.451 1.481 
Middle Eastern Indian 103 0.02% 1.45 6 1.281 1.612 
Pacific Islander 443 0.09% 1.41 5 1.329 1.484 
Asian/Pacific Islander 129 0.03% 1.32 3 1.211 1.424 
Missing 52230 10.62% 1.45 8 1.439 1.454 
As can be seen in Table 3.4 and Figure 3.2, biracial patients had highest index value with an 
average of 1.76 complications. African American, Hispanic, and Native American patients all had 
index values above the population average. Asian/Pacific Islander patients had the lowest index 
value at 1.32. 
 
Figure 3.2- Comorbidity index value by race/ethnicity 
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Table 3.5- Comorbidity index value in rural vs urban diabetic patients 
Urban/Rural 
Status 
Num. of 
Observations 
Percentage Mean Maximum 
Lower 95% 
CI  
Upper 95% 
CI 
Whole 
Population 
492025 100% 1.53 11 1.529 1.535 
Rural 99628 20.25% 1.52 11 1.511 1.523 
Urban 391087 79.49% 1.54 10 1.534 1.540 
Missing 1310 0.27% 1.27 5 1.241 1.292 
 
 Table 3.5 and Figure 3.3a depict the comorbidity index of rural and urban diabetics. Urban 
patients had slightly higher number of co-exiting complications and this difference was statistically 
meaningful at the level of 95%. Comorbidity index was not statistically different between males 
and females as is demonstrated in Table 3.6 and Figure 3.3b. 
Table 3.6-Comorbidity index value by gender  
Gender 
Num. of 
Observations 
Percentage Mean Maximum 
Lower 95% 
CI  
Upper 95% 
CI 
Whole 
Population 
492025 100% 1.53 11 1.529 1.535 
Female 231924 47.14% 1.54 10 1.535 1.543 
Male 233391 47.43% 1.53 11 1.528 1.536 
Missing 26710 5.43% 1.47 8 1.460 1.481 
                    
Figure 3.3a              Figure 3.3b   
Figure 3.3a- Comorbidity index value in rural vs urban diabetic patients 
Figure 3.3b- Comorbidity index value by gender 
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Diabetes Complications Prevalence in Different Demographic Groups 
In this section, we compare the prevalence of major diabetes complication by demographic 
groups. Figures 3.4a and 3.4b demonstrate the racial/ethnic prevalence of complications. 
Caucasians had the highest prevalence of neurological manifestations and heart disease, while 
renal manifestations were highest among Asians. Strokes were more prevalent among African 
Americans, and Native Americans suffered from the highest rates of ophthalmic manifestations, 
retinopathy, and hyperglycemia. Ketoacidosis and gastroparesis were most common in Hispanics, 
and hyperosmolarity was more prevalent in African American and Asian patients than other 
races. 
 
Figure 3.4a-Diabetes complications' prevalence by race/ethnicity 
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Figure 3.4b- Diabetes complications' prevalence by race/ethnicity 
Figure 3.5 compares the prevalence of diabetes complications among rural versus urban patients. 
Based on our analysis, neurological manifestations, stroke, heart disease, and gastroparesis were 
more prevalent among patients in urban areas compared to rural areas. On the other hand, renal 
manifestations, ophthalmic manifestations, retinopathy, peripheral circularity disorder, and 
hyperglycemia had a higher prevalence in rural compared to urban areas. Rates of other 
complications were similar for both rural and urban areas. 
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Figure 3.5-Diabetes complications' prevalence: rural versus urban 
A comparison of complications between males and females is shown in Figure 3.6. Neurological 
manifestations, stroke, ophthalmic manifestations, retinopathy, and gastroparesis were more 
prevalent among women than men, while renal manifestations, peripheral circularity disorder, and 
heart disease were more common in men. Rates of other complications were similar for both 
groups. 
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Figure 3.6-Diabetes complications' prevalence: females versus males 
Association Analysis Results 
The results of the association analysis among the major diabetes complications are provided in 
this section. We first performed association analysis on the entire study population followed by 
analyses for each demographic group. We first evaluated each set of generated rules based on 
objective measures (support, adjusted_support, and lift), and second, by consulting clinical 
experts, we assessed the rules subjectively. All rules shown in Tables 3.7, 3.8a, 3.8b, 3.8c, and 
3.8d were strong two-item rules, which means they passed the thresholds for the objective 
measures. All of these rules had the following characteristics: 
𝐴𝑑𝑗𝑢𝑠𝑡𝑒𝑑_𝑆𝑢𝑝𝑝𝑜𝑟𝑡 ≥ 10% 
𝐿𝑖𝑓𝑡 ≥ 1 
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Since all of the presented rules met thresholds for adjusted_support and confidence, we compared 
rules using lift and sorted them in the following tables by lift values. As described in Section 3.1, 
any rule with lift greater than 1 is considered useful rule, which means that rule provides extra 
information that helps better decision making. 
Table 3.7- Two-item association rules- general population 
No. Rule Support (%) Adjusted_Support (%) Lift 
1 Hypo_g ==> Hyper_g 0.06 20.95 6.93 
2 Ophthal ==> Retino 11.38 91.71 6.08 
3 Skin ==> Hyper_g 0.07 16.53 5.46 
4 Hypo_g ==> Heart 0.07 24.95 2.86 
5 Coma ==> Keto 0.16 23.90 2.37 
6 Skin ==> PCD 0.11 24.14 2.21 
7 Skin ==> Heart 0.07 16.62 1.90 
8 Hyperos ==> Keto 0.52 17.63 1.75 
9 Arthro ==> Neuro 0.04 70.83 1.72 
10 Hyper_g ==> Heart 0.45 14.83 1.70 
11 Neuro ==> Gastro 4.16 68.08 1.66 
12 Renal ==> Retino 4.70 37.90 1.52 
13 Gastro ==> Keto 0.88 14.37 1.43 
14 Renal ==> Ophthal 5.33 35.37 1.42 
15 Skin ==> Neuro 0.25 57.06 1.39 
16 Gastro ==> Retino 1.04 16.98 1.37 
Even though all of the rules in Table 3.7 were objectively strong, some were not subjectively 
interesting or meaningful. For example, rule “Hypo_g ==> Hyper_g” shows a strong association 
between “diabetes with hypoglycemia” and “diabetes with hyperglycemia” and values for 
adjusted_support, confidence, and lift exceeding threshold values. However, this rule is not very 
insightful as hospitalized diabetics may experience both high and low glycemic levels due to their 
medications. Another rule that appeared to objectively meaningful but was not subjectively 
interesting was “Ophthal ==> Retino.” Both items in the rule (ophthalmic manifestations and 
retinopathy) are eye-related complications; therefore, discovering a strong association between 
two closely related complications would be expected and, subsequently, of little use for 
clinicians.  
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As the results in Table 3.7 show, diabetic patients with skin complications had a high potential of 
also being diagnosed with hyperglycemia, peripheral circulatory disorder, heart disease, and 
neurological manifestations. Hypoglycemia was strongly associated with heart disease as 
demonstrated by rule 4, which shows diabetics with hyperglycemia were 2.86 times more likely 
to develop heart disease than the general population of diabetic patients. Rule 8 shows that 
diabetics with hyperosmolarity were 1.75 times more likely to have ketoacidosis. Based on rules 
9 and 11, neurological manifestations were strongly associated with diabetic arthropathy and 
gastroparesis. Diabetics with renal manifestations (rules 12 and 14) were 1.52 and 1.42 times 
more likely to have retinopathy and ophthalmic manifestations compared to random diabetic 
patients. 
According to the results presented in Table 3.8a, the association between neurological 
manifestations and gastroparesis was much stronger among African American diabetics compared 
to general diabetics’ population. Besides that, African American diabetics diagnosed with other 
coma, were about two times more likely to have hyperosmolarity compared to a random African 
American diabetic, but we did not discover this association rule in general diabetics’ population. 
In addition, there was a strong association between hypoglycemia and gastroparesis among 
African Americans while there was not such association among general population of diabetics. 
In Hispanic diabetic population, we could find a couple of differences compared to general 
population (Table 3.8b). For instance, the association between neurological manifestation and 
gastroparesis was stronger (lift of 1.90 versus 1.66). However, the association of other coma and 
ketoacidosis among Hispanics was weaker compared to general population, lift for the rule 
“Coma ==> Keto” was 1.45, while lift for the same rule in general population was 2.37. 
We could discover some association rules among Native American diabetics that we did not 
observe in general population (Table 3.8c). The association rule “Gastro ==> PCD” was one of 
them that shows the association between gastroparesis and peripheral circularity disorder. The 
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other one was the association between neurological manifestations and peripheral circularity 
disorder (rule number 6 in Table 3.8c). Besides these two rules that did not exist in general 
population, there were other rules with significantly different degree of strength. For instance, 
rules “Skin ==> PCD”, “Neuro ==> Gastro”, and “Skin ==> Neuro” were stronger among Native 
Americans, but rule “Skin ==> Hyper_g” was weaker among them compared to the general 
population. 
Two-item association rules in race/ethnicity groups that were different from general population  
Table 3.8a- African Americans 
No. Rule Support (%) Adjusted_Support (%) Lift 
1 Neuro ==> Gastro 5.55 73.53 2.03 
2 Coma ==> Hyperos 0.08 11.02 1.99 
3 Hypo_g ==> Gastro 0.05 14.09 1.87 
Table 3.8b- Hispanics 
No. Rule Support (%) Adjusted_Support (%) Lift 
1 Neuro ==> Gastro 6.42 76.82 1.90 
2 Coma ==> Keto 0.14 20.34 1.45 
Table 3.8c- Native Americans 
No. Rule Support (%) Adjusted_Support (%) Lift 
1 Skin ==> Hyper_g 0.19 27.45 4.12 
2 Skin ==> PCD 0.21 29.41 3.67 
3 Neuro ==> Gastro 3.59 74.29 2.15 
4 Skin ==> Neuro 0.44 62.75 1.81 
5 Gastro ==> PCD 0.55 11.43 1.43 
6 Neuro ==> PCD 3.84 47.85 1.38 
Table 3.8d- Asians 
No. Rule Support (%) Adjusted_Support (%) Lift 
1 Arthro ==> Hyperos 0.01 50.00 13.92 
2 Hypo_g ==> Heart 0.09 41.18 5.63 
3 Skin ==> Heart 0.05 28.57 3.91 
4 Skin ==> PCD 0.05 28.57 3.29 
5 Arthro ==> Retino 0.01 50.00 3.09 
6 Arthro ==> Renal 0.03 100.00 2.61 
7 Gastro ==> Neuro 2.47 65.98 2.44 
8 Skin ==> Neuro 0.10 57.14 2.11 
9 Skin ==> Ophthal 0.06 35.71 1.80 
10 Hypo_g ==> PCD 0.03 11.76 1.35 
11 Hypo_g ==> Neuro 0.08 35.29 1.30 
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Among Asian diabetics, we found several association rules that did not exist in general 
population (Table 3.8d). Diabetic arthropathy patients were extremely likely to have 
hyperosmolarity and that was about 14 times more likely compared to a random Asian diabetic. 
The same group of patients (Asians with diabetic arthropathy), were at a very high risk of having 
retinopathy and renal manifestations (rules number 6 and 7 in Table 3.8d). Among Asians, 
hypoglycemia was strongly associated with both peripheral circularity disorder and neurological 
manifestations, associations that we did not recognize in the general diabetics’ population. 
Besides these new rules, there were multiple rules that were significantly stronger form their 
counterparts in general population. Rules number 2, 3, 4, 7, 8, and 9 in Table 3.8d were in that 
category. 
Association analysis in rural and urban diabetic patients revealed some difference between these 
two groups. The strength of several association rules were significantly different comparing the 
rural and urban patients. The following rules were stronger among rural diabetic patients: 
“Hypo_g ==> Heart”, “Arthro ==> Neuro”, “Neuro ==> Gastro”, “Skin ==> Neuro”. On the 
other hand, these rules had greater lift among urban patients: “Skin ==> Hyper_g”, “Coma ==> 
Keto”, “Hyperos ==> Keto”, “Hyper_g ==> Heart”, “Renal ==> Retino”, “Gastro ==> Keto, 
“Gastro ==> Retino”. Other than these strength differences, there was an association between 
hypoglycemia and ketoacidosis among urban diabetics while we did not observe such an 
association among rural diabetic patients. Association patterns among female and male diabetics 
were different in some rules. The association rule “Hypo_g ==> Gastro” which was discovered 
among female diabetics, was not captured in male patients. Several rules had significantly 
different strength comparing female and male diabetics. For instance, rules “Skin ==> Heart” and 
“Skin ==> PCD” were stronger among females. And rules “Skin ==> Hyper_g”, “Hyperos ==> 
Keto”, “Arthro ==> Neuro”, “Hyper_g ==> Heart”, “Keto ==> Gastro”, and “Gastro ==> Retino” 
had higher degree of strength among male diabetic patients. 
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Association rules can include more than two items. So far, what we showed in Tables 3.7, 3.8a, 
3.8b, 3.8c, and 3.8d, all were two-item rules. But, in Table 3.9, we present three-item association 
rules among diabetes complications in general population of diabetics. As it is clear form a 
comparison between the results in Tables 3.7 and 3.9, the lift of the three-item rules was much 
greater than the lift of the two-item association rules. The reason is that more items in an 
association rules, conveys more information, and as a results we expect to have stronger rules. 
For instance, compare the rule number 3 in Table 3.7, to the rule number 5 in Table 3.9. These 
two rules had the following characteristics: 
Skin ==> Hyper_g,    lift= 5.46 
Skin & PCD ==> Hyper-g,   lift= 8.01 
In the second association rule, we had more information and that was the knowledge about the 
existence of both PCD and skin complications, therefore the likelihood of having hyperglycemia 
was about 2.5 times higher with this extra information. Other rules in the Table 3.9 can be 
compared to their counterpart two-item rules in Table 3.7. Similar to previous rules in Tables 3.7, 
3.8a, 3.8b, 3.8c, and 3.8d, three-item rules must be assessed with subjective measures as well as 
objective ones. For instance, rule number 3, because of the existence of hyperglycemia and 
hypoglycemia at two sides of the rule, and rule number 8, because of the existence of ophthalmic 
manifestations and retinopathy at two sides of the rule, failed to pass the subjective assessment. 
There were other rules that did not pass the subjective measure, thus are not shown in Table 3.9. 
The same analysis has been performed for higher number of items in association rules and also 
for different demographic groups, but because of the space limitation we did not provide the 
results in this manuscript, but they would be available upon request.   
Based on what we observed in all of the tables representing the association rules, there were 
numerous association rules that would not be discovered if we did not used the adjusted_support. 
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The value of support in many of these rules was even less than 1%, but they had high enough 
adjusted_support to be selected, and the results showed those rules had high lift values that is 
indicator of their usefulness. 
Table 3.9-Three-item association rules- general population 
No. Rule Support (%) Adjusted_Support (%) Lift 
1 PCD & Hyper-g ==> Skin 0.03 20.69 47.26 
2 Skin ==> Neuro & Hyper-g 0.05 12.12 17.73 
3 Neuro & Hypo-g ==> Hyper-g 0.03 31.21 10.32 
4 Skin & Heart ==> Hyper-g 0.02 28.49 9.42 
5 Skin & PCD ==> Hyper-g 0.03 24.23 8.01 
6 Skin & Renal ==> Hyper-g 0.02 23.87 7.89 
7 Skin ==> Neuro & Heart 0.05 11.37 7.36 
8 Ophthal & Gastro ==> Retino 1.01 89.41 7.21 
9 Skin & Neuro ==> Hyper-g 0.05 21.24 7.02 
10 Hypo-g ==> Neuro & Heart 0.03 10.02 6.48 
11 Gastro ==> Neuro & Keto 0.77 37.90 6.22 
12 Coma & Gastro ==> Keto 0.03 57.20 5.68 
13 Retino & Keto ==> Gastro 0.25 33.21 5.45 
14 Ophthal & Keto ==> Gastro 0.27 31.47 5.16 
15 Retino & Coma ==> Gastro 0.02 31.38 5.15 
16 Hyperos & Gastro ==> Keto 0.11 50.61 5.02 
17 Keto & Heart ==> Hyperos 0.02 14.48 4.91 
18 Coma & Ophthal ==> Gastro 0.02 28.14 4.62 
19 Coma & Neuro ==> Gastro 0.05 27.55 4.52 
20 Renal & Keto ==> Gastro 0.31 27.49 4.51 
 
3.3. Discussion and Conclusion 
The application of data analytics in health care has led to discovering insightful and interesting 
information that can lead to advances in health care delivery [5]. The rapid advances in data 
science coupled with the growing amount of available data in all aspects of the health care 
industry make health care analytics even more efficient and beneficiary. In this study, we tried to 
add to the data mining literature by introducing the adjusted_support in rare item association 
analysis, and to the health care analytics literature by performing comorbidity and association 
analysis among major complications of diabetes. 
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Several research studies have shown the impact of comorbidity on the management of diabetes. 
Poor management of comorbidity may lead to ineffective control of the disease and subsequent 
increases in both mortality rates and treatment costs ([105], [106]).  The comparison of 
comorbidity index values, showed that among racial/ethnic groups, Biracial, African Americans, 
Hispanics, and Native Americans had the highest number of comorbid complications. Moreover, 
Pacific Islanders, Middle Eastern Indians, Asians, and Caucasians had the lowest comorbidity 
index values, respectively. These results show a potential effective comorbidity management 
among Biracial, African Americans, Hispanics, and Native Americans and more attention should 
be paid to these races for a better disease control.  
The next step in this study was taking a closer look at different diabetes complications prevalence 
among various demographic groups. Knowledge about the prevalence of complications among 
different groups of patients at more granular levels has several benefits. First, it could help policy 
makers to provide more effective high-level plans. For instance, if we know there is a higher rate 
of retinopathy among Native Americans compared to other races, it could be the indication of low 
level of ophthalmic care management among that race, thus necessary actions can be taken. 
Second, it would help the researchers to study relationships between genetic characteristics of 
people and different diseases. Third, it could help clinicians to provide targeted treatments and 
interventions for specific groups of patients. Based on the results of our study, neurological 
manifestations and heart disease were more prevalent among Caucasians, renal disease and 
hyperosmolarity were more prevalent among Asians, stroke and hyperosmolarity had the highest 
prevalence among African Americans, eye related diseases and hyperglycemia were more 
common among Native Americans, and Hispanics had the highest prevalence in ketoacidosis and 
gastroparesis compared to other races. By comparing diabetics in urban versus rural areas, we 
reached to these results: neurological manifestations, stroke, heart disease, and gastroparesis were 
more prevalent among urban patients; and renal manifestations, ophthalmic manifestations, 
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retinopathy, peripheral circularity disorder, and hyperglycemia had a higher prevalence among 
diabetics in rural areas. Between different genders, females had higher rates of diagnosis with 
neurological manifestations, stroke, ophthalmic manifestations, retinopathy, and gastroparesis 
compared to males; and males were diagnosed with renal manifestations, peripheral circularity 
disorder, and heart disease more often compared to females.  
Our methodological contribution in this research topic was addressing the rare item problem. To 
address this problem, we proposed a new objective metric for association rules and called it 
adjusted_support. By considering adjusted_support instead of support that has been used in 
traditional association analysis, we could capture the rare association rules from the data without 
over generating the useless association rules. We performed association analysis both in general 
diabetics’ population as well as various demographic groups for better understanding of the 
association patterns among complications in those demographic groups. The knowledge about the 
association among complications of diabetes can facilitate the diagnosing of different 
complication of diabetes, it also can be a hint to study the scientific reasons behind those 
associations, and last but not the least it could lead to better management of diabetes and its 
comorbid complications.  
All of the generated rules in our analysis were assessed by both objective and subjective metrics. 
For objective assessment, we used our proposed metric, adjusted_support beside support and lift. 
In addition, for subjective assessment we consulted with our medical advisors. Based on our 
results, skin complication was strongly associated with hyperglycemia, Peripheral circulatory 
disorder, heart disease, and neurological manifestations. Hyperosmolarity co-existed with 
ketoacidosis very often. Neurological manifestations co-existed with diabetic arthropathy and 
gastroparesis very frequently. Diabetics with renal manifestations were highly potential of 
suffering from eye related disease such as retinopathy. Finally, gastroparesis was strongly 
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associated with both ketoacidosis and retinopathy. The results of the association analysis are 
provided in Section 3.2 in various demographic groups in more details. 
Similar to any other research, we faced some limitations in this study. First, the scope of our 
research was limited to the complications of diabetes that are specified in ICD 9 and ICD 10. 
Therefore, other disease that patients may have been diagnosed with, were not considered in our 
study. Perhaps including those potential existing complications would lead to even more 
insightful findings. Another limitation was related to the nature of EHR data. Because these types 
of dataset are collected for reasons other than the purpose of this research, they may lack some 
degree of accuracy, for instance, some of the complications of a patient may not be recorded in 
her visit. However, the large amount of the data that was available in our study can compensate 
this limitation. 
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CHAPTER IV 
 
 
A DATA ANALYTICS APPROACH TO BUILDING A CLINICAL DECISION SUPPORT 
SYSTEM FOR DIABETIC RETINOPATHY: DEVELOPING AND DEPLOYING A MODEL 
ENSEMBLE 
 
 
 
In this chapter, we explain various steps of developing the CDSS for diabetic retinopathy. We 
also present our proposed ensemble approach, confidence margin and assess its performance in 
comparison with existing ensemble methods. We expect that the CDSS we develop in this effort 
will be able to detect diabetic retinopathy at its early stages with a high degree of accuracy. This 
CDSS, which relies exclusively on lab data, not only helps overcome one of the major barriers to 
the early diagnosis of diabetic retinopathy, but also provides a new standard of care that will 
improve quality and increase compliance in healthcare without raising costs. 
4.1. Methodology 
Data cleaning and preprocessing is a very important aspect in any comprehensive data analytics 
study. This is even more important in healthcare analytics, especially when real-world EMR data 
is involved—because the data are captured and stored in different clinical/hospital settings and 
47 
 
for reasons other than data analytics [107]. Hence, in this study, data preparation was taken very 
seriously. 
Dara Preprocessing 
The data used for this research was obtained from the Cerner Corporation’s Health Facts data 
warehouse; a comprehensive, relational repository of real-world, de-identified, and HIPAA-
compliant patient data. A simplified conceptual data diagram of the Cerner Health Facts data 
warehouse is presented in Figure 4.1. 
Processing and analyzing large EMR datasets involves various challenges. Jagadish, et al. [108] 
classify these challenges into five categories: data acquisition; information extraction and 
cleaning; data integration, aggregation, and representation; modeling and analysis; and 
interpretation. Regarding the large number of variables in the data warehouse, we spent a 
significant amount of time to understand the purpose and relevance of each variable. An even 
more demanding step in preparing the dataset for final analysis was aggregrating the records at 
the patient level and integrating patients’ comorbid conditions. Hence,  information extraction 
and cleaning, together with data integration, aggregation, and representation constituted the 
majority of our data preprocessing efforts.  
The nature of EMR data posed yet another difficulty to this study. Because EMR data is collected 
for purposes other than performing data analytics, it suffers from mutiple defficiencies. First, 
since EMR data is collected from several facilities around the country, it lacks integrity and 
consistency. For instance, different units or even naming might be used in different hospitals. 
Second, data missingness or incompleteness, which are endemic in EMR data, need to be 
addressed. And third, outliers and other data entry errors are prevalent in EMR data. We describe 
the approach we used in the data preparation step to address these challenges later in this section. 
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Figure 4.1- A simplified conceptual data model for Cerner Health Facts data warehouse 
For the purpose of this research, we extracted data of more than 1.4 million unique diabetic 
patients from approximately 5.3 million visits. Since the number of variables collected from 
different data tables was rather large (300+), we needed to take many data selection, aggregation, 
and preparation steps. 
First, data from all tables (e.g., encounter, patient, lab procedure, clinical event, etc.) for diabetes 
diagnosis and all associated complications, such as diabetic neuropathy, nephropathy, and 
retinopathy, were extracted. The table that included the lab procedure data was very important in 
this regard. The first dataset extracted from this table for diabetic patients included more than 800 
different lab procedures. This primary dataset was very sparse, since not every patient had all of 
these lab results. We dropped those lab procedures that lacked sufficient results in the data. After 
taking several data cleaning steps, 88 lab procedures remained. Because EMR data are collected 
from hundreds of facilities across the United States, different names may be used for the same lab 
procedures. We consulted with clinical experts and merged identical lab procedures into one 
variable. As a result of this step, 58 lab procedures remained in our dataset. 
The lab procedure table contained a column labeled “lab_procedure_name” that included all lab 
procedures for individual visits (encounters). We transposed this table so that each lab procedure 
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had its own column. This increased the number of columns in the lab procedure table from 35 to 
about 100. Since every patient at each visit (hospital stay) could have multiple results for the 
same lab procedure, we retained the last result as consultations with physicians and clinical 
experts suggested these values could be considered the stable condition for a patient. Moreover, 
because our focus was on developing a CDSS for the early detection of retinopathy, we selected 
each patient’s first chronological visit to increase the validity and generalizability of our findings.  
In the next step, we used table keys (i.e., “Patient_ID,” “Encounter_ID,” and “Diagnosis_ID”) to 
join data from multiple tables into a single table that included lab results, demographic data, and 
diagnosis data, with each record representing an individual diabetic patient. The resulting table 
included data from over 300,000 unique patients. Figure 4.2 depicts different data preparation 
steps in our study. 
Data Data
Raw Data
Data Preprocessing 3
ü Merging tables
ü Selecting first visits
Prepared 
Data
Data Preprocessing 
2 (Other Tables)
ü Cleaning
ü Selecting
ü Transforming
Data Preprocessing 1 (Lab 
Procedure )
ü Selecting populated lab tests
ü Aggregating same lab tests 
with different names
ü Transposing the table 
 
Figure 4.2- Data preparation steps 
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Modeling Procedure 
To develop the predictive models, we employed logistic regression, decision tree, random forest, 
and artificial neural networks. Building each of these models was preceded by various data 
manipulation steps, including transforming variables to approximate a normal distribution, 
replacing and filtering extreme data points, and applying different imputation methods, and at the 
end, we compared the results. The modeling procedure is shown in Figure 4.3. 
The target variable was a binary variable, where 0 denoted no diabetic retinopathy diagnosis and 
1 denoted diabetic retinopathy diagnosis. Diabetic patients without a retinopathy diagnosis were 
included as the control group. The final dataset was largely imbalanced. In fact, we may face 
imbalanced data in several real world problems: fraud detection, oil-spill detection, and medical 
applications (Kubat, et al. [109], Rao, et al. [110], Chan, et al. [111]). The majority class in the 
dataset was diabetic patients without retinopathy (95%), and our class of interest, diabetics with 
retinopathy (5%), was the minority class. The main challenge in analyzing imbalanced datasets is 
that the performance of most standard machine learning techniques will be poor in terms of 
identifying the target variable [112]. Therefore, a balanced dataset is necessary to develop 
predictive models with high accuracy. Since there were a reasonable number of retinopathy 
patients in the minority class (about 15,000 patients), we created a balanced dataset by randomly 
under-sampling the majority class. The next step was to partition the data into training and 
validation datasets to objectively assess the different model types. In the following section, we 
provide a brief description of each of the modeling techniques used in this study. 
Modeling Techniques 
Logistic regression: Logistic regression is a classic statistical model. This method is capable of 
predicting and classifying categorical variables, but is mostly used for binary variables [113]. It is 
an extended version of linear regression, but instead of modeling a continuous value, binary 
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logistic regression models the log odds of the probability of an event, as opposed to its 
occurrence, as a linear function of the predictors.  
Selection methods are often used to construct an optimal regression equation using a large 
number of predictors. Three statistical regression methods of variable selection are forward 
selection, backward elimination, and stepwise selection. The training in forward selection starts 
with an empty equation and adds predictors one at a time starting with the most significant 
predictor. Selection ends when all remaining predictors fail to meet the specified F-to-enter value. 
Backward elimination training starts with all predictors and removes, one at a time, the least 
significant predictors. Elimination ends when all remaining predictors fail to meet the specified 
F-to-remove value. The stepwise method is a variation of the above methods. It starts with an 
empty model, and after each step in which a predictor is added based on the F-to-enter value, it 
evaluates predictors in the model against the specified significance level. Those that fall below 
this level are removed. In this study, we applied the stepwise method. The binary logistic 
regression equation is shown in Equation 4.1 and Equation 4.2. 
𝑙𝑜𝑔𝑖𝑡[𝑃(𝑥)] = ln [
𝑃(𝑥)
1−𝑃(𝑥)
] = 𝛽0 + 𝛽1𝑥1 + ⋯ + 𝛽𝑛𝑥𝑛 (4.1) 
𝑃(𝑥) =
𝑒𝛽0+𝛽1𝑥1+⋯+𝛽𝑛𝑥𝑛
1+𝑒𝛽0+𝛽1𝑥1+⋯+𝛽𝑛𝑥𝑛
=
1
1+𝑒−𝑙𝑜𝑔𝑖𝑡[𝑝(𝑥)]
 (4.2) 
𝑃(𝑥) is the probability that the target variable belongs to a specific category (in our study, a 
patient has retinopathy) and 𝛽𝑖 is the coefficient of the 𝑖
th predictor. 
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Figure 4.3- Modeling procedure 
Artificial Neural Network: Artificial neural network (ANN) is a very popular model in healthcare 
analytics. ANN can be defined as “massively parallel processors, which tend to preserve 
experimental knowledge and enable their further use” [114]. One of the advantages of the neural 
network model is its ability in handling highly complex problem structures with non-linear 
relationships among variables. A limitation of this method, however, is its high sensitivity to 
model parameters (i.e., structure/architecture of the model, learning rate, number of layers and 
neurons in each layer, etc.) [115]. Figure 4.4 exhibits a simple two-layer perceptron network. In 
this example, there are three inputs and two neurons in the hidden layer. There is a transfer 
function for the output layer and for each neuron in the hidden layer. In this study, we used two-
layer perceptron networks with hyperbolic tangent transfer functions in the hidden layer and a 
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soft-max transfer function in the output layer (see Equations 4.3, 4.4, and 4.5). We also used the 
conjugate-gradient optimization technique to optimize the network. For more details about the 
neural networks design, we refer the readers to Hagan, et al. [116]. 
𝑎1 = 𝑓1(𝑤11𝑥1 + 𝑤21𝑥2 + 𝑤31𝑥3 + 𝑏1) (4.3) 
𝑎2 = 𝑓2(𝑤12𝑥1 + 𝑤22𝑥2 + 𝑤32𝑥3 + 𝑏2) (4.4) 
𝑦 = 𝑓(𝑤1𝑎1 + 𝑤2𝑎2 + 𝑏) (4.5) 
x1
x2
x3
w11
w12
w21
w22
w31
w32
w1
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Figure 4.4- Two-layer perceptron neural networks 
In these equations, 𝑥1, 𝑥2 𝑎𝑛𝑑 𝑥3 are input variables; 𝑤𝑖𝑗 is the weight of the input 𝑖 for neuron 𝑗; 
𝑏𝑗 and 𝑎𝑗 are the bias and output of neuron 𝑗 respectively; 𝑓1 and 𝑓2 are the transfer functions for 
the hidden layer; 𝑓 is the transfer function of the output layer; and 𝑦 is the output of the network. 
In this study, we developed neural network models in two settings. In the first setting, we fed all 
of the variables into the neural network models, but in the second setting, we only used the 
variables that were selected through the stepwise method in logistic regression. 
Decision Tree: Decision tree is a method that recursively partitions the data based on a predictor 
[117]. The training process in this method starts at the root node (i.e., all the records and 
predictors). The tree is built by splitting the records at each stage (i.e., each node) according to 
the best cut-off value of a predictor. There are several criteria to select the best split. In this study, 
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we used Pearson’s 𝜒2 p-value and the Gini index. Pearson’s 𝜒2 p-value measures the level of 
separation achieved by the split. To calculate this measure, consider a 2 × 2 contingency table for 
the split. Columns represent the branch directions and rows specify the target variable (0 or 1). 
The 𝜒2 value is calculated as in Equation 4.6. 
𝜒2 = ∑ ∑
(𝑂𝑖𝑗−𝐸𝑖𝑗)
2
𝐸𝑖𝑗
2
𝑗=1
2
𝑖=1  (4.6) 
In this equation 𝑂𝑖𝑗 is the observed frequency in row 𝑖 and column 𝑗, and 𝐸𝑖𝑗 is the expected 
frequency in row 𝑖 and column 𝑗. The p-value of the 𝜒2 is then calculated. The smaller the p-
value, the better the split or the higher the level of separation.  
The Gini index shows the level of purity achieved by the split. Gini is the probability that 
two randomly selected members of a population are the same. For a pure population, this index 
would be 1. The calculation of the Gini index in each leaf of a split is as in Equation 4.7, where 
𝑝1 and 𝑝2 are the proportions of each level. 
𝐺𝑖𝑛𝑖 = 𝑝1
2 + 𝑝2
2 (4.7) 
Then, the Gini score of the split is calculated as in Equation 4.8, where 𝑤𝑙𝑒𝑓𝑡 and 𝑤𝑟𝑖𝑔ℎ𝑡 are the 
proportion of the records in each leaf. 
𝐺𝑖𝑛𝑖𝑠𝑐𝑜𝑟𝑒 = 𝑤𝑙𝑒𝑓𝑡𝐺𝑖𝑛𝑖𝑙𝑒𝑓𝑡 + 𝑤𝑟𝑖𝑔ℎ𝑡𝐺𝑖𝑛𝑖𝑟𝑖𝑔ℎ  (4.8) 
The higher the Gini score, the higher the level of purity achieved by the split. Although the 
decision tree method is easy to understand, especially for those without knowledge of theories 
underlying data mining methods, one of its major drawbacks is that data partitioning may result in 
one leaf comprised of few data points, precluding any useful information from that portion of the 
data [115]. 
Random Forest: Random forest could be considered an extension of decision tree. This method 
develops multiple smaller trees that classify each member of the sample data. The final predicted 
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class for a particular sample member is determined using a voting mechanism based on the 
prediction of all trees [118]. Each tree in the random forest uses a subset of records and variables. 
Random sampling with replacement is used for building each tree. In this study, after examining 
several scenarios developed by altering model characteristics, we used 60% of the training data 
and the square root of the number of variables to build each tree. Several advantages can be 
enumerated for random forest. Besides high accuracy, this method provides a variable importance 
metric that can be used for identifying important risk factors. Random forest can also handle 
datasets with a large number of variables [16]. 
Predictive Model Sets 
In this research, four different sets of predictive models were developed (see Figure 4.5). The first 
set, called the basic models, encompassed models that were developed using lab procedures and 
demographic data of diabetic patients. In the second set, models were built on lab procedures, 
demographics, and comorbidity data. These models are called comorbid models. The third set, 
dubbed over-sampled models, consisted of models built using the over-sampled data by applying 
the synthetic minority over-sampling technique (SMOTE). And, the fourth set included ensemble 
models that were developed based on the outputs of individual classifiers. 
Basic Models: In this set of models, we used the data compiled during the data preparation phase. 
We call this dataset “basic data” as it only included demographic and lab results of the diabetic 
patients. 
Models Based on Comorbid Data: The second set of predictive models was based on the 
comorbidity information. To develop these models, comorbidity data were added to the basic data 
through several data preparation steps. In these models, we considered the existence of other 
diabetes-related complications to predict diabetic retinopathy. The following complications were 
included in our analyses: neuropathy, nephropathy, peripheral circularity, hyperosmolarity, 
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diabetes-related coma, and other specified diabetes-related conditions. To prepare the comorbid 
dataset, we performed several steps on the primary data table, which consisted of the list of 
patients, their complication (diagnosis code), and their demographic and lab data. Since each 
complication of a patient generated a different record in the database, we extracted all records in 
which the diagnosis was one of the aforementioned complications and saved them in separate 
tables. Next, we merged these tables by patient ID and added a binary variable for each 
complication. Therefore, for each patient, in addition to the demographic and lab data, we added 
information about their other co-existing complications. After taking these steps, the dataset 
became ready for the development of the predictive models. 
Predictive Models
Set 1:
Models based on Lab 
and Demographic 
Data (Basic Data)
Set 2:
Models based on Basic 
and Comorbidity Data
Set 3:
Models based on 
Over-sampled Data
Set 4 (Ensemble 
Models)
 
Figure 4.5- Predictive model sets 
 
Models Based on Over-Sampled Data: In the previous two sets of models, we carried out random 
under-sampling for the majority class to create a balanced dataset. One obvious limitation of 
under-sampling is the possibility of losing important information about the majority class by 
removing some fractions of the data [76]. The other available approach to create a balanced 
dataset is to over-sample the minority class. Numerous over-sampling methods have been 
proposed in recent years, and among them synthetic data generation for the minority class has one 
of the best performances. By generating synthetic data, new examples of the minority class are 
generated using different techniques to reach some desired degree of balanced class distribution. 
SMOTE [78] is one of the most famous methods in this regard. In this method, synthetic data 
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points are generated on the line joining each minority sample and any/all of its 𝑘 minority class 
nearest neighbors (minority class with the smallest Euclidean distance from the original sample). 
Consider 𝑥 a minority class, and 𝑥𝑖 one of its k minority class nearest neighbors. The new data 
will be generated as in Equation 4.9, 
𝑥𝑛𝑒𝑤 = (1 − 𝛿)𝑥 + 𝛿𝑥𝑖  (4.9) 
where 𝛿 is a random number between [0, 1]. Figure 4.6 depicts the synthetic data generation 
process. 
x Xi
Generated Data, 
Xnew
p1
p2
 
Figure 4.6 - Synthetic Minority Over-Sampling Technique (SMOTE) 
The number of  𝑘 nearest neighbors to be used depends on the amount of over-sampling required. 
For instance, if we want to increase the minority class by 300%, 𝑘 would be equal to 3. We can 
enumerate several advantages for this method. First, it requires no information other than the 
dataset itself [119]. Further, since it is a preprocessing method, over-sampled data can be used in 
any classification technique with good performance on balanced data [120]. Finally, by 
generating synthetic minority data, as opposed to simply replicating existing minority data, the 
minority region can be generalized and overfitting, a limitation of replication, can be avoided 
[85]. 
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In this study, we considered 5 neighbors to increase the size of the minority class by 10 times, 
which means we generated two synthetic data points on each line connecting the minority class 
and each of its five nearest neighbors. Rather than over-sampling the minority class up to the 
level of the majority class, we increased the size of the minority class to some extent and then 
under-sampled the majority class to reach a balanced dataset, which is consistent with Chawla, et 
al. [78] study that showed the combination of SMOTE and under-sampling of the majority class 
has a better result compared to plain under-sampling. For simplicity, from this point to the end of 
the this chapter, we call models in Set 1 “basic models”, models in Set 2 “comorbid models”, and 
models in Set 3 “over-sampled models”.  
Ensemble Models 
In this study, we developed a new ensemble approach, called confidence margin ensemble. We 
assessed the performance of confidence margin in comparison to four other exiting ensemble 
techniques, which are simple average, weighted average, voting-based, and random forest. We 
explained the random forest model earlier in this section. A description of other approaches is 
presented next. 
Simple average ensemble models – In this method, each model contributes an equally weighted 
output to compute an average. For instance, if there are 5 single models 𝐴, 𝐵, 𝐶, 𝐷 and 𝐸 with 
outputs of 0.66, 0.45, 0.76, 0.92, and 0.48 for a record, the average output would be 0.654. The 
final classification decision would be YES, even though two of the single models would classify 
the record as NO (assuming that the decision cut-off is set at 0.50).  
Weighted average ensemble models – Rather than assuming all classifiers contribute equally; this 
method assigns different weights to single classifier outputs for calculating the final result. The 
weight of each single classifier corresponds to its accuracy. Again, suppose there are 5 single 
models 𝐴, 𝐵, 𝐶, 𝐷 and 𝐸. The weights will be determined as in Equation 4.10.  
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𝑊𝐴 =
𝐴𝑐𝑐𝑢𝑟𝑎𝑐𝑦𝐴
𝐴𝑐𝑐𝑢𝑟𝑎𝑐𝑦𝐴+𝐴𝑐𝑐𝑢𝑟𝑎𝑐𝑦𝐵+𝐴𝑐𝑐𝑢𝑟𝑎𝑐𝑦𝐶+𝐴𝑐𝑐𝑢𝑟𝑎𝑐𝑦𝐷+𝐴𝑐𝑐𝑢𝑟𝑎𝑐𝑦𝐸
 (4.10) 
So, the more accurate a model, the greater weight the model will have in calculating the weighted 
average. The final prediction for a record can be calculated as in Equation 4.11. 
𝑃 = 𝑊𝐴𝑃𝐴 + 𝑊𝐵𝑃𝐵 + 𝑊𝐶𝑃𝐶 + 𝑊𝐷𝑃𝐷 + 𝑊𝐸𝑃𝐸 (4.11) 
Confidence margin ensemble models - To build these ensemble models, we define a metric, 
named confidence margin (𝑐_𝑚). Confidence margin is calculated for each record predicted by 
each single model. The cut-off point to make the decision is considered to be 0.5, hence the 
confidence margin for record 𝑖, predicted by model 𝐴 is defined as in Equation 4.12. 
𝑐_𝑚𝑖
𝐴 = {
𝑃𝑖
𝐴 − 0.5 𝑖𝑓 𝑃𝑖
𝐴 > 0.5 
0.5 − 𝑃𝑖
𝐴 𝑖𝑓 𝑃𝑖
𝐴 ≤ 0.5
 (4.12) 
where 𝑃𝑖
𝐴 is the prediction output of model 𝐴 for record 𝑖.  
Therefore, we say a model is more confident in predicting a record (or the confidence margin is 
greater) when its prediction is farther away from the cut-off. Final predictions are obtained after 
calculating confidence margins for all records in all models. Similar to the two previous ensemble 
models, the average of the single models’ predictions is calculated, but different weights are used 
at both model and record levels. The weight of the prediction for record 𝑖 by model 𝐴 is 
calculated as in Equation 4.13. 
𝑊𝑖
𝐴 =
𝑐_𝑚𝑖
𝐴
𝑐_𝑚𝑖
𝐴+𝑐_𝑚𝑖
𝐵+𝑐_𝑚𝑖
𝐶+𝑐_𝑚𝑖
𝐷+𝑐_𝑚𝑖
𝐸 (4.13) 
Therefore, the final prediction for record 𝑖 can be calculated as in Equation 4.14.  
𝑃𝑖 = 𝑊𝑖
𝐴𝑃𝑖
𝐴 + 𝑊𝑖
𝐵𝑃𝑖
𝐵 + 𝑊𝑖
𝐶𝑃𝑖
𝐶 + 𝑊𝑖
𝐷𝑃𝑖
𝐷 + 𝑊𝑖
𝐸𝑃𝑖
𝐸 (4.14) 
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Voting-based ensemble models - In these models, a voting procedure is utilized to make the final 
decision. When the number of single models is odd, the final decision is the majority vote. But 
when the number of single models is even, in case of equal votes between two classes, the final 
decision is made by comparing the sum of confidence margins for models that voted YES to the 
sum of confidence margins for models that voted NO (see Equation 4.15). 
{
𝑖𝑓 ∑ 𝑐_𝑚𝑖
𝑗+
𝑗+∈𝑀𝑜𝑑𝑙𝑒𝑠 𝑤ℎ𝑖𝑐ℎ 𝑣𝑜𝑡𝑒𝑑 𝑌𝐸𝑆 > ∑ 𝑐_𝑚𝑖
𝑗−
𝑗−∈𝑀𝑜𝑑𝑙𝑒𝑠 𝑤ℎ𝑖𝑐ℎ 𝑣𝑜𝑡𝑒𝑑 𝑁𝑂     −→ 𝑌𝐸𝑆 
𝑖𝑓 ∑ 𝑐_𝑚𝑖
𝑗+
𝑗+∈𝑀𝑜𝑑𝑙𝑒𝑠 𝑤ℎ𝑖𝑐ℎ 𝑣𝑜𝑡𝑒𝑑 𝑌𝐸𝑆 ≤ ∑ 𝑐_𝑚𝑖
𝑗−
𝑗−∈𝑀𝑜𝑑𝑙𝑒𝑠 𝑤ℎ𝑖𝑐ℎ 𝑣𝑜𝑡𝑒𝑑 𝑁𝑂  −→ 𝑁𝑂
 (4.15) 
Variable Importance Evaluation 
One of the major benefits of analytics and data mining in healthcare is the identification of factors 
that have strong predictive power in detecting a disease. In this section, we elucidate the 
procedure used to evaluate the predictive power of different independent variables (predictors). 
To assess the predictive power (variable importance) of a variable, we used the Gini impurity 
reduction metric in the random forest models. As was mentioned earlier, random forest is a 
collection of multiple decision trees. Thus, to calculate the Gini impurity reduction for different 
variables in a random forest model, the average Gini impurity reduction for each variable in all 
decision trees needs to be computed. The calculation of the Gini purity index for a node in a 
decision tree was shown in Equation 4.7; therefore, the Gini impurity index, which is showed 
by 𝐺𝑖𝑛𝑖𝑖𝑚𝑝, is calculated as in Equation 4.16, 
𝐺𝑖𝑛𝑖𝑖𝑚𝑝 = 1 − 𝐺𝑖𝑛𝑖 = 1 − (𝑝1
2 + 𝑝2
2) = 𝑝1(1 − 𝑝1) + 𝑝2(1 − 𝑝2)  (4.16) 
where 𝑝1 and 𝑝2 are the proportions of each level of the target variable at the node. If a variable is 
used for a split in a decision tree, the Gini impurity reduction (𝐺𝐼𝑅) for that variable is calculated 
as in Equation 4.17, 
 𝐺𝐼𝑅 = 𝐺𝑖𝑛𝑖𝑖𝑚𝑝𝑝𝑎𝑟𝑒𝑛𝑡 − 𝑤𝑙𝑒𝑓𝑡𝐺𝑖𝑛𝑖𝑖𝑚𝑝𝑙𝑒𝑓𝑡 − 𝑤𝑟𝑖𝑔ℎ𝑡𝐺𝑖𝑛𝑖𝑖𝑚𝑝𝑟𝑖𝑔ℎ𝑡   (4.17) 
61 
 
where 𝑤𝑙𝑒𝑓𝑡 and 𝑤𝑟𝑖𝑔ℎ𝑡 are the proportion of the records in each leaf. Now suppose T trees are 
generated in a random forest model; the 𝐺𝐼𝑅 for a variable in that random forest will be given as 
in Equation 4.18, 
 𝐺𝐼𝑅𝑅𝐹 =
∑ 𝐺𝐼𝑅𝑡
𝑇
𝑡=1
𝑇
        (4.18) 
The higher the GIR of a variable in the random forest, the more important that variable is for 
detecting the target variable. Since we have developed several random forest models in different 
data preparation settings, we develop the final ranking of important variables by following this 
procedure: first GIR for all variables is calculated in all random forest models in Sets 2 and 3; 
then, GIRs are normalized in each random forest model; and finally, the average of normalized 
GIRs for each variable in different random forest models is computed to obtain the variable 
importance metric for that variable. Since any manipulation in the data could change the models’ 
output and, hence, the variable importance ranking, we believe our procedure for creating the list 
of important variables is more robust and more reliable. 
4.2. Results 
Variable Description 
The independent variables (predictors) in our dataset can be divided into three categories: 
demographic, lab, and comorbidity variables. Tables 4.1, 4.2 and 4.3 provide a brief description 
of the variables (out of 68 variables in the data) that made it to the final models. Table 4.1 
describes the four demographic variables: gender, race, marital status, and urban/rural status. 
There were slightly more females than males. Most of the patients were Caucasian, followed by 
African Americans and Hispanics. More than 37% of the patients were married and others were 
single, widowed, or legally separated. 
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Table 4.1- Demographic variables 
Name Levels Mode  
Gender Female/Male/ Unknown Female 
Race Caucasian/ African American/ Hispanic/ Asian/ Native 
American/ Pacific Islander/ Unknown/ Null 
Caucasian 
Marital Status Married/ Single/ Widowed/ Legally Separated/ Life Partner/ 
Null 
Married 
Urban Rural Status Urban (99%)/ Rural (1%) Urban 
Table 4.2 provides some descriptive statistics for lab procedures. In this table, mean, standard 
deviation (SD), skewness, kurtosis, and the missing value percentage for each variable are 
presented. A brief description of the comorbidity variables (other diabetes-related complications) 
is provided in Table 4.3.  
Table 4.2- Lab procedure variables 
Name Description Mean StDev Skewness Kurtosis Missing 
(%) 
Alanine 
Aminotransferase 
(ALT) 
This test assesses the level 
of ALT enzyme in the 
blood. 
31.14 31.66 5.814 46.38 0.49 
Albumin Serum This test measures the level 
of albumin in the blood. 
3.11 0.80 3.673 135.16 0.47 
Anion Gap 
(Blood) 
This test evaluates the 
electrically charged 
particles such as sodium, 
chloride, and bicarbonate 
in the blood.  
9.61 3.68 0.868 3.49 0.39 
Aspartate 
Aminotransferase 
(AST) 
This test measures the level 
of AST enzyme in the 
blood. AST test usually 
ordered with ALT. 
28.49 26.03 5.174 34.73 0.44 
Blood Urea 
Nitrogen (BUN) 
BUN measures the amount 
of nitrogen in the blood 
that comes from urea. This 
test evaluates the 
functionality of kidneys 
and liver. 
20.70 14.59 2.786 11.94 0.22 
Calcium Serum  This test evaluates the 
amount of the calcium in 
the blood. 
8.48 1.11 -3.501 18.86 0.26 
Chloride Serum This test helps detecting 
the abnormal amounts of 
chloride in the blood. 
102.52 4.66 -1.47 30.47 0.21 
Creatinine Serum This test evaluates kidney 
function. Creatinine is a 
waste product of muscle 
metabolism and eating 
meat. 
0.77 1.20 4.088 22.67 0.20 
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Glucose Serum 
Plasma 
This test assesses the blood 
glucose level, a major test 
to screen for pre-diabetes 
and diabetes. 
155.19 80.50 2.39 10.47 0.29 
Hematocrit This test measures the 
percentage of red blood 
cells in the blood. 
35.27 9.09 -2.104 6.32 0.30 
Hemoglobin This test measures the 
amount of hemoglobin in 
the blood. 
12.27 4.45 15.217 297.57 0.28 
Mean 
Corpuscular 
Hemoglobin 
Concentration  
MCH measures the 
average concentration of 
hemoglobin per red blood 
cell. 
33.23 1.39 -5.627 163.68 0.34 
Mean Platelet 
Volume (MPV) 
MPV is automated 
measurement of average 
size of platelets in the 
blood.  
8.38 1.52 0.238 3.60 0.43 
Potassium Serum This test measures the level 
of potassium in the blood.  
3.76 0.61 -0.003 2.55 0.20 
Protein Total 
Serum 
This test evaluates the 
amounts of albumin and 
globulin proteins in the 
blood. 
6.13 1.16 -2.199 9.96 0.50 
Red Blood Cell 
(RBC) Count 
RBC measures the number 
of red blood cells in the 
blood and usually is 
ordered as a part of a 
complete blood cell  test. 
3.72 1.31 21.354 725.58 0.36 
Sodium Serum This test assesses the level 
of sodium and detects 
abnormal low/high sodium 
in the blood. 
138.03 3.95 -6.576 226.32 0.22 
White Blood Cell 
(WBC) Count 
This test determines the 
number of WBC in the 
blood and helps to 
diagnose infections and 
other medical conditions. 
8.16 4.77 11.475 281.13 0.30 
 
Table 4.3- Comorbidity variables 
Name Description 
Neuropathy Type of nerve disorder; particularly prevalent in the feet and legs. 
Nephropathy Kidney disease  
Peripheral Circulatory Arterial blockage due to atherosclerosis; mostly affects lower extremities. 
Ketoacidosis High levels of ketone bodies, or blood acids, resulting from the breaking 
down of fat rather than glucose for energy; may lead to coma. 
Hyperosmolarity Extremely high blood sugar level in which excess blood sugar is passed 
into the urine; may lead to life-threatening dehydration. 
Other Complications Other specified complications of diabetes are in this category 
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Models’ Output 
The results of the different sets of models are presented in Tables 4.4, 4.5, and 4.6, which include 
area under the curve (AUC) of the receiver operating characteristic (ROC), accuracy, sensitivity, 
and specificity. As the results show, the accuracy, sensitivity, specificity, and AUC of the models 
improved from the basic to the comorbid, and from the comorbid to the over-sampled models. 
Finally, for each set of models, ensemble models outperformed single models. 
In set 1 (basic models), the best performance was obtained from random forests without 
imputation of missing values, with AUCs standing at 81.90%, 81.80% and 81.50%. This was 
followed by neural networks, with AUCs of 80.00% and 79.80%. In this set, following the 
random forest and neural networks, logistic regression models ranked third, and decision trees 
had the poorest performance. 
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Table 4.4 – Set 1 - Basic models’ results 
Data 
Manipulation 
Imputation 
Technique 
Modeling 
Technique 
AUC Accuracy Sensitivity Specificity 
No 
Manipulation 
No 
Imputation 
DT-Gini 77.30% 70.76% 63.95% 77.56% 
DT-Prob 𝜒2 77.30% 70.71% 65.04% 76.38% 
RF* 81.80% 73.78% 72.37% 75.19% 
Mean DT-Gini 76.30% 70.98% 65.50% 76.47% 
DT-Prob 𝜒2 75.60% 71.12% 59.76% 82.48% 
RF 79.20% 71.87% 67.46% 76.29% 
LR 78.00% 71.26% 63.27% 79.24% 
ANN 79.40% 72.96% 69.69% 76.24% 
ANN-Reg# 79.80% 72.28% 67.64% 76.92% 
Tree DT-Gini 75.20% 70.25% 56.62% 83.89% 
DT-Prob 𝜒2 75.30% 70.41% 60.13% 80.70% 
RF@ 79.80% 72.33% 67.50% 77.15% 
LR 78.00% 71.92% 65.50% 78.33% 
ANN 79.60% 72.67% 70.82% 74.51% 
ANN-Reg# 80.00% 72.99% 68.50% 77.47% 
Extreme Point 
Replacement 
No 
Imputation 
DT-Gini 77.30% 70.76% 63.95% 77.56% 
DT-Prob 𝜒2 77.30% 70.71% 65.04% 76.38% 
RF* 81.90% 73.78% 71.01% 76.56% 
Mean DT-Gini 76.40% 71.01% 65.91% 76.10% 
DT-Prob 𝜒2 76.00% 71.10% 60.17% 82.02% 
RF 79.20% 72.05% 67.14% 76.97% 
LR 76.70% 69.71% 59.76% 79.65% 
ANN 78.50% 72.01% 66.36% 77.65% 
ANN-Reg 78.30% 72.14% 63.40% 80.88% 
Tree DT-Gini 75.10% 70.35% 56.26% 84.53% 
DT-Prob 𝜒2 76.20% 70.89% 60.63% 81.16% 
RF 79.30% 71.94% 66.32% 77.56% 
LR 77.80% 71.48% 63.68% 79.29% 
ANN# 80.00% 73.26% 67.96% 78.56% 
ANN-Reg 79.40% 72.30% 67.73% 76.88% 
Max Normal 
Variable 
Transformation 
No 
Imputation 
DT-Gini 77.20% 70.69% 64.00% 77.38% 
DT-Prob 𝜒2 77.30% 70.71% 65.04% 76.38% 
RF* 81.50% 73.33% 69.64% 77.01% 
Mean DT-Gini 76.60% 71.01% 62.72% 79.29% 
DT-Prob 𝜒2 75.60% 71.17% 60.67% 81.66% 
RF@ 79.70% 72.05% 67.46% 76.65% 
LR 78.10% 71.69% 66.77% 76.60% 
ANN 79.60% 72.60% 68.37% 76.83% 
ANN-Reg 79.30% 72.23% 66.95% 77.51% 
Tree DT-Gini 75.30% 70.69% 61.00% 80.38% 
DT-Prob 𝜒2 76.60% 70.91% 61.77% 80.06% 
RF 79.50% 71.71% 66.50% 76.92% 
LR 78.20% 71.55% 67.60% 75.51% 
ANN@ 79.70% 72.78% 68.32% 77.24% 
ANN-Reg 79.40% 72.46% 68.55% 76.38% 
* Top three models  # Second top three models @ Third top three models 
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Table 4.5 – Set 2 - Comorbid models’ results 
Data 
Manipulation 
Imputation 
Technique 
Modeling 
Technique 
AUC Accuracy Sensitivity Specificity 
No 
Manipulation 
No 
Imputation 
DT-Gini 83.40% 78.65% 76.83% 80.47% 
DT-Prob 𝜒2 83.60% 79.06% 78.88% 79.24% 
RF* 88.40% 80.61% 75.97% 85.25% 
Mean DT-Gini 84.20% 79.38% 79.88% 78.88% 
DT-Prob 𝜒2 83.80% 79.18% 78.88% 79.47% 
RF# 87.50% 79.81% 74.37% 85.25% 
LR 86.20% 79.09% 70.41% 87.76% 
ANN 87.00% 80.29% 74.42% 86.16% 
ANN-Reg 86.90% 79.97% 73.83% 86.12% 
Tree DT-Gini 83.30% 78.81% 72.14% 85.48% 
DT-Prob 𝜒2 84.70% 78.77% 68.78% 88.76% 
RF# 87.70% 80.18% 75.92% 84.43% 
LR 86.50% 79.40% 71.19% 87.62% 
ANN@ 87.40% 80.13% 75.47% 84.80% 
ANN-Reg# 87.40% 80.18% 75.24% 85.12% 
Extreme Point 
Replacement 
No 
Imputation 
DT-Gini 83.40% 78.65% 76.83% 80.47% 
DT-Prob 𝜒2 83.60% 79.06% 78.88% 79.24% 
RF* 88.60% 80.38% 74.60% 86.16% 
Mean DT-Gini 84.20% 79.38% 79.88% 78.88% 
DT-Prob 𝜒2 83.80% 79.18% 78.88% 79.47% 
RF@ 87.40% 79.84% 74.28% 85.39% 
LR 85.90% 78.88% 69.78% 87.98% 
ANN 86.40% 80.13% 74.15% 86.12% 
ANN-Reg 86.30% 79.72% 73.51% 85.94% 
Tree DT-Gini 84.20% 79.20% 74.51% 83.89% 
DT-Prob 𝜒2 84.40% 79.22% 74.51% 83.93% 
RF 87.40% 79.95% 74.37% 85.53% 
LR 85.90% 79.13% 70.28% 87.98% 
ANN 87.30% 79.97% 75.56% 84.39% 
ANN-Reg 86.10% 79.77% 72.05% 87.48% 
Max Normal 
Variable 
Transformation 
No 
Imputation 
DT-Gini 83.40% 78.70% 76.74% 80.66% 
DT-Prob 𝜒2 83.60% 79.06% 78.88% 79.24% 
RF* 88.50% 80.41% 74.74% 86.07% 
Mean DT-Gini 84.10% 79.27% 79.79% 78.74% 
DT-Prob 𝜒2 83.80% 79.18% 78.88% 79.47% 
RF@ 87.40% 79.90% 73.78% 86.03% 
LR 86.30% 79.49% 72.64% 86.35% 
ANN 86.60% 79.72% 73.96% 85.48% 
ANN-Reg 86.50% 79.63% 73.69% 85.57% 
Tree DT-Gini 84.30% 78.95% 71.83% 86.07% 
DT-Prob 𝜒2 85.00% 79.20% 73.60% 84.80% 
RF 87.40% 79.79% 73.46% 86.12% 
LR 85.70% 79.34% 71.46% 87.21% 
ANN 86.30% 79.40% 74.65% 84.16% 
ANN-Reg 86.10% 79.70% 71.73% 87.67% 
* Top three models  # Second top three models @ Third top three models 
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Table 4.6 – Set 3 - Over-sampled models’ results 
Data 
Manipulation 
Imputation 
Technique 
Modeling 
Technique 
AUC Accuracy Sensitivity Specificity 
No 
Manipulation 
No 
Imputation 
DT-Gini 93.00% 89.13% 89.05% 89.20% 
DT-Prob 𝜒2 93.00% 89.14% 88.85% 89.42% 
RF* 97.90% 92.71% 90.00% 95.43% 
Mean DT-Gini 89.90% 84.16% 89.03% 79.07% 
DT-Prob 𝜒2 90.10% 84.16% 89.18% 79.13% 
RF@ 95.20% 88.03% 90.77% 85.28% 
LR 87.40% 78.33% 68.25% 88.42% 
ANN 92.20% 84.97% 86.95% 83.00% 
ANN-Reg 93.20% 85.96% 87.47% 84.46% 
Tree DT-Gini 91.90% 87.17% 86.53% 87.81% 
DT-Prob 𝜒2 92.10% 87.18% 86.51% 87.84% 
RF# 96.00% 89.83% 90.04% 89.63% 
LR 87.50% 79.79% 72.72% 86.85% 
ANN 93.30% 86.91% 87.44% 86.37% 
ANN-Reg 91.40% 84.06% 87.57% 80.56% 
Extreme Point 
Replacement 
No 
Imputation 
DT-Gini 93.00% 89.13% 89.05% 89.21% 
DT-Prob 𝜒2 93.00% 89.14% 89.08% 89.21% 
RF* 97.90% 92.76% 90.22% 95.30% 
Mean DT-Gini 89.90% 84.14% 88.72% 79.57% 
DT-Prob 𝜒2 90.10% 84.14% 88.87% 79.42% 
RF@ 95.20% 88.02% 90.75% 85.28% 
LR 83.40% 77.50% 67.38% 87.62% 
ANN 92.20% 85.06% 86.66% 83.46% 
ANN-Reg 91.70% 84.21% 88.08% 80.36% 
Tree DT-Gini 92.20% 87.27% 86.74% 87.80% 
DT-Prob 𝜒2 92.20% 87.28% 86.76% 87.79% 
RF 91.00% 89.66% 60.11% 94.20% 
LR 87.80% 79.54% 72.13% 86.96% 
ANN 93.50% 87.03% 87.74% 86.33% 
ANN-Reg 91.50% 83.72% 86.72% 80.73% 
Max Normal 
Variable 
Transformation 
No 
Imputation 
DT-Gini 93.00% 89.13% 89.05% 89.21% 
DT-Prob 𝜒2 93.00% 89.14% 89.08% 89.21% 
RF* 97.90% 92.71% 89.98% 95.43% 
Mean DT-Gini 90.30% 84.36% 89.12% 79.61% 
DT-Prob 𝜒2 89.30% 84.31% 89.25% 79.37% 
RF# 95.20% 88.04% 90.69% 85.51% 
LR 87.20% 77.86% 68.21% 87.51% 
ANN 92.40% 85.17% 86.72% 83.63% 
ANN-Reg 93.40% 86.27% 87.64% 84.91% 
Tree DT-Gini 92.20% 88.01% 88.45% 87.57% 
DT-Prob 𝜒2 92.20% 88.04% 88.65% 87.43% 
RF# 96.10% 89.94% 90.18% 89.69% 
LR 88.80% 80.66% 83.90% 77.43% 
ANN@ 93.90% 87.57% 87.22% 87.92% 
ANN-Reg 92.00% 84.30% 86.60% 82.00% 
* Top three models  # Second top three models @ Third top three models 
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In set 2 (comorbid models), random forests once again had the best performance with AUCs of 
88.60%, 88.50% and 88.40% for the top three models. Similar to the basic models, neural 
networks, logistic regressions, and decision trees ranked second, third, and fourth, respectively. In 
set 3 (over-sampled models), random forest models had the highest accuracy in detecting 
retinopathy among diabetic patients. The best models in set 3 had an AUC of 97.80%, which is 
remarkable. AUCs for other models in this set were significantly high, mostly over 92%. Neural 
networks were the second-best models in this set, but unlike sets 1 and 2, decision trees had the 
third rank in over-sampled models, and logistic regressions had the worst performance. 
 
No data manipulation- Tree imputation 
  
Max normal transformation- Tree imputation 
 
No data manipulation- Mean imputation 
 
Extreme points replacement- Mean imputation 
Figure 4.7 - AUC comparison among modeling techniques and modeling sets 
Graphs in Figure 4.7 compare the modeling techniques within and between the three sets: basic, 
comorbid, and over-sampled. As expected, there clearly is a significant improvement (about 10%) 
from the basic to the comorbid models. Except for the logistic regression, the accuracy of the 
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models built on the over-sampled sets are considerably higher than that of the comorbid sets for 
all the modeling techniques. Specifically, the AUCs of the over-sampled models (for random 
forest, neural networks, and decision tree techniques) were about 8% higher than the AUCs of 
their counterparts in the comorbid models. This improvement is expected, since in over-sampled 
models there are more data points available to train the models. The only modeling technique that 
did not improve by using over-sampled data was logistic regression, which was the only linear 
model used in this study. All other models (i.e., random forest, neural networks, and decision 
tree) are non-linear; so, unlike logistic regression, they can take advantage of richer and more 
complicated data, leading to higher accuracy with over-sampled data. 
 
 
Random forest models (No data manipulation- no imputation) 
 
 
Decision tree-Gini (Extreme point replacement- mean imputation) 
 
 
Neural networks (Extreme point replacement- tree imputation) 
 
 
Logistic regression (Max normal transformation- tree imputation) 
Figure 4.8 - ROC charts of modeling techniques in different sets 
70 
 
The ROC charts of each one of the modeling techniques used in the three modeling sets is 
provided in Figure 4.8, which demonstrates the superiority of the over-sampled models over the 
comorbid and basic models, and the dominance of the comorbid models over the basic models. In 
addition to the AUC, we compared the basic, comorbid, and over-sampled models using the 
difference between sensitivity (true positive rate) and specificity (true negative rate) for each 
model in each set. Even though the overall accuracy is an important metric to compare models, a 
desired model is one that can classify both positive targets (in our case, patients with diabetic 
retinopathy) and negative targets (patients without diabetic retinopathy) at a high rate. Therefore, 
the lower the difference between sensitivity and specificity of a model, the better and more 
reliable that model. The average differences between sensitivity and specificity for models in set 
1 (basic models), set 2 (comorbid models), and set 3 (over-sampled models) were 12.93%, 9.63%, 
and 6.06%, respectively. Thus, not only did the over-sampled models had the highest accuracy, 
but they were also more robust and reliable than the comorbid and basic models, with the 
comorbid models being more robust than the basic models. 
Table 4.7 presents the accuracies of the best single model, existing ensemble approaches, and our 
proposed ensemble approach for the various datasets used in this study. As it can be seen, almost 
all ensemble models (except for 5 out of 90) have improved the prediction accuracy compared to 
the best single model. Those 5 simple average ensembles did not outperform their best 
constituting single models for a simple reason: not all models composing the ensemble had a 
good performance, however, they all were given an equal weight in determining the ensemble’s 
final decision. Consequently, the overall accuracy of the ensembles created by simple averaging 
suffered in comparison to the accuracy of the best constituting single models. In fact, one of the 
most important requirements for building a good ensemble is to have comparably accurate and 
diverse single classifiers [121]. The results also show that the prediction accuracies improve from 
the simple average to the weighted average and culminate in the confidence margin ensemble 
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models. Reaching to a performance peak in the confidence margin ensembles reflects their more 
accurate and more reliable assignment of weights compared to the weighted-average ensemble 
models. Voting-based ensembles outperformed the best single models in all cases. In two cases, 
voting-based models had the best predictive performance among all ensemble models. Similarly, 
random forest models outperformed all other types of ensembles in two cases.  Overall, our 
proposed ensemble approach, the confidence margin ensemble, had the best performance in this 
study. More specifically, it excelled in 14 out of 18 total different data settings. It deserves to 
mention that we used logistic regression, decision tree, and neural network models for developing 
the simple average, weighted average, voting based, and confidence margin ensemble models. 
Table 4.7- Set 4 - Ensemble models results 
Accuracy of Ensemble Models 
Best 
Single 
Model 
Ensemble Model Type 
Existing Approaches 
Our 
Approach 
Simple 
Average 
Weighted 
Average 
Voting 
Based 
Random 
Forest 
Confidence 
Margin  
Ensemble of models in set 1       
No Manipulation /Tree Imputation 72.99% 73.31% 73.37% 73.36% 72.33% 73.56% 
No Manipulation /Mean Imputation 72.96% 72.93% 72.99% 73.03% 71.87% 73.45% 
Extreme Point Replacement /Tree Imputation 73.26% 73.28% 73.35% 73.46% 71.94% 73.42% 
Extreme Point Replacement / Mean Imputation 72.14% 72.20% 72.34% 72.30% 72.05% 73.56% 
Variable Transformation/Tree Imputation 72.78% 72.60% 72.89% 72.83% 71.71% 73.25% 
Variable Transformation/Mean Imputation 72.60% 72.62% 72.75% 72.80% 72.05% 73.85% 
Ensemble of models in set 2       
No Manipulation/Tree Imputation 80.18% 80.16% 80.60% 80.78% 80.18% 80.64% 
No Manipulation /Mean Imputation 80.29% 80.57% 80.65% 80.62% 79.81% 80.97% 
Extreme Point Replacement /Tree Imputation 79.97% 80.15% 80.29% 80.35% 79.95% 80.80% 
Extreme Point Replacement / Mean Imputation 80.13% 80.25% 80.40% 81.05% 79.84% 80.93% 
Variable Transformation/Tree Imputation 79.70% 80.11% 80.37% 80.40% 79.79% 80.75% 
Variable Transformation/Mean Imputation 79.72% 80.20% 80.38% 80.40% 79.90% 80.81% 
Ensemble of models in set 3       
No Manipulation/Tree Imputation 87.18% 88.23% 88.27% 88.03% 89.83% 88.38% 
No Manipulation /Mean Imputation 85.96% 86.15% 86.92% 87.11% 89.83% 89.21% 
Extreme Point Replacement /Tree Imputation 87.28% 87.01% 88.68% 88.60% 89.66% 89.84% 
Extreme Point Replacement / Mean Imputation 85.06% 86.08% 86.98% 87.15% 88.02% 88.42% 
Variable Transformation/Tree Imputation 88.04% 87.91% 88.58% 88.52% 89.94% 90.12% 
Variable Transformation/Mean Imputation 86.27% 86.52% 87.05% 87.62% 88.04% 88.25% 
Variable Importance 
As we mentioned in previous sections, 68 independent variables were included in our analyses. 
Understanding the predictive power of each of these variables could be helpful for physicians in 
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better managing the course of the disease by controlling factors that are highly associated with 
retinopathy. As the results show, random forest models have the best performance among other 
modeling techniques; therefore, to specify the importance of variables according to their 
predictive powers, we applied the Gini reduction metric on the validation datasets using the 
output from random forest models. Figure 4.9 shows the variable importance in detecting 
retinopathy based on the Gini reduction score in multiple random forest models. Based on our 
findings, neuropathy; creatinine serum and blood urea nitrogen (both measures of kidney 
function); glucose serum plasma (used to screen for pre-diabetes and diabetes); and hematocrit (a 
measure of red blood cell concentration) were the most important variables for detecting diabetic 
retinopathy. 
 
Figure 4.9- Variable importance ranking in detecting diabetic retinopathy 
[Y-axis represents the average of normalized Gini reduction] 
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4.3. Discussion and Conclusion 
In this study, we analyzed data from more than 1.4 million diabetic patients. Our objective was to 
develop a CDSS to detect diabetic retinopathy using demographic, lab procedure, and 
comorbidity data only. Several aspects distinguish this research study from other existing studies 
in this area. First, this study included a far greater number of patients and risk factors in the 
analysis, which contribute to the rigor and robustness of the findings. While other similar studies 
used data from several hundred patients, we employed data from more than 300,000 patients to 
develop the predictive models. Second, through a series of database operations and data 
preparation steps conducted in SAS, we incorporated patients’ comorbidity data into our models, 
which significantly improved the accuracy of our predictive analytics-based CDSS. The results 
we obtained from the comorbid models were in line with other research that emphasizes the 
importance, and advantage, of analyzing concurrent conditions instead of studying each condition 
in isolation. Third, we over-sampled the rare event, which made it possible to preserve important 
features in the data that could have been lost through pure under-sampling. Models we built by 
utilizing over-sampled data were much more accurate and robust compared to comorbid and basic 
models, especially in non-linear modeling techniques (such as random forest, neural network, and 
decision tree) that can handle more complex data.  
In this study, we developed and evaluated a novel ensemble approach, which we call the 
confidence margin ensemble. Our evaluations showed that confidence margin ensembles had 
better overall performance compared to the existing ensemble models. In confidence margin 
ensemble, we assign different weights in both model and record levels. To calculate these 
weights, first, the confidence margin metric needs to be computed for every model at each record. 
Confidence margin metric is the absolute difference between the model’s output and decision cut-
off value. The greater the confidence margin, the more confident the model in predicitng the 
record. For instance, if the decisin cut-off is 50%, a model with the output of 95% is more 
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confident compared to a model with the output of 60%. After computing all of the confidence 
margin metrics, the weight of the prediction for each record by every model is calculated by 
normalizing the confidence metrics of all models in each record. In this research we also 
addressed the issue of tie in voting-based ensemble models by comparing the confidence margins 
of the base predictors. 
To make sure that the quality and veracity of our datasets were acceptable, we devoted a 
considerable amount of time and effort to data cleaning and preparation. We analyzed the 
distribution, missing value percentage, and potential outliers of each of the predictors, and 
included only those variables that were rich enough and had significant predictive powers. As a 
result, there should be little doubt about the quality, robustness, and accuracy of our models.  
Based on our analyses, diabetic neuropathy had the strongest predictive power in detecting 
diabetic retinopathy, followed by creatinine serum, blood urea nitrogen, glucose serum plasma, 
and hematocrit.  The results showed it is possible to predict diabetic retinopathy with 92.76% 
accuracy using only the results of a routine blood test. The accuracy of our CDSS may not be as 
high as the fundus image-based solutions (for example, Kumar and Madheswaran [57] reached an 
accuracy of 97%), but considering the ease-of-use and the cost-effectiveness of our approach, the 
resulting CDSS is not only competitive to the existing fundus image-based solutions, but also it 
can reduce the currently high rate of noncompliance with annual routine ophthalmologic exams. 
A conspicuous benefit of our CDSS, therefore, is a lower number of patients who would 
eventually develop retinopathy, which in turn will result in a more efficient healthcare delivery 
and management system. 
Medical researchers and clinicians (e.g., Sabanayagam, et al. [122]) have noted the necessity of 
developing an accurate predictive model for diabetic retinopathy. We believe our CDSS, which 
has several practical and clinical applications, fills this gap. First, as mentioned earlier, it makes 
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up for the low compliance rate of annual comprehensive eye examination for retinopathy. This 
annual eye examination is necessary for every diabetic patient, but because of inconvenience of 
the procedure and unavailability of equipment and specialists, it has one of the lowest compliance 
rates in the U.S. healthcare. Second, the input to this CDSS is nothing but the results of a routine 
blood test that makes it easy for clinicians, and even for patients, to use. Unlike the current 
procedure of diagnosing retinopathy, there is no need for an ophthalmologist and special cameras 
to employ this CDSS; clinician can refer high risk patients (based on the result of our CDSS) to 
ophthalmologists for more accurate examination and potential treatments. Third, our models 
identify factors that are most strongly related to diabetic retinopathy. By controlling these factors, 
doctors and patients will be able to manage the course of the disease in a more effective way. 
Finally, applying our CDSS can help detect this complication at early stages, and since there 
exists an effective laser therapy to prevent the progress of retinopathy, vision can be saved for 
many diabetic patients.  
In conclusion, considering the prevalence of retinopathy among diabetic patients (about one third 
of diabetics have retinopathy [123]) and the significant proportion of individuals whose 
susceptibility to retinopathy remains undiagnosed (about 50% of all diabetic retinopathy patients), 
our CDSS provides a great value to people who suffer from diabetes all over the world. Based on 
the current statistics (about 30 million in the US and  415 million worldwide [2]), diabetic 
retinopathy remains undiagnosed in 5.5 million US citizens (30𝑀 × 30% × 50% = 5.5𝑀) and in 
more than 62 million individuals around the globe (415𝑀 × 30% × 50% = 62.25𝑀). Therefore, 
if our CDSS helps diagnose even a small percentage of these cases at early stages of the disease, 
vision, and quality of life, can be saved for a large number of diabetics. Although we cannot 
appraise the value of sight to an individual, we can enumerate some of the costs associated with 
losing it, such as medical care, assistance programs, and loss of productivity costs. Therefore, the 
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application of our CDSS helps save a large amount of expenses in both healthcare and welfare 
systems. 
We admit that our study has a number of limitations. First, in the EMR data we used, we did not 
have information about the time a patient’s disease was first diagnosed.  As a results, we could 
not incorporate the duration of time the patients lived with diabetes into our models. Since longer 
duration of diabetes has been shown to be a strong predictor of retinopathy [62], our CDSS could 
even perform better had we had access to the patients’ date of diagnosis.  Fortunately, having 
access to several other predictors made up for the lack of this variable.  Additionally, we should 
note that every machine learning technique has several parameters that can be adjusted. Even 
though we tried to systematically adjust these parameters to achieve better results, those values 
cannot be considered optimal.
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CHAPTER V 
 
 
DEVELOPING A SYNTHETIC INFORMATIVE MINORITY OVER-SAMPLING (SIMO) 
ALGORITHM EMBEDDED INTO SUPPORT VECTOR MACHINE TO LEARN FROM 
IMBALANCED DATASETS 
 
 
 
In this chapter, we describe our proposed synthetic informative minority over-sampling (SIMO) 
algorithm, which is imbedded into support vector machine (SVM) for learning from imbalanced 
datasets. Here we discuss why we chose over-sampling versus other methods to handle the 
imbalanced data learning challenge, and why we chose SVM. 
First, to apply a sampling method, no extra information is required other than the dataset itself 
[124]. However, in cost-sensitive methods, the information about the misclassification cost for 
each class is required, while this kind of information is unknown. The only known fact is that the 
misclassification cost for minority class is higher than misclassification cost for majority class 
([88],[76]).  Second, we apply over-sampling versus under-sampling. The major limitation in 
under-sampling is the possibility of losing important information by removing some parts of the 
data, while there is not such a problem in over-sampling. 
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There are three main reasons for choosing SVM as the classifier. First, this method has a very 
strong and at the same time simple theoretical background which makes it easy to explain 
intuitively [125]. Second, this method develops a hyperplane (decision boundary) that separates 
the data space for classifying the data points (examples). It is known that the data points near the 
decision boundary are more important and difficult to classify [126]. Therefore, identifying the 
near boundary data samples is rather easy in SVM. Finally, SVM has been shown to have a very 
good performance and high generalization power in many practical applications compared to 
other machine learning techniques ([125], [100]). 
5.1. Support Vector Machine 
SVM is a machine learning technique that can be applied to both regression and pattern 
recognition (classification) problems. For the classification, SVM develops a decision boundary 
that separates two classes in the data space. To build this decision boundary, SVM maximizes the 
separating margin between two classes in the data space while it minimizes the classification 
error. Figure 5.1 shows a linear SVM decision boundary. Dots and stars denote the two classes in 
the data. The data points that lie on the margins at both sides of the decision boundary are called 
support vectors. These support vectors are shown in Figure 5.1 with a circle around them. 𝑤 is the 
normal to the decision boundary and 𝑏/|𝑤| is the perpendicular distance of the decision boundary 
from the origin [127]. When two classes are not completely separable, some of the examples will 
be misclassified. In Figure 5.1, one star data point has misclassified as a dot, the distance of this 
point from the decision boundary is −𝜀/|𝑤|. 
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Figure 5.1-Linear SVM hyperplane 
SVM can be applied to both linear and non-linear separable problems. When two classes are not 
linearly separable, kernel trick can be employed and the data is mapped to a feature space (using a 
mapping function 𝜙(. )), which is in a higher dimension [128]. In the feature space, two classes 
will be linearly separable and the problem will be handled similar to the linearly separable case.  
Now we describe the SVM mathematical formulation. Let the training dataset for a two-class 
problem be represented as S = {(𝑥1, 𝑦1), (𝑥2, 𝑦2), … , (𝑥𝑁, 𝑦𝑁) } . 𝑥1, 𝑥2, … , 𝑥𝑁 ∈ 𝑅
𝑚  are the 𝑚 
dimensional training data points and 𝑦1, 𝑦2, … , 𝑦𝑁 ∈ {−1, +1} are their corresponding class labels 
(-1 for majority class and +1 for minority class). By solving the optimization problem in 
Formulation 5.1, SVM develops a decision boundary that separates two classes. 
min
𝑤,𝑏 
1
2
𝑤𝑇𝑤 + 𝐶 ∑ 𝜀𝑖
𝑁
𝑖=1  (5.1) 
𝑠. 𝑡.  
𝑦𝑖(𝑤
𝑇𝜙(𝑥𝑖) + 𝑏) ≥ 1 − 𝜀𝑖 
𝜀𝑖 ≥ 0 
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𝜀𝑖 are positive slack variables. When a classification error occurs, these variables will be greater 
than 1. 𝐶 is a parameter that determines the error penalty. 𝐶, which the user chooses is a tradeoff 
between minimizing the error and maximizing the margin. 
Usually the Lagrangian formulation of SVM is solved (Formulation 5.2). The Lagrangian 
formulation is easier to handle because the constraints in Formulation 5.1 are replaced by 
Lagrangian multipliers [127]. 
𝐿𝑃(𝑤, 𝑏, 𝜀, 𝛼, 𝜇) =
1
2
𝑤𝑇𝑤 + 𝐶 ∑ 𝜀𝑖
𝑁
𝑖=1 − ∑ 𝛼𝑖(𝑦𝑖(𝑤
𝑇𝜙(𝑥𝑖) + 𝑏) − 1 + 𝜀𝑖) − ∑ 𝜇𝑖𝜀𝑖
𝑁
𝑖=1
𝑁
𝑖=1  (5.2) 
where 𝛼𝑖  and 𝜇𝑖  are positive Lagrangian multipliers associated with first and second sets of 
constraints in Formulation 5.1. The Krush-Kuhn-Tucker conditions for the Lagrangian primal 
(Formulation 5.2) are as follows, 
𝑤 = ∑ 𝛼𝑖𝑦𝑖
𝑁
𝑖=1 𝜙(𝑥𝑖) (5.3) 
0 ≤ 𝛼𝑖 ≤ 𝐶 (5.4) 
∑ 𝛼𝑖
𝑁
𝑖=1 𝑦𝑖 = 0 (5.5) 
The Lagrangian dual form of Formulation 5.2 is obtained by replacing the Equation 5.3 in 5.2. 
Formulation 5.6 shows the Lagrangian dual [127], 
max 
𝛼 
 ∑ 𝛼𝑖 −
𝑁
𝑖=1
1
2
∑ ∑ 𝛼𝑖𝛼𝑗𝑦𝑖𝑦𝑗 𝐾(𝑥𝑖 , 𝑥𝑗)
𝑁
𝑗=1   
𝑁
𝑖=1  (5.6) 
𝑠. 𝑡. 
 ∑ 𝛼𝑖
𝑁
𝑖=1 𝑦𝑖 = 0 
0 ≤ 𝛼𝑖 ≤ 𝐶 
where 𝐾(𝑥𝑖, 𝑥𝑗) = 𝜙(𝑥𝑖)
𝑇𝜙(𝑥𝑗) is the kernel function that calculates the inner product of data 
points in the feature space. 
The solution for 𝑤 is given by 
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𝑤 = ∑ 𝛼𝑖𝑦𝑖
𝑁𝑠
𝑗=1 𝜙(𝑥𝑖) (5.7) 
Here 𝑁𝑠 is the number of support vectors. In fact Equation 5.7 is the same as Equation 5.3, but 
because in the optimal solution of the Lagrangian dual only 𝛼𝑖 corresponding to the support vectors 
have non-zero values, the summation in Equation 5.7 is only on support vectors [127]. 
To determine the class of a new sample, 𝑥, a sign function (sgn(.)) is used, it is obtained using, 
𝑦 = 𝑠𝑔𝑛{𝑤𝑇𝜙(𝑥) + 𝑏} (5.8) 
or 
 𝑦 = 𝑠𝑔𝑛{∑ 𝛼𝑖
∗𝑦𝑖  𝐾(𝑥𝑖, 𝑥) + 𝑏
𝑁𝑠
𝑖=1 }         (5.9) 
where 𝛼∗ is the solution of Lagrangian formulation in 5.6. 
SVM on Imbalanced Datasets 
Although SVM has a very good performance on balanced datasets, when applied to imbalanced 
datasets, its performance deteriorates dramatically, especially on the minority class. The SVM 
decision boundary in an imbalanced dataset is closer toward the minority class region compared 
to the ideal classification decision boundary. As a result, a considerable number of minority class 
examples will be misclassified as the majority. Wu and Chang [129] mentioned two reasons for 
this decision boundary skewness. The first reason is in regard to the imbalanced training data 
ratio, because the negative data points outnumber the positive examples, these positive examples 
are further away from the “ideal” decision boundary compared to the majority examples. Second, 
the imbalanced supports vector ratio, because the number of the negative (majority class) support 
vectors is much more than the positive (minority class) support vectors, a positive test data point 
might have more negative support vector neighbors, and as a result will be misclassified as 
negative (majority) class. Akbani, et al. [97] pointed out another reason for the skewed decision 
boundary. The objective of the SVM model is to maximize the margin between two classes as 
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well as minimizing the classification errors and there is a tradeoff between these two. When the 
number of negative examples is much more than the positive ones, the cumulative 
misclassification cost of the positive points is relatively small, therefore SVM tends to maximize 
the margin to its highest possible degree by classifying most (sometimes all) of the examples as 
negative. Thus, the decision boundary will be shifted toward the minority class region. In the next 
section, we describe our proposed remedy to this problem. 
5.2. SIMO and W-SIMO Algorithms 
In this study, we developed a novel synthetic informative minority over-sampling (SIMO) 
algorithm embedded into SVM. As we mentioned earlier, when SVM is applied to an imbalanced 
dataset, the decision boundary will be closer to the minority class space in favor of the majority 
class examples. Therefore, a considerable portion of minority examples will be misclassified. In 
SIMO, we generate synthetic data points that belong to the minority class. In this way, the 
distribution of the dataset will be more balanced and a better performance will be expected from 
machine learning techniques. Research has shown the data points that are close to the boundary of 
classes are the important data points in forming the classifiers [76]. Therefore, in SIMO we focus 
on the minority data points near the boundary of two classes. 
The first step in performing SIMO (Algorithm 5.1) is to partition the dataset into training and test 
datasets. This partitioning is conducted in a way that the imbalance ratio in training and test 
datasets will be the same as the imbalance ratio in the original dataset. The reason for partitioning 
the data is to avoid biases and to assess the SIMO performance fairly on imbalanced data with the 
original imbalance ratio (test dataset). Next, we calculate the imbalanced gap in the training 
dataset. Imbalanced gap is the difference between the number of majority examples and minority 
examples in the training dataset. Imbalanced gap is the upper bound for generating the synthetic 
data points in our algorithm. In the next stage, we develop a SVM on the original imbalanced 
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training dataset and evaluate this initial model by computing the G mean. As it can be seen in 
Figure 5.2a, the initial SVM decision boundary is close to the minority class data space in favor 
of majority class data space and the ideal decision boundary should be located farther away from 
the minority dataspace.  
The next step in SIMO is to calculate the Euclidean distance of the minority data points from the 
SVM decision boundary. As we mentioned earlier, data points close to the boundary of classes 
are important and informative. In order to select the informative minority data points, we identify 
those that are close to the SVM decision boundary. Therefore, after calculating the Euclidean 
distance of the minority data points from the decision boundary, the top ∆% of them that are the 
closest ones to the decision boundary will be selected as informative minority data points (Figure 
5.2b). Next, we generate synthetic data points in the space of the informative minority examples 
and append the generated data points to the training dataset. At this stage, we have a new training 
dataset that includes more minority examples compared to the previous training dataset (Figure 
5.2c). The number of synthetically generated data points and their indices will be recorded at each 
iteration. Next, a new SVM will be developed on the updated training dataset. The decision 
boundary of this new SVM will be shifted toward the majority class data space closer to the ideal 
decision boundary (Figure 5.2d). The reason is that by generating synthetic minority examples, 
the imbalance ratio of the training dataset will be reduced and following that, the imbalance ratio 
of the support vectors will be alleviated. Therefore, the decision boundary will be shifted toward 
the majority class dataspace (As we discussed in detail in Section 5.1, the position of the SVM 
decision boundary only depends on the support vectors). The new SVM will be assessed by 
computing the G mean, and the G mean will be logged into a vector for further evaluations. 
Again, in the updated training dataset, the Euclidean distance of the minority data points from the 
new SVM decision boundary is calculated, informative ones will be selected, and new synthetic 
minority data points will be generated. Another SVM will be developed on the updated dataset, 
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the SVM will be assessed, and the results will be recorded. These steps will be repeated until the 
number of synthetically generated examples reaches the imbalanced gap. 
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Figure 5.2- SIMO algorithm mechanism (simplified) 
The performance of machine learning techniques highly depends on the structure and complexity 
of datasets. In our algorithm, in each iteration, we create a new updated dataset by generating 
more synthetic minority examples. Even though the performance of the SVM improves on the 
updated training datasets compared to the original imbalanced dataset, the improvement in the 
performance of the SVM in each iteration compared to the previous iteration is not guaranteed in 
all datasets. In the other words, the G mean might not always be increasing through the iterations. 
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Therefore, we keep track of the SVM performances and their corresponding training dataset in 
each iteration. At the end of the loop, the best performing model is identified by comparing the G 
mean values, and the training dataset associated with that model/iteration will be selected as the 
final over-sampled training dataset. 
In this study, we proposed another version of SIMO that we call weighted synthetic informative 
minority over-sampling (W-SIMO). Steps 1 to 8 in W-SIMO (Algorithm 5.2) are the same as 
SIMO, i.e. an initial SVM is developed on the original imbalanced training dataset, and top ∆% 
minority data points close to the SVM decision boundary are identified as informative minority 
examples. In the next step, informative minority examples will be classified into two groups: first, 
those that are correctly classified (𝑆inf_c
+ ) through SVM, and second, those that are incorrectly 
classified (𝑆inf_ic
+ ). The data points in 𝑆inf_ic
+  will be over-sampled to a higher degree compared to 
the data points in 𝑆inf_c
+ . We adopt this idea from AdaBoost, which pays more attention to the 
incorrectly classified examples [89]. In W-SIMO, by over-sampling the examples in 𝑆inf_ic
+  with a 
higher degree, we consider them even more informative compared to the examples in 𝑆inf_c
+ . It 
means that more synthetic minority data points will be generated in the space of 𝑆inf_ic
+  examples. 
After over-sampling (synthetically generating) the informative minority data points in 𝑆inf_ic
+  and 
𝑆inf_c
+ , the reminder of the W-SIMO is similar to SIMO. Applying the SIMO and W-SIMO is not 
limited to the SVM. We use SVM in our algorithms to identify informative data points to over 
sample them, however the final over-sampled data can be used in any other machine learning 
technique, such as decision tree, logistic regression, and random forest. The notations of 
Algorithms 5.1 and 5.2 are shown in Table 5.1. 
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Table 5.1-Notations for SIMO and W-SIMO algorithms 
Notations 
D: Initial imbalanced dataset 
?̂?: Initial imbalanced training dataset 
T: Imbalanced test dataset 
∆: Top ∆% of minority data points close to decision boundary 
𝒑: Oversampling degree for minority informative data points that are correctly classified at 
each iteration 
𝑷: Oversampling degree for minority informative data points that are incorrectly classified at 
each iteration 
𝑺_𝑮_𝑫: Synthetic generated data points count 
𝑴𝒂𝒙_𝑰: Maximum iteration number 
𝑮_𝒎_𝑳: 𝑮 𝒎𝒆𝒂𝒏 variation log in each iteration 
 
Algorithm 5.1- SIMO 
Given 𝐷, ∆, 𝑝, 𝑀𝑎𝑥_𝐼 
1. Partition 𝐷 into Training ?̂?, and Test 𝑇 datasets 
2. Calculate the 𝐼𝑚𝑏𝑎𝑙𝑎𝑛𝑐𝑒𝑑_𝐺𝑎𝑝 in ?̂? 
𝐼𝑚𝑏𝑎𝑙𝑎𝑛𝑐𝑒_𝐺𝑎𝑝 = 𝑀𝑎𝑗𝑜𝑟𝑖𝑡𝑦_𝐶𝑜𝑢𝑛𝑡 − 𝑀𝑖𝑛𝑜𝑟𝑖𝑡𝑦_𝐶𝑜𝑢𝑛𝑡 
3. Develop the 𝐼𝑛𝑖𝑡𝑖𝑎𝑙 𝑆𝑉𝑀 model on ?̂?, 𝐼𝑛𝑖𝑡𝑖𝑎𝑙 𝑆𝑉𝑀 decision boundary: 𝐷_?̂? = ?̂?𝑇𝑥 + ?̂?      
{?̂? = ∑ ?̂?𝑖𝑦𝑖
𝑁𝑠
𝑗=1 𝜙(𝑥𝑖)} 
4. Compute 𝐺 𝑚𝑒𝑎𝑛 for 𝐼𝑛𝑖𝑡𝑖𝑎𝑙 𝑆𝑉𝑀 on 𝑇: 𝐼𝑛𝑖𝑡𝑖𝑎𝑙_𝐺 𝑀𝑒𝑎𝑛 
5. 𝑆 = ?̂?, 𝐼 = 0 (𝑖𝑡𝑒𝑟𝑎𝑡𝑖𝑜𝑛), 𝑆𝑉𝑀 = 𝐼𝑛𝑖𝑡𝑖𝑎𝑙 𝑆𝑉𝑀, 𝐷_𝐵 = 𝐷_?̂?, 
𝐺_𝑚_𝐿 = 𝐼𝑛𝑖𝑡𝑖𝑎𝑙_𝐺 𝑀𝑒𝑎𝑛,   𝑆_𝐺_𝐷 = 0 
While   𝑆_𝐺_𝐷 <  𝐼𝑚𝑏𝑎𝑙𝑎𝑛𝑐𝑒_𝐺𝑎𝑝 AND 𝐼 < 𝑀𝑎𝑥_𝐼 
6. 𝐼 = 𝐼 + 1 
7. Calculate the Euclidean distance of minority data points form 𝐷_𝐵 
𝐸𝑢𝑐_𝐷(𝑥𝑘+) =
| ∑ 𝑤𝑡𝑥𝑡
𝑘+ + 𝑏|𝑚𝑡=1
√∑ 𝑤𝑡 2
𝑚
𝑡=1
 
8. Identify informative minority data points: 𝑆𝑖𝑛𝑓
+  
Top ∆% of minority data points close to 𝐷_𝐵 based on the Euclidean distance 
9. Over-sample data points in 𝑆inf
+  by 𝑝%, name the synthetic generated data points ?́?𝑖𝑛𝑓
+  
10. 𝑆 = 𝑆 ∪ ?́?𝑖𝑛𝑓
+  
11. Calculate the number of synthetic generated data points 
𝑆_𝐺_𝐷 = 𝑆_𝑐𝑜𝑢𝑛𝑡 − ?̂?_𝑐𝑜𝑢𝑛𝑡 
12. Develop a support vector machine on 𝑆, 𝑆𝑉𝑀 
13. Compute 𝐺 𝑚𝑒𝑎𝑛 for 𝑆𝑉𝑀 on 𝑇 
14. Add the 𝐺 𝑚𝑒𝑎𝑛 to the 𝐺_𝑚_𝐿, (𝐺_𝑚_𝐿 = [𝐺_𝑚_𝐿; 𝐺 𝑚𝑒𝑎𝑛]) 
End   
15. Find the maximum  𝐺 𝑚𝑒𝑎𝑛 and its index in 𝐺_𝑚_𝐿 
16. Select the over-sampled training dataset associated with the maximum 𝐺 𝑚𝑒𝑎𝑛 
17. Train the model of interest on the final over-sampled training dataset 
18. Evaluate the model on the test dataset by computing the 𝐺 𝑚𝑒𝑎𝑛 and 𝐴𝑈𝐶 
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Algorithm 5.2- W-SIMO 
Given 𝐷, ∆, 𝑝, 𝑃, (𝑝 < 𝑃), 𝑀𝑎𝑥_𝐼 
1. Partition 𝐷 into Training ?̂?, and Test 𝑇 datasets 
2. Calculate the 𝐼𝑚𝑏𝑎𝑙𝑎𝑛𝑐𝑒𝑑_𝐺𝑎𝑝 in ?̂? 
𝐼𝑚𝑏𝑎𝑙𝑎𝑛𝑐𝑒_𝐺𝑎𝑝 = 𝑀𝑎𝑗𝑜𝑟𝑖𝑡𝑦_𝐶𝑜𝑢𝑛𝑡 − 𝑀𝑖𝑛𝑜𝑟𝑖𝑡𝑦_𝐶𝑜𝑢𝑛𝑡 
3. Develop the 𝐼𝑛𝑖𝑡𝑖𝑎𝑙 𝑆𝑉𝑀 model on ?̂?, 𝐼𝑛𝑖𝑡𝑖𝑎𝑙 𝑆𝑉𝑀 decision boundary: 𝐷_?̂? = ?̂?𝑇𝑥 +
?̂?      
{?̂? = ∑ ?̂?𝑖𝑦𝑖
𝑁𝑠
𝑗=1 𝜙(𝑥𝑖)} 
4. Compute 𝐺 𝑚𝑒𝑎𝑛 for 𝐼𝑛𝑖𝑡𝑖𝑎𝑙 𝑆𝑉𝑀 on 𝑇: 𝐼𝑛𝑖𝑡𝑖𝑎𝑙_𝐺 𝑀𝑒𝑎𝑛 
5. 𝑆 = ?̂?, 𝐼 = 0 (𝑖𝑡𝑒𝑟𝑎𝑡𝑖𝑜𝑛), 𝑆𝑉𝑀 = 𝐼𝑛𝑖𝑡𝑖𝑎𝑙 𝑆𝑉𝑀, 𝐷_𝐵 = 𝐷_?̂?, 
𝐺_𝑚_𝐿 = 𝐼𝑛𝑖𝑡𝑖𝑎𝑙_𝐺 𝑀𝑒𝑎𝑛,   𝑆_𝐺_𝐷 = 0 
While   𝑆_𝐺_𝐷 <  𝐼𝑚𝑏𝑎𝑙𝑎𝑛𝑐𝑒_𝐺𝑎𝑝 AND 𝐼 < 𝑀𝑎𝑥_𝐼 
6. 𝐼 = 𝐼 + 1 
7. Calculate the Euclidean distance of minority data points form 𝐷_𝐵 
𝐸𝑢𝑐_𝐷(𝑥𝑘+) =
| ∑ 𝑤𝑡𝑥𝑡
𝑘+ + 𝑏|𝑚𝑡=1
√∑ 𝑤𝑡 2
𝑚
𝑡=1
 
8. Identify informative minority data points: 𝑆𝑖𝑛𝑓
+  
Top ∆% of minority data points close to 𝐷_𝐵 based on the Euclidean distance 
 
9. Classify informative minority data points using the 𝑆𝑉𝑀 model, form: 
i. 𝑆inf_c
+ , informative minority data points that are correctly classified 
ii. 𝑆inf_𝑖𝑐
+ , informative minority data points that are incorrectly classified 
10. Over-sample data points in 𝑆inf_c
+  by 𝑝%, name the synthetic generated data points ?́?𝑖
+ 
11. Over-sample data points in 𝑆inf_𝑖𝑐
+  by 𝑃%, name the synthetic generated data points ?́?𝑖𝑖
+ 
12. 𝑆 = 𝑆 ∪ ?́?𝑖
+ ∪ ?́?𝑖𝑖
+ 
13. Calculate the number of synthetic generated data points 
𝑆_𝐺_𝐷 = 𝑆_𝑐𝑜𝑢𝑛𝑡 − ?̂?_𝑐𝑜𝑢𝑛𝑡 
14. Develop a support vector machine on 𝑆, 𝑆𝑉𝑀 
15. Compute 𝐺 𝑚𝑒𝑎𝑛 for 𝑆𝑉𝑀 on 𝑇 
16. Add the 𝐺 𝑚𝑒𝑎𝑛 to the 𝐺_𝑚_𝐿, (𝐺_𝑚_𝐿 = [𝐺_𝑚_𝐿; 𝐺 𝑚𝑒𝑎𝑛]) 
End   
17. Find the maximum  𝐺 𝑚𝑒𝑎𝑛 and its index in 𝐺_𝑚_𝐿 
18. Select the over-sampled training dataset associated with the maximum 𝐺 𝑚𝑒𝑎𝑛 
19. Train the model of interest on the final over-sampled training dataset 
20. Evaluate the model on the test dataset by computing the 𝐺 𝑚𝑒𝑎𝑛 and 𝐴𝑈𝐶 
 
5.3. Numerical Experiments 
In this section, we provide the results of our numerical experiments to assess the performance of 
SIMO and W-SIMO compared to other existing algorithms in imbalanced data learning. First, we 
describe the evaluation metrics that we used for the assessments. Second, we provide the 
characteristics of the benchmark imbalanced datasets that we used. Finally, we present the results 
of the numerical experiments. 
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Evaluation Metrics 
In classification or pattern recognition problems confusion matrix plays an important role to 
assess the predictive models. Figure 5.3 shows a confusion matrix. As was pointed out earlier, in 
this study, we consider the minority class as positive, and the majority class as negative class. 
Accuracy of prediction (Formulation 5.10) is a common evaluation metric in the balanced 
datasets; however, it is misleading in assessing the predictive models when applied in imbalanced 
datasets. Consider an imbalanced dataset with the 10% rate of the positive examples. Because 
negative examples outnumber the positive ones, simply classifying all of the examples as 
negative will result in a 90% accuracy. Therefore, in imbalanced datasets other appropriate 
evaluation metrics such as sensitivity, specificity, G mean, and AUC should be applied [130]. 
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Figure 5.3-Confusion Matrix 
𝐴𝑐𝑐𝑢𝑟𝑎𝑐𝑦 =
𝑇𝑃+𝑇𝑁
𝑇𝑃+𝐹𝑁+𝐹𝑃+𝑇𝑁
 (5.10) 
Sensitivity or true positive rate (TPR) (it is also called hit rate or recall) is a metric that evaluates 
the accuracy of predicting the positive examples. On the other hand, specificity or true negative 
rate (TNR) assesses the accuracy of detecting the negative examples. Formulations 5.11 and 5.12 
show the calculation of TPR and TNR. 
𝑇𝑃𝑅 =
𝑇𝑃
𝑇𝑃+𝐹𝑁
 (5.11) 
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𝑇𝑁𝑅 =
𝑇𝑁
𝐹𝑃+𝑇𝑁
 (5.12) 
TPR and TNR assess the detection accuracy in positive and negative examples separately. 
Therefore, considering one of them without the other one would not be helpful, therefore, we 
need a metric such as G mean that incorporates these two metrics at the same time. G mean is the 
geometric mean of TPR and TNR (Formulation 5.13). Thus, any model with poor performance on 
either positive or negative examples will have a low G mean. 
𝐺 𝑚𝑒𝑎𝑛 = √𝑇𝑃𝑅 × 𝑇𝑁𝑅 (5.13) 
Another assessment tool that is independent of the data distribution is Receiving Operator 
Characteristic (ROC) chart. ROC shows the tradeoff between TPR and TNR by manipulating the 
decision cut-off. Decision cut-off is the threshold value for decision making based on the output 
of a predictive model. When the decision cut-off for a model is 0, all of the examples will be 
classified as positive, therefore TPR=100% but TNR=0%. On the other hand, if decision cut-off 
is 1, TPR=0% and TNR=100%. Thus, by changing the decision cut-off from 1 to 0, we can 
increase the TPR, and TNR will decrease at the same time. In ROC chart, the x-axis shows the 1-
TNR and y-axis denotes the TPR, in this way the graph will be increasing. Each point on the 
ROC chart shows the value of TPR and 1-TNR for a specific decision cut-off value. The closer 
the ROC chart to the top left point, the better the performance of the classifier. Figure 5.4 shows a 
ROC chart, the 45-degree line is the base line model (random), the dash line corresponds to a 
good performing model, and dotted line is for the perfect model. An easier way to assess the 
models and compare different classifiers is to measure the area under the curve (AUC) in ROC 
chart. AUC takes values between 0 to 100%. AUC for the base line model is 50%, and therefore, 
classifiers with AUC below 50% are even worse than random guess. The closer the AUC of 
classifier to 100%, the better the performance of the classifier.  
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Figure 5.4-ROC chart 
Datasets 
In this study, we used 15 benchmark imbalanced datasets that are publicly available in UCI 
Machine Learning Repository (http://archive.ics.uci.edu/ml/). We tried to use datasets with 
various imbalance ratios from 1:1.38 to 1:8.9, i.e. the percentage of minority class in the 
benchmark datasets ranges from 42% to 10%. To test SIMO and W-SIMO on datasets with more 
severe imbalance ratio, we randomly removed some portions of minority class examples from 
Breast Cancer dataset and generated datasets with 1:3.91(BreastC20 dataset) and 1:8.9 
(BreastC10) imbalance ratio. Table 5.2 shows the name and characteristics of these datasets. 
Results 
In this study, we compared the performance of our algorithms, SIMO and W-SIMO to six other 
exiting approaches in imbalanced data learning. We also provided the modeling results on the 
original imbalanced data for reference. For all of the algorithms, we used the parameters 
suggested by their developers. We assessed SIMO and W-SIMO in comparison with these 
algorithms: under-sampling, SMOTE, borderline SMOTE, safe-level SMOTE, cluster SMOTE, 
and cost sensitive SVM. In cost sensitive SVM, we assigned the error cost of the two classes 
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based on the imbalance ratio in the dataset. For instance, if the imbalance ratio in a data is 1:4, the 
error cost for the minority class is 4 times greater that the error cost for majority class. 
Table 5.2 -Benchmark datasets characteristics 
Dataset Minority 
class 
Majority 
class 
# of 
variables 
# of 
records 
Imbalance 
ratio 
Liver Disorders (Liver) “1” “2” 7 345 1 : 1.38 
Ionosphere bad good 34 351 1 : 1.79 
Pima Indians Diabetes (Pima) “1” “0” 8 768 1 : 1.87 
Breast Cancer Wisconsin Original 
(BreastCO) 
malignant benign 
10 699 
1 : 1.91 
Iris Versicolor All other 5 150 1 : 2 
Yeast NUC All other 8 1484 1 : 2.6 
Statlog Vehicle Silhouettes (Vehicle) van All other 18 846 1 : 3.25 
Contraceptive Method Choice (CMC) Long-term All other 9 1473 1 : 3.42 
Breast Cancer Wisconsin_20% 
(BreastC20) 
malignant benign 
10 699 
1 : 3.91 
Connectionist Bench_Vowel 
Recognition (Vowel) 
“0” & “1” All other 
11 990 
1 : 4.5 
Ecoli pp All other 8 336 1 : 5.46 
Libras Movement_12 (Libras12) “1” & “2” All other 91 360 1 : 5.88 
Libras Movement_34 (Libras34) “3” & “4” All other 91 360 1 : 6.34 
Glass Identification (Glass) “7” All other 9 214 1 : 6.38 
Breast Cancer Wisconsin_10% 
(BreastC10) 
malignant benign 
10 699 
1 : 8.9 
 
To avoid over-fitting and fairly assess the generalizability and performance of various 
approaches, we applied 4-fold cross validation in our numerical experiments [74].  In a 4-fold 
cross validation, the original dataset is partitioned into four mutually exclusive and exhaustive 
subsets with equal sizes (𝑆𝑢𝑏1, 𝑆𝑢𝑏2, 𝑆𝑢𝑏3, and 𝑆𝑢𝑏4). Then, the models are developed four 
times, each time the model is trained on three of the subsets, and is tested on the fourth one. The 
final performance will be the average of the models 1, 2, 3, and 4. Figure 5.5 shows the 
mechanism of 4-fold cross validation.  
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Figure 5.5- 4-fold cross validation mechanism 
In order to further reduce the effect of randomness, we ran each 4-fold cross validation on all 
approaches 10 times. Therefore, each approach has been applied to each dataset 40 times. As a 
result, for each evaluation metric we have both average value and 95% confidence interval. 
Tables 5.3 and 5.4 show the performance of all of the 8 imbalanced data learning approaches as 
well as the learning from original imbalanced dataset in a linear SVM classifier. The first row for 
each dataset in this table shows the evaluation metric average (G mean in Table 5.3 and AUC in 
Table 5.4), the second row shows the half of the 95% confidence interval width (HCI) for the 
evaluation metric, and the third row shows the performance ranking of each approach compared 
to other approaches. 
As it can be seen in Tables 5.3 and 5.4, in all of the 15 imbalanced datasets, our proposed 
algorithms, SIMO and W-SIMO had the best performance compared to other approaches 
(approaches with ranks 1, 2, and 3 are bolded in Tables 5.3 and 5.4). In addition, the difference 
between the G mean and AUC value for SIMO and W-SIMO and other approaches is significant. 
To show this difference and the achieved improvement thorough applying our algorithm, we 
calculated the difference between the G mean and AUC of our algorithm and the G mean and 
AUC of the best algorithm among other approaches (the approach with rank 3 in Tables 5.3 and 
5.4) in all datasets. We also calculated the difference between the G mean and AUC of the best 
and second best algorithms among approaches other than our algorithm (the approaches with rank 
3 and 4 in Tables 5.3 and 5.4) in all 15 benchmark datasets. Table 5.5 shows the average of these 
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differences in all datasets. We ran a t-test to compare the improvement from the approach with 
rank 3 to our algorithm with the achieved improvement from the approach with rank 4 to the 
approach with rank 3 (best and second best approaches not including SIMO and W-SIMO). The 
p-values for G mean and AUC were 0.0091 and 0.0122 respectively. Therefore, the t-test showed 
that the difference between our algorithm and the best algorithm among other existing approaches 
was significantly greater than the difference between the approaches with rank 3 and 4 at the 
confidence level of 95%. Table 5.6 demonstrates the overall ranking of SIMO and W-SIMO 
compared to other imbalanced data learning approaches when applied to linear SVM. The overall 
ranking is calculated based on the average of various approaches’ ranking in 15 benchmark 
datasets. Since W-SIMO and SIMO had the first and second places in all datasets, their overall 
ranking is 1.1 and 1.9 respectively. 
As we mentioned earlier, the oversampled training data by SIMO and W-SIMO can be used in 
any other machine learning technique. Therefore, SIMO and W-SIMO can be considered pre-
processing oversampling algorithms. To evaluate the performance of SIMO and W-SIMO in 
other data mining techniques, we applied them in SVM with RBF kernel function, logistic 
regression, and decision tree. Tables 5.7, 5.8, and 5.9 present the overall rankings of our 
algorithms as well as their counterparts when applied to SVM with RBF kernel, logistic 
regression, and decision tree in all benchmark datasets. As it can be seen in Tables 5.7, 5.8, and 
5.9, the overall ranking of W-SIMO and SIMO is not about 1 and 2, unlike what we observed in 
Table 5.6. This means that our algorithms were not always the best when applied in machine 
learning techniques other than linear SVM. In fact, these results were expected since SIMO and 
W-SIMO are imbedded into linear SVM, therefore, we expected them to have a better 
performance in linear SVM. Even though our algorithms were not always the best ones in other 
machine learning techniques, their overall performance was better compared to other approaches. 
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As Tables 5.7, 5.8, and 5.9 show, either SIMO or W-SIMO was the best overall algorithm in 
SVM with RBF kernel, logistic regression, and decision tree. 
Table 5.5-Average difference between our algorithm and other approaches 
 Average difference between our algorithm 
and the best one among other approaches 
Average difference between the best and 
second best ones among other approaches 
G mean 2.46% 0.44% 
AUC 2.28% 0.24% 
 
Table 5.6-Overall ranking on linear SVM 
Approach G Mean AUC 
W-SIMO 1.1 1.1 
SIMO 1.9 1.9 
Cluster SMOTE 4.7 4.7 
Cost Sensitive 5.0 5.2 
SMOTE 5.5 5.6 
Safe Level SMOTE 5.5 5.7 
Under Sampling 6.3 6.3 
BorSMOTE 7.3 7.1 
Original Data 7.7 7.3 
 
Table 5.7-Overall ranking- SVM-RBF kernel 
Approach G Mean AUC 
W-SIMO 3.3 3.0 
Cluster SMOTE 3.7 3.7 
SIMO 4.4 4.0 
Cost Sensitive 4.7 5.1 
Under Sampling 4.9 5.1 
Safe Level SMOTE 5.3 5.2 
SMOTE 5.3 5.4 
BorSMOTE 5.9 6.3 
Original Data 7.3 7.2 
 
 
Table 5.8-Overall ranking on logistic regression 
Approach G Mean AUC 
W-SIMO 2.9 2.9 
Cluster SMOTE 3.1 3.0 
SMOTE 3.6 3.7 
SIMO 3.9 4.1 
Safe Level SMOTE 4.4 4.4 
Under Sampling 5.2 5.1 
BorSMOTE 5.8 5.8 
Original Data 7.1 7.1 
 
Table 5.9- Overall ranking on decision tree 
Approach G Mean AUC 
SIMO 3.29 3.07 
Under Sampling 3.29 3.21 
W-SIMO 3.36 3.29 
SMOTE 4.43 4.71 
Cluster SMOTE 4.50 4.71 
Original Data 5.21 4.93 
Safe Level SMOTE 5.21 5.36 
BorSMOTE 6.86 6.71 
 
 
As we noted at the beginning of this chapter, one of the reasons that we used SVM in our 
algorithm was its great performance and accuracy compared to other machine learning 
techniques. The results of the numerical experiments in logistic regression and decision tree 
showed that our algorithm was not always the best in all datasets in these data mining techniques. 
However, when we compared the best performing algorithms (imbalanced data learning 
algorithms, such as SIMO, SMOTE, and under-sampling) in each machine learning technique in 
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each dataset, it turned out that SVM always outperformed other data mining techniques. 
Therefore, our algorithm might not always have the best performance when applied to logistic 
regression and decision tree, but its performance in SVM is better and has higher G mean and 
AUC. Table 5.10 demonstrates these results. For each dataset, we provide the G mean and AUC 
of the best imbalanced data learning approach in each of the four machine learning techniques, 
linear SVM, SVM with RBF kernel, logistic regression, and decision tree. The bold numbers 
show the best performing machine learning technique in each dataset and the underlined numbers 
are the results of our algorithms. Only in three datasets, the best performing model was not 
incorporated with our algorithm; those cases are shown in italic bold. The output of our algorithm 
in those cases is shown in parenthesis and they are not much lower than the best performing 
approaches. Overall, no one can claim that their algorithm is the best performing algorithm in all 
datasets, because the performance of a technique or algorithm highly depends on the distribution, 
size, and complexity of datasets, however, the overall performance of algorithms on multiple 
datasets from various domains can be a fair comparison measure. 
Table 5.10-The performance of best approach in each machine learning technique 
 SVM-Linear SVM-RBF Logistic Regression Decision Tree 
 G mean AUC G mean AUC G mean AUC G mean AUC 
Liver 68.81% 69.18% 62.27% 64.09% 65.09% 66.68% 62.44% 63.17% 
Ionosphere 84.77% 85.37% 94.10% 
(93.96%) 
94.13% 
(94.00%) 
81.54% 82.57% 87.59% 87.75% 
Pima 76.05% 76.26% 70.43% 70.54% 74.51% 74.65% 69.24% 69.33% 
BreastCO 97.61% 97.62% 97.04% 97.07% 96.47% 96.49% 94.75% 94.76% 
Iris 78.31% 79.25% 97.06% 97.12% 75.05% 75.40% 94.28% 94.43% 
Yeast 71.95% 72.15% 70.25% 70.34% 70.85% 71.08% 66.18% 66.29% 
Vehicle 96.68% 96.71% 95.83% 95.95% 96.22% 96.24% 91.51% 91.55% 
CMC 66.36% 66.57% 66.15% 66.28% 65.74% 65.88% 61.82% 61.98% 
BreastC20 97.28% 97.32% 97.25% 97.27% 96.35% 96.38% 93.52% 93.57% 
Vowel 91.07% 91.22% 99.58% 99.59% 90.31% 90.36% 95.57% 95.60% 
Ecoli 91.82% 91.91% 93.50% 
(91.83%) 
93.61% 
(92.08%) 
90.65% 90.77% 86.10% 86.82% 
Libras12 86.89% 87.97% 97.64% 97.71% 39.37% 42.79% 84.27% 85.76% 
Libras34 91.76% 91.92% 92.97% 93.07% 82.74% 83.05% 82.74% 83.05% 
Glass 92.62% 92.98% 89.33% 89.91% 91.55% 91.89% 92.37% 92.61% 
BreastC10 95.77% 95.86% 96.73% 96.79% 94.68% 94.81% 92.13% 92.33% 
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Another advantage of our proposed algorithm is that it makes a minimal alteration to the original 
distribution of the dataset. While other over-sampling approaches generate enough data points to 
completely fill the imbalanced gap in the data, SIMO and W-SIMO only focus on the informative 
data points close to the decision boundary between two classes in the data, and therefore, they do 
not generate as many synthetic data points as other over-sampling methods. Table 5.11 
demonstrates the imbalanced gap between majority and minority class in various datasets. It also 
shows the average number of data points generated by our algorithms as well as other over-
sampling approaches. The number in parenthesis shows the amount of the synthetically generated 
data points as a percentage of the total imbalanced gap in the training datasets. As it can be seen, 
SIMO and W-SIMO usually generate less number of data points compared to other over-
sampling methods. This result shows two advantages of our proposed algorithms. First, our 
algorithms do not dramatically change the distribution of the data from its original shape. Second, 
with less amount of data generated, the further computational cost in training the machine 
learning techniques will be lower.  
Table 5.11- Imbalanced gap and average # of synthetically generated data points  
(% of the imbalance gap) 
 
 
Imbalanced Gap 
in Training Data 
Other 
Approaches 
SIMO W-SIMO 
Liver 41 41 (100%) 20 (48.8%) 22 (53.7%) 
Ionosphere 75 75 (100%) 18 (24%) 22 (29.3%) 
Pima 174 174 (100%) 104 (59.8%) 96 (55.1%) 
BreastCO 154 154 (100%) 25 (16.2%) 30 (19.5%) 
Iris 38 38 (100%) 25 (65.8%) 24 (63.1%) 
Yeast 467 467 (100%) 392 (83.9%) 373 (79.9%) 
Vehicle 336 336 (100%) 50 (14.9%) 46 (13.7%) 
CMC 606 606 (100%) 543 (89.6%) 569 (93.9%) 
BreastC20 229 229 (100%) 13 (5.7%) 18 (7.9%) 
Vowel 473 473 (100%) 173 (36.6%) 152 (32.1%) 
Ecoli 174 174 (100%) 60 (34.5%) 58 (33.3%) 
Libras12 175 175 (100%) 29 (16.6%) 17 (9.7%) 
Libras34 180 180 (100%) 20 (11.1%) 17 (9.4%) 
Glass 117 117 (100%) 5 (4.2%) 6 (5.1%) 
BreastC10 282 282 (100%) 35 (12.4%) 19 (6.7%) 
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Sensitivity Analysis 
For applying SIMO and W-SIMO, their parameters, i.e. ∆, p, and P need to be specified. To 
evaluate the performance of SIMO in different parameters values, we performed a sensitivity 
analysis. In the sensitivity analysis, we considered values 10% to 50% for ∆, and 5% to 50% for 
p. Table 5.12 depicts the results of the sensitivity analysis for ∆=10, 20, 30, and 40% and 𝑝=10 
and 40%. As shown in Table 5.12, different values of parameters do not make a considerable 
difference in the performance of SIMO. Therefore, SIMO is not very sensitive to the values of its 
parameters. Moreover, except in 4 cases, in all of the other cases, with even the worst parameters’ 
value, SIMO had a better performance compared to the 3rd best approach. Based on this analysis, 
we suggest the following policy for choosing the parameters’ values. When the imbalance ratio of 
the data is high (the minority class rate below 20%), it is better to select higher values for ∆ and 
𝑝, i.e. values between 30% to 40% for ∆, and values between 25% to 50% for 𝑝. The reason is 
that because the number of the minority data points in highly imbalanced datasets is very low, by 
selecting relatively higher values for ∆, we consider greater numbers of minority data points for 
over-sampling. Therefore, we avoid the potential overfitting. On the other hand, for datasets with 
lower imbalanced ratio (the minority class rate between 20-40%), choosing lower values for ∆ 
and 𝑝 will generate better results. Selecting the parameters for W-SIMO follows the same policy 
with one difference, and that is selecting a higher value for 𝑃 compared to 𝑝. Our suggestion 
based on the sensitivity analysis is to choose 20% to 30% greater values for 𝑃. For example, if 
𝑝=20%, values between 40% to 50% are appropriate for 𝑃. 
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  Table 5.12- Sensitivity analysis on SIMO parameters 
  SIMO 
3rd best 
approach 
  ∆=10% ∆=20% ∆=30% ∆=40% 
Best 
 ∆ & 𝑝 
 
  𝒑=10% 𝒑=40% 𝒑=10% 𝒑=40% 𝒑=10% 𝒑=40% 𝒑=10% 𝒑=40%   
Liver G mean 68.41% 68.23% 68.35% 68.15% 68.15% 68.11% 67.91% 67.90% ∆=10% 65.62% 
AUC 68.76% 68.44% 68.70% 68.36% 68.32% 68.20% 68.19% 68.08% 𝑝=10% 66.25% 
Ionosphere G mean 84.63% 84.48% 84.69% 84.07% 84.33% 83.88% 83.98% 83.71% ∆=20% 83.25% 
AUC 85.20% 85.09% 85.22% 84.22% 85.02% 84.43% 84.65% 84.40% 𝑝=05% 84.01% 
Pima G mean 75.28% 75.19% 75.40% 75.32% 75.25% 75.15% 75.14% 75.09% ∆=20% 74.31% 
AUC 75.48% 75.40% 75.63% 75.54% 75.58% 75.37% 75.36% 75.21% 𝑝=10% 74.46% 
BreastCO G mean 97.60% 97.57% 97.63% 97.62% 97.55% 97.48% 97.36% 97.21% ∆=15% 96.97% 
AUC 97.61% 97.59% 97.65% 97.63% 97.56% 97.5% 97.37% 97.22% 𝑝=15% 96.98% 
Iris G mean 77.86% 77.97% 78.41% 77.67% 78.31% 77.59% 78.02% 77.56% ∆=20% 75.56% 
AUC 78.56% 78.70% 79.18% 78.40% 79.01% 78.36% 78.78% 78.09% 𝑝=25% 76.51% 
Yeast G mean 71.29% 71.81% 71.71% 71.47% 71.79% 71.26% 71.35% 71.08% ∆=10% 70.95% 
AUC 71.53% 71.99% 71.90% 71.70% 71.94% 71.51% 71.61% 71.29% 𝑝=15% 71.06% 
Vehicle G mean 96.30% 96.34% 96.28% 96.29% 96.43% 96.26% 96.34% 96.35% ∆=30% 95.83% 
AUC 96.32% 96.35% 96.31% 96.31% 96.46% 96.29% 96.36% 96.37% 𝑝=30% 95.87% 
CMC G mean 65.49% 65.58% 65.82% 66.01% 65.91% 65.87% 65.55% 65.46% ∆=20% 65.35% 
AUC 65.79% 65.87% 66.05% 66.30% 66.19% 66.15% 65.85% 65.78% 𝑝=40% 65.61% 
BreastC20 G mean 97.26% 97.12% 97.27% 97.10% 96.98% 96.99% 96.93% 96.84% ∆=12% 96.12% 
AUC 97.27% 97.13% 97.28% 97.11% 97.00% 97.00% 96.94% 96.85% 𝑝=05% 96.13% 
Vowel G mean 90.48% 90.94% 90.52% 90.73% 90.69% 90.35% 90.64% 90.46% ∆=10% 89.71% 
AUC 90.60% 91.04% 90.65% 90.86% 90.80% 90.44% 90.76% 90.58% 𝑝=35% 89.83% 
Ecoli G mean 90.89% 90.92% 91.59% 91.52% 91.58% 91.29% 91.57% 91.37% ∆=12% 89.90% 
AUC 91.10% 91.13% 91.70% 91.63% 91.68% 91.39% 91.65% 91.48% 𝑝=20% 90.02% 
Libras12 G mean 86.42% 86.59% 86.89% 86.27% 86.22% 85.99% 85.92% 85.98% ∆=20% 70.42% 
AUC 87.60% 87.73% 87.97% 87.50% 87.32% 87.08% 87.17% 87.29% 𝑝=10% 73.76% 
Libras34 G mean 90.72% 90.85% 90.95% 91.06% 91.25% 91.34% 91.23% 91.18% ∆=30% 89.84% 
AUC 90.90% 91.04% 91.24% 91.27% 91.45% 91.52% 91.40% 91.34% 𝑝=25% 90.11% 
Glass G mean 92.40% 92.16% 92.11% 92.33% 92.30% 92.57% 92.37% 92.07% ∆=30% 91.79% 
AUC 92.70% 92.47% 92.44% 92.63% 92.60% 92.86% 92.70% 92.42% 𝑝=40% 92.09% 
BreastC10 G mean 94.95% 95.32% 95.13% 95.35% 95.39% 95.17% 95.50% 95.68% ∆=40% 95.28% 
AUC 95.10% 95.39% 95.27% 95.44% 95.50% 95.29% 95.61% 95.77% 𝑝=35% 95.35% 
 
5.4. Discussion and Conclusion 
Imbalanced datasets are widespread in various domains such as healthcare, finance, and 
information system security. In an imbalanced dataset, the number of examples belonging to one 
class outnumbers the number of examples from the other class. Therefore, in an imbalanced 
dataset, there are majority and minority classes of examples. Training machine learning 
techniques using imbalanced datasets is a critical challenge in data analytics. The prediction 
accuracy of a data mining technique, especially prediction accuracy of detecting the minority 
class in an imbalanced dataset, is inferior to the performance of the same technique when applied 
to a balanced dataset. There has been an enormous effort to address the problem of imbalanced 
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data learning in recent years. Sampling methods along with cost sensitive approaches are among 
the most efficient remedies to the imbalanced data learning problem. 
In this study, we proposed a synthetic informative minority oversampling (SIMO) algorithm 
imbedded into SVM to enhance the performance of machine learning techniques when applied to 
imbalanced datasets. In this algorithm, first SVM is applied to the original imbalanced dataset. In 
the next step, minority examples close to the SVM decision boundary are selected as the 
informative minority examples. Next, these examples are over-sampled to a pre-specified degree. 
Finally, a new SVM model is developed on the updated dataset. This process iterates until we 
reach a pre-specified balance level. In each iteration, we have an updated training dataset, which 
is formed by adding the newly generated data points to the previous dataset. Each of these 
training datasets is used to develop a SVM model, and the SVM model is assessed on the test 
dataset. At the end, the best model and its associated training dataset is selected as the final over-
sampled training dataset. In this research, we also developed another version of SIMO called W-
SIMO. W-SIMO is different from SIMO in the degree of over-sampling the informative minority 
examples. In W-SIMO, informative minority examples that are incorrectly classified are over-
sampled with a higher degree compared to the informative minority examples that are correctly 
classified. In this way, there is more focus on incorrectly classified minority examples. 
SIMO and W-SIMO have several advantages compared to other imbalanced data learning 
methods. First, they are embedded into SVM, which is a powerful machine learning technique in 
pattern recognition problems. Second, in SIMO and W-SIMO, we over-sample the minority 
examples rather than under-sampling the majority examples, therefore we avoid losing potentially 
useful information by discarding some portion of the data. Third, our focus in SIMO and W-
SIMO is only on the data points (examples) near the decision boundary as the informative 
minority data points. This focus is even more important in W-SIMO where we over-sample the 
incorrectly classified examples with a higher degree. Therefore, SIMO and W-SIMO concentrate 
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on the informative minority examples that usually are misclassified by standard machine learning 
techniques. Fourth, compared to other oversampling methods, SIMO generates fewer synthetic 
data points. Therefore, the changes to the original distribution of the data and further 
computational costs will be lower compared to other oversampling approaches. Fifth, the 
oversampled data through SIMO can be used to train any other machine learning technique, thus 
its application is not limited only to SVM. Finally, SIMO and W-SIMO are not very sensitive to 
their parameters, even though we suggest to select higher values for ∆ and p in highly imbalanced 
datasets and lower values in moderately imbalanced datasets.  
We applied our algorithms to 15 publicly available benchmark imbalanced datasets and assessed 
their performance in comparison with existing approaches in the area of imbalanced data 
learning. These approaches were cost sensitive SVM, under sampling, SMOTE, cluster SMOTE, 
safe level SMOTE and borderline SMOTE as well as the original imbalanced dataset. Our 
algorithm had the best performance in all datasets compared to the other seven approaches in the 
linear SVM. In fact, the difference between our algorithm and second best algorithm was 
significantly greater than the difference between other algorithms (for instance, the difference 
between second and third best approaches). Besides linear SVM that SIMO and W-SIMO were 
embedded into, we also assessed SIMO and W-SIMO in other machine learning techniques such 
as SVM with RBF kernel, logistic regression, and decision tree. Our algorithms were not always 
the best in these machine learning techniques in all bench mark datasets, however their overall 
performances were better than all other imbalanced data learning approaches. Moreover, the 
results showed that the best performing machine learning technique in all datasets was either 
linear SVM or SVM with RBF kernel function, and except for in three datasets, our algorithms 
were the best ones. From the practical implication point of view, our proposed algorithm can 
enhance the performance of the predictive models and decision support systems in various 
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domains such as diagnosing diseases, detecting re-admissions, and predicting the loan defaults in 
financial institutions among other application domains. 
Here we briefly explain the performing mechanism of our algorithms, SIMO and W-SIMO and 
suggest an outline for using them. SIMO and W-SIMO are over-sampling algorithms that aim to 
decrease the imbalance ratio in imbalanced datasets through generating synthetic data points 
belonging to the minority class. These algorithms first develop a SVM model on the imbalanced 
data, and form the SVM decision boundary. Next, minority data points near the decision 
boundary are identified as informative minority data points. To identify these informative 
minority data points, the Euclidean distance of all of the minority data points from the SVM 
decision boundary is computed, then the top ∆% of them, which are the closest ones to the 
decision boundary are selected. Next, these informative minority data points are over-sampled by 
generating synthetic data points in their data space. Thus, unlike other general over-sampling 
approaches such as SMOTE that over-sample the whole minority data points, in SIMO and W-
SIMO the focus is on the data points near the boundary of the classes in the data. There are two 
reasons for focusing on the data points near the decision boundary. First, they are the data points 
that are hard to classify, and second, they will form the support vectors in SVM that are important 
for developing the model. After over-sampling the informative minority data-points, a new SVM 
model is developed on the updated data. This process iterates until we reach to a desired balanced 
distribution in the data.  
To apply SIMO and W-SIMO, ∆, 𝑝, and 𝑃 need to be specified as the parameters of the 
algorithms. ∆ specifies the level of minority data that we want to focus on as informative minority 
data points. Smaller value for the ∆ means that we will only focus on the data points that are very 
close to the decision boundary. 𝑝 and 𝑃 are the degree of over-sampling the informative minority 
data points. Greater value for 𝑝 and 𝑃 is indicative of generating more synthetic data points at 
each iteration of the algorithms. We suggest the following strategy for choosing these parameters’ 
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value. When the imbalance ratio of the data is high (the minority class rate below 20%), it is 
better to select higher values for ∆ and 𝑝, i.e. values between 30% to 40% for ∆, and values 
between 25% to 50% for 𝑝. On the other hand, for datasets with lower imbalanced ratio (the 
minority class rate between 20-40%), choosing lower values for ∆ and 𝑝 will generate better 
results. Finally, always select a higher value for 𝑃 compared to 𝑝. 
Our proposed algorithms may have a limitation that all of the over-sampling approaches face. 
This limitation is the computational time when the algorithms are applied to very large size 
datasets. Even though considering the recent advances in computational power of the computers, 
the computational time is not as critical as it used to be, we still need to enhance the speed of our 
algorithms in large size datasets. Therefore, we consider speeding up our algorithms in big data 
usage as one of the most important directions for future research. One way to achieve higher 
speed could be decreasing the size of the data thorough approaches such as variable selection 
before using the data in over-sampling algorithms. Another way could be improving the SVM 
training algorithms. We are considering another direction for future research, and that is applying 
our developed algorithms to develop a clinical decision support system for predicting kidney 
disease among diabetic patients. The dataset that we are going to use for that research contains 
the lab, demographic, clinical events, and comorbidity data of a large number of diabetic patients. 
We believe that this future research will reveal the performance and efficiency of our algorithm in 
a larger imbalanced dataset.
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CHAPTER VI 
 
 
CONCLUSION 
 
 
 
In this dissertation we conducted three studies. In the first study, we addressed the rare items 
problem in association rule mining. This problem emerges when some of the items in the data are 
not as frequent as others. Even though these items may not occur frequently, they can be very 
important. Therefore, discovering their associations with other items usually is in the interest of 
data analysts and managers. To address this problem, we proposed a new assessment metric for 
evaluating association rules and called this metric adjusted_support. Applying adjusted_support, 
enabled us to retrieve rare rules without over-generating association rules. In this research, we 
used adjusted_support in order to discover the association patterns among complications of 
diabetes. Identifying associations among diabetes complications has several benefits. First, it 
could lead to better diagnoses of diabetes complications when the existence of some other 
diabetes-related complications is known. For example, if there exists a strong association between 
neuropathy and retinopathy, then a patient diagnosed with diabetic neuropathy would also be at 
risk for diabetic retinopathy.  Second, knowledge of strong associations among frequently 
occurring diabetes complications can help physicians provide more effective intervention and 
treatment plans. Third, it may provide useful information 
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Begin for medical scientists to better understand the relationships among different diseases. We 
discovered several strong associations between various complications of diabetes that can be in 
the interest of physicians and clinicians. We also analyzed the comorbidity index among various 
demographic groups of diabetic patients. Finally, we studied the prevalence of diabetes 
complications in every demographic group of patients and compared them. 
In the second research, we addressed the problem of low compliance rate with annual eye 
examination for diabetic patients that leads to a very high undiagnosed rate of diabetic 
retinopathy (over 50%). To address this problem, we developed a CDSS for diabetic retinopathy. 
Our developed CDSS for diabetic retinopathy has several advantages over the existing diagnostic 
systems. First and foremost, it only uses the results of a simple blood test and demographic data 
to predict the risk of diabetic retinopathy. Therefore, unlike the dominant approach in the extant 
literature that uses image processing on images of retina, it does not require eye exams, thereby 
addressing the low rates of compliance with annual ophthalmologic tests for diabetic patients. 
Equally important, our CDSS eliminates the need to have access to specialists, which is 
particularly critical for patients living in remote areas. Second, our decision support system is 
based on a large database of clinical encounters that span over several years and across several 
states of the US. The decisions of this system are more generalizable and valid compared to those 
of other systems that employ a similar approach but only use data from a few hundred patients. 
Finally, our CDSS uses a greater number of risk factors to predict the outcome. This not only 
improves the prediction results, but also sheds more light on contribution and importance of 
different risk factors on diabetic patients’ susceptibility to retinopathy. 
To develop this CDSS, we proposed a new ensemble approach to further enhance the prediction 
accuracy.  We termed this ensemble approach confidence margin.  While exiting ensemble 
methods assigns various weights at model level, confidence margin calculates different weights at 
both model and record level.  To calculate the weight of each model at each record, the difference 
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between the model’s output and the decision cutoff is calculated (confidence margin). Next, a 
weight is assigned to models at each record based on the calculated confidence margins.  We 
conducted a numerical analysis to assess the performance of confidence margin ensemble in 
comparison to other exiting ensemble methods. The results of this analysis showed that 
confidence margin ensemble had the best performance in most cases (14 out of 18). 
In the third research, we addressed the problem of imbalanced data learning. Data mining 
techniques do not have a very good performance in imbalanced datasets. In this research we 
developed a synthetic informative minority over-sampling algorithm imbedded into support 
vector machine in order to enhance the performance of predictive modeling techniques when 
applied to imbalanced datasets. The proposed algorithm, SIMO, generates synthetic minority data 
points that are located near the boundary between two classes in the data space. After applying 
SIMO in an imbalanced dataset, the number of minority class data points will be increased and 
the dataset will be more balanced. In this research, we developed another version of SIMO, which 
we call weighted SIMO (W-SIMO). In W-SIMO, after identifying the informative minority 
examples, they are grouped into two categories. First, those that are correctly classified by the 
SVM, and second, those that are incorrectly classified by the SVM. At the over-sampling stage, 
more data points are generated in the space of the minority data examples that are misclassified. 
The over-sampled dataset through SIMO and W-SIMO can be used by other machine learning 
techniques and it is not limited only to the SVM.  
We performed numerical experiments to evaluate the performance of SIMO and W-SIMO in 
comparison to exiting imbalanced data learning approaches that are widely used in literature and 
practice. These approaches are cost-sensitive SVM, under sampling, SMOTE, cluster SMOTE, 
safe level SMOTE and borderline SMOTE. To conduct the numerical experiments, we used 15 
benchmark imbalanced datasets with various imbalance ratio. The results of the numerical 
experiments showed that SIMO and W-SIMO had the best performance on all benchmark 
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datasets compared to other existing approaches in linear SVM. We replicated the same 
experiments in other machine learning techniques, such as decision tree, logistic regression, and 
SVM with RBF kernel function. Based on the results of these analyses, either SIMO or W-SIMO 
had the best overall performance in decision tree, logistic regression, and SVM with RBF. 
Another advantage of SIMO and W-SIMO compared to other over-sampling approaches is that 
SIMO and W-SIMO generate the least number of synthetic data points. Therefore, the alteration 
to the original data distribution will be minimal. In addition, because the size of the over-sampled 
data will be smaller, the computational cost of training predictive models will be lower. 
109 
 
REFERENCES 
 
 
 
 
 
[1] A. B. Martin, M. Hartman, J. Benson, A. Catlin, and N. H. E. A. Team, "National health 
spending in 2014: faster growth driven by coverage expansion and prescription drug 
spending," Health Affairs, vol. 35, no. 1, pp. 150-160, 2016. 
[2] "IDF Diabetes Atlas, 7th edn.," International Diabetes Federation, Brussels, Belgium 
International Diabetes Federation2015. 
[3] "National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United 
States," Centers for Disease Control and Prevention, Atlanta, GA: U.S. Department of 
Health and Human Services2014. 
[4] R. Wullianallur, "Data Mining in Healthcare," in Healthcare Informatics: CRC Press, 
2010, pp. 211-224. 
[5] W. Raghupathi and V. Raghupathi, "Big data analytics in healthcare: promise and 
potential," Health Information Science and Systems, vol. 2, no. 1, p. 1, 2014. 
[6] J. R. Evans and C. H. Lindner, "Business analytics: the next frontier for decision 
sciences," Decision Line, vol. 43, no. 2, pp. 4-6, 2012. 
[7] D. Delen and H. Demirkan, "Data, information and analytics as services," Decision 
Support Systems, vol. 55, no. 1, pp. 359-363, 4// 2013. 
[8] D. Delen, Real-World Data Mining: Applied Business Analytics and Decision Making. 
FT Press (a Pearson Publishing Company), 2015. 
[9] R. Agrawal, T. Imieliński, and A. Swami, "Mining association rules between sets of 
items in large databases," in Acm sigmod record, 1993, vol. 22, no. 2, pp. 207-216: ACM. 
[10] D. S. Fong et al., "Diabetic Retinopathy," Diabetes Care, vol. 26, no. suppl 1, pp. s99-
s102, January 1, 2003 2003. 
[11] P. K. Chan, F. Wei, A. L. Prodromidis, and S. J. Stolfo, "Distributed data mining in credit 
card fraud detection," Intelligent Systems and their Applications, IEEE, vol. 14, no. 6, pp. 
67-74, 1999. 
[12] J. M. Valderas, B. Starfield, B. Sibbald, C. Salisbury, and M. Roland, "Defining 
comorbidity: implications for understanding health and health services," The Annals of 
Family Medicine, vol. 7, no. 4, pp. 357-363, 2009. 
[13] D.-C. Suh, I.-S. Choi, C. Plauschinat, J. Kwon, and M. Baron, "Impact of comorbid 
conditions and race/ethnicity on glycemic control among the US population with type 2 
diabetes, 1988–1994 to 1999–2004," Journal of Diabetes and its Complications, vol. 24, 
no. 6, pp. 382-391, 2010.
110 
 
 
[14] P. C. Albertsen, D. F. Moore, W. Shih, Y. Lin, H. Li, and G. L. Lu-Yao, "Impact of 
comorbidity on survival among men with localized prostate cancer," Journal of Clinical 
Oncology, vol. 29, no. 10, pp. 1335-1341, 2011. 
[15] A. D. Hanchate, K. M. Clough-Gorr, A. S. Ash, S. S. Thwin, and R. A. Silliman, 
"Longitudinal patterns in survival, comorbidity, healthcare utilization and quality of care 
among older women following breast cancer diagnosis," Journal of general internal 
medicine, vol. 25, no. 10, pp. 1045-1050, 2010. 
[16] H. M. Zolbanin, D. Delen, and A. Hassan Zadeh, "Predicting overall survivability in 
comorbidity of cancers: A data mining approach," Decision Support Systems, vol. 74, pp. 
150-161, 6// 2015. 
[17] S. Hill et al., "Survival disparities in Indigenous and non-Indigenous New Zealanders 
with colon cancer: the role of patient comorbidity, treatment and health service factors," 
Journal of epidemiology and community health, vol. 64, no. 2, pp. 117-123, 2010. 
[18] H. Teppo and O.-P. Alho, "Comorbidity and diagnostic delay in cancer of the larynx, 
tongue and pharynx," Oral oncology, vol. 45, no. 8, pp. 692-695, 2009. 
[19] T. G. Dietterich, "Ensemble methods in machine learning," in International workshop on 
multiple classifier systems, 2000, pp. 1-15: Springer. 
[20] E. Dimitriadou, A. Weingessel, and K. Hornik, "A cluster ensembles framework, Design 
and application of hybrid intelligent systems," ed: IOS Press, Amsterdam, The 
Netherlands, 2003. 
[21] G. Pandey, G. Atluri, F. Gang, R. Gupta, M. Steinbach, and V. Kumar, "Association 
analysis techniques for analyzing complex biological data sets," in 2009 IEEE 
International Workshop on Genomic Signal Processing and Statistics, 2009, pp. 1-4. 
[22] C. Becquet, S. Blachon, B. Jeudy, J.-F. Boulicaut, and O. Gandrillon, "Strong-
association-rule mining for large-scale gene-expression data analysis: a case study on 
human SAGE data," Genome Biology, vol. 3, no. 12, p. 1, 2002. 
[23] S. Naulaerts et al., "A primer to frequent itemset mining for bioinformatics," Briefings in 
bioinformatics, vol. 16, no. 2, pp. 216-231, 2015. 
[24] D. Gnatyshak, D. I. Ignatov, A. Semenov, and J. Poelmans, "Gaining insight in social 
networks with biclustering and triclustering," in International Conference on Business 
Informatics Research, 2012, pp. 162-171: Springer. 
[25] R. Rathipriya, K. Thangavel, and J. Bagyamani, "Binary particle swarm optimization 
based biclustering of web usage data," arXiv preprint arXiv:1108.0748, 2011. 
[26] P.-N. Tan and V. Kumar, "Mining association patterns in web usage data," 2002. 
[27] C. Potter et al., "Global teleconnections of climate to terrestrial carbon flux," Journal of 
Geophysical Research: Atmospheres, vol. 108, no. D17, 2003. 
[28] C. Potter et al., "Understanding global teleconnections of climate to regional model 
estimates of Amazon ecosystem carbon fluxes," Global Change Biology, vol. 10, no. 5, 
pp. 693-703, 2004. 
[29] H. Xiong, P.-N. Tan, and V. Kumar, "Mining strong affinity association patterns in data 
sets with skewed support distribution," in Data Mining, 2003. ICDM 2003. Third IEEE 
International Conference on, 2003, pp. 387-394: IEEE. 
[30] J. Liu, X. Fan, and Z. Qu, "A new interestingness measure of association rules," in 
Genetic and Evolutionary Computing, 2008. WGEC'08. Second International Conference 
on, 2008, pp. 393-397: IEEE. 
[31] X. Yan, C. Zhang, and S. Zhang, "Confidence Metrics for Association Rule Mining," 
Applied Artificial Intelligence, vol. 23, no. 8, pp. 713-737, 2009. 
[32] P.-N. Tan, V. Kumar, and J. Srivastava, "Selecting the right interestingness measure for 
association patterns," presented at the Proceedings of the eighth ACM SIGKDD 
111 
 
international conference on Knowledge discovery and data mining, Edmonton, Alberta, 
Canada, 2002.  
[33] S. Kotsiantis and D. Kanellopoulos, "Association rules mining: A recent overview," 
GESTS International Transactions on Computer Science and Engineering, vol. 32, no. 1, 
pp. 71-82, 2006. 
[34] B. Liu, W. Hsu, and Y. Ma, "Mining association rules with multiple minimum supports," 
in Proceedings of the fifth ACM SIGKDD international conference on Knowledge 
discovery and data mining, 1999, pp. 337-341: ACM. 
[35] H. Yun, D. Ha, B. Hwang, and K. H. Ryu, "Mining association rules on significant rare 
data using relative support," Journal of Systems and Software, vol. 67, no. 3, pp. 181-191, 
2003. 
[36] K. Wang, Y. He, and J. Han, "Pushing support constraints into association rules mining," 
IEEE Transactions on Knowledge and Data Engineering, vol. 15, no. 3, pp. 642-658, 
2003. 
[37] M. Seno and L. Karypis, "An algorithm for finding frequent itemsets using length-
decreasing support constraint. 2001 IEEE Intl," in Conf on Data Mining, San Jose, 2001, 
pp. 505-512. 
[38] E. R. Omiecinski, "Alternative interest measures for mining associations in databases," 
IEEE Transactions on Knowledge and Data Engineering, vol. 15, no. 1, pp. 57-69, 2003. 
[39] R. U. Kiran and P. K. Re, "An improved multiple minimum support based approach to 
mine rare association rules," in Computational Intelligence and Data Mining, 2009. 
CIDM'09. IEEE Symposium on, 2009, pp. 340-347: IEEE. 
[40] Y. S. Koh and S. D. Ravana, "Unsupervised Rare Pattern Mining: A Survey," ACM 
Transactions on Knowledge Discovery from Data (TKDD), vol. 10, no. 4, p. 45, 2016. 
[41] G. J. Simon, J. Schrom, M. R. Castro, P. W. Li, and P. J. Caraballo, "Survival association 
rule mining towards type 2 diabetes risk assessment," in AMIA Annual Symposium 
Proceedings, 2013, vol. 2013, p. 1293: American Medical Informatics Association. 
[42] G. J. Simon, P. J. Caraballo, T. M. Therneau, S. S. Cha, M. R. Castro, and P. W. Li, 
"Extending association rule summarization techniques to assess risk of diabetes mellitus," 
IEEE Transactions on Knowledge and Data Engineering, vol. 27, no. 1, pp. 130-141, 
2015. 
[43] A. Ramezankhani, O. Pournik, J. Shahrabi, F. Azizi, and F. Hadaegh, "An application of 
association rule mining to extract risk pattern for type 2 diabetes using tehran lipid and 
glucose study database," International journal of endocrinology and metabolism, vol. 13, 
no. 2, 2015. 
[44] M. D. Kamalesh, K. H. Prasanna, B. Bharathi, R. Dhanalakshmi, and R. A. Canessane, 
"Predicting the Risk of Diabetes Mellitus to Subpopulations Using Association Rule 
Mining," in Proceedings of the International Conference on Soft Computing Systems, 
2016, pp. 59-65: Springer. 
[45] A. M. Shin et al., "Diagnostic analysis of patients with essential hypertension using 
association rule mining," Healthcare informatics research, vol. 16, no. 2, pp. 77-81, 
2010. 
[46] F. Valent, S. Tillati, and L. Zanier, "Prevalence and comorbidities of known diabetes in 
northeastern Italy," Journal of diabetes investigation, vol. 4, no. 4, pp. 355-360, 2013. 
[47] H. S. Kim, A. M. Shin, M. K. Kim, and Y. N. Kim, "Comorbidity study on type 2 
diabetes mellitus using data mining," The Korean journal of internal medicine, vol. 27, 
no. 2, pp. 197-202, 2012. 
[48] I. Torre-Díez, B. Martínez-Pérez, M. López-Coronado, J. R. Díaz, and M. M. López, 
"Decision Support Systems and Applications in Ophthalmology: Literature and 
112 
 
Commercial Review Focused on Mobile Apps," Journal of Medical Systems, journal 
article vol. 39, no. 1, pp. 1-10, 2014. 
[49] A. Karma, S. Gummerus, E. Kujansuu, and T. Pitkäjärvi, "Predicting Diabetic 
Retinopathy," Acta Ophthalmologica, vol. 65, no. S182, pp. 136-139, 1987. 
[50] R. Klein, B. K. Klein, S. E. Moss, M. D. Davis, and D. L. DeMets, "GLycosylated 
hemoglobin predicts the incidence and progression of diabetic retinopathy," JAMA, vol. 
260, no. 19, pp. 2864-2871, 1988. 
[51] P. Kahai, K. R. Namuduri, and H. Thompson, "A Decision Support Framework for 
Automated Screening of Diabetic Retinopathy," International Journal of Biomedical 
Imaging, vol. 2006, p. 8, 2006, Art. no. 45806. 
[52] A. Paunksnis, V. Barzdziukas, D. Jegelevicius, S. Kurapkiene, and G. Dzemyda, "The 
use of information technologies for diagnosis in ophthalmology," Journal of 
Telemedicine and Telecare, vol. 12, no. suppl 1, pp. 37-40, July 1, 2006 2006. 
[53] K. Marsolo, M. Twa, M. A. Bullimore, and S. Parthasarathy, "Spatial Modeling and 
Classification of Corneal Shape," IEEE Transactions on Information Technology in 
Biomedicine, vol. 11, no. 2, pp. 203-212, 2007. 
[54] C. L. Tsai et al., "Automated Retinal Image Analysis Over the Internet," IEEE 
Transactions on Information Technology in Biomedicine, vol. 12, no. 4, pp. 480-487, 
2008. 
[55] K. Noronha, U. Acharya, K. Nayak, S. Kamath, and S. Bhandary, "Decision support 
system for diabetes retinopathy using discrete wavelet transform," Proceedings of the 
Institution of Mechanical Engineers, Part H: Journal of Engineering in Medicine, p. 
0954411912470240, 2012. 
[56] S.-E. Bursell, L. Brazionis, and A. Jenkins, "Telemedicine and ocular health in diabetes 
mellitus," Clinical and Experimental Optometry, vol. 95, no. 3, pp. 311-327, 2012. 
[57] S. J. J. Kumar and M. Madheswaran, "An Improved Medical Decision Support System to 
Identify the Diabetic Retinopathy Using Fundus Images," Journal of Medical Systems, 
journal article vol. 36, no. 6, pp. 3573-3581, 2012. 
[58] D. Xiao, J. Vignarajan, J. Lock, S. Frost, M.-L. Tay-Kearney, and Y. Kanagasingam, 
"Retinal image registration and comparison for clinical decision support," The 
Australasian medical journal, vol. 5, no. 9, p. 507, 2012. 
[59] M. R. K. Mookiah, U. R. Acharya, C. K. Chua, C. M. Lim, E. Ng, and A. Laude, 
"Computer-aided diagnosis of diabetic retinopathy: A review," Computers in biology and 
medicine, vol. 43, no. 12, pp. 2136-2155, 2013. 
[60] P. Prasanna, S. Jain, N. Bhagat, and A. Madabhushi, "Decision support system for 
detection of diabetic retinopathy using smartphones," in Pervasive Computing 
Technologies for Healthcare (PervasiveHealth), 2013 7th International Conference on, 
2013, pp. 176-179: IEEE. 
[61] A. Bourouis, M. Feham, M. A. Hossain, and L. Zhang, "An intelligent mobile based 
decision support system for retinal disease diagnosis," Decision Support Systems, vol. 59, 
pp. 341-350, 2014. 
[62] R. Klein, B. E. Klein, S. E. Moss, M. D. Davis, and D. L. DeMets, "The Wisconsin 
Epidemiologic Study of Diabetic Retinopathy: III. Prevalence and risk of diabetic 
retinopathy when age at diagnosis is 30 or more years," Archives of ophthalmology, vol. 
102, no. 4, pp. 527-532, 1984. 
[63] R. Klein, B. E. Klein, S. E. Moss, M. D. Davis, and D. L. DeMets, "The Wisconsin 
Epidemiologic Study of Diabetic Retinopathy: II. Prevalence and risk of diabetic 
retinopathy when age at diagnosis is less than 30 years," Archives of ophthalmology, vol. 
102, no. 4, pp. 520-526, 1984. 
113 
 
[64] R. J. Tapp et al., "The prevalence of and factors associated with diabetic retinopathy in 
the Australian population," Diabetes care, vol. 26, no. 6, pp. 1731-1737, 2003. 
[65] B. E. Klein, S. E. Moss, R. Klein, and T. S. Surawicz, "The Wisconsin Epidemiologic 
Study of Diabetic Retinopathy: XIII. Relationship of serum cholesterol to retinopathy and 
hard exudate," Ophthalmology, vol. 98, no. 8, pp. 1261-1265, 1991. 
[66] E. Y. Chew et al., "Association of elevated serum lipid levels with retinal hard exudate in 
diabetic retinopathy: Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22," 
Archives of ophthalmology, vol. 114, no. 9, pp. 1079-1084, 1996. 
[67] D. S. Fong et al., "Retinopathy in Diabetes," Diabetes Care, vol. 27, no. suppl 1, pp. s84-
s87, 2004. 
[68] R. Klein, B. E. Klein, S. E. Moss, and K. J. Cruickshanks, "The Wisconsin epidemiologic 
study of diabetic retinopathy: XVII: The 14-year incidence and progression of diabetic 
retinopathy and associated risk factors in type 1 diabetes11Proprietary interest: none," 
Ophthalmology, vol. 105, no. 10, pp. 1801-1815, 1998. 
[69] R. Klein, M. D. Knudtson, K. E. Lee, R. Gangnon, and B. E. Klein, "The Wisconsin 
Epidemiologic Study of Diabetic Retinopathy XXIII: the twenty-five-year incidence of 
macular edema in persons with type 1 diabetes," Ophthalmology, vol. 116, no. 3, pp. 497-
503, 2009. 
[70] M. Skevofilakas, K. Zarkogianni, B. G. Karamanos, and K. S. Nikita, "A hybrid Decision 
Support System for the risk assessment of retinopathy development as a long term 
complication of Type 1 Diabetes Mellitus," in Engineering in Medicine and Biology 
Society (EMBC), 2010 Annual International Conference of the IEEE, 2010, pp. 6713-
6716. 
[71] V. Balakrishnan, M. R. Shakouri, and H. Hoodeh, "Developing a hybrid predictive 
system for retinopathy," Journal of Intelligent & Fuzzy Systems, Article vol. 25, no. 1, pp. 
191-199, 2013. 
[72] M. S. Roy, R. Klein, B. J. O'Colmain, B. E. Klein, S. E. Moss, and J. H. Kempen, "The 
Prevalence of Diabetic Retinopathy Among Adult Type1 Diabetic Persons in the United 
States," Archives of Ophthalmology, vol. 122, no. 4, pp. 546-551, 2004. 
[73] J. W. Tukey, "Exploratory data analysis," 1977. 
[74] G. Seni and J. F. Elder, "Ensemble methods in data mining: improving accuracy through 
combining predictions," Synthesis Lectures on Data Mining and Knowledge Discovery, 
vol. 2, no. 1, pp. 1-126, 2010. 
[75] L. Rokach, "Ensemble-based classifiers," Artificial Intelligence Review, journal article 
vol. 33, no. 1, pp. 1-39, 2009. 
[76] H. He and E. A. Garcia, "Learning from imbalanced data," Knowledge and Data 
Engineering, IEEE Transactions on, vol. 21, no. 9, pp. 1263-1284, 2009. 
[77] X.-Y. Liu, J. Wu, and Z.-H. Zhou, "Exploratory undersampling for class-imbalance 
learning," IEEE Transactions on Systems, Man, and Cybernetics, Part B (Cybernetics), 
vol. 39, no. 2, pp. 539-550, 2009. 
[78] N. V. Chawla, K. W. Bowyer, L. O. Hall, and W. P. Kegelmeyer, "SMOTE: synthetic 
minority over-sampling technique," Journal of artificial intelligence research, pp. 321-
357, 2002. 
[79] H. Han, W.-Y. Wang, and B.-H. Mao, "Borderline-SMOTE: a new over-sampling 
method in imbalanced data sets learning," in Advances in intelligent computing: Springer, 
2005, pp. 878-887. 
[80] C. Bunkhumpornpat, K. Sinapiromsaran, and C. Lursinsap, "Safe-Level-SMOTE: Safe-
Level-Synthetic Minority Over-Sampling TEchnique for Handling the Class Imbalanced 
Problem," in Advances in Knowledge Discovery and Data Mining: 13th Pacific-Asia 
Conference, PAKDD 2009 Bangkok, Thailand, April 27-30, 2009 Proceedings, T. 
114 
 
Theeramunkong, B. Kijsirikul, N. Cercone, and T.-B. Ho, Eds. Berlin, Heidelberg: 
Springer Berlin Heidelberg, 2009, pp. 475-482. 
[81] D. A. Cieslak, N. V. Chawla, and A. Striegel, "Combating imbalance in network 
intrusion datasets," in GrC, 2006, pp. 732-737. 
[82] S. Barua, M. M. Islam, X. Yao, and K. Murase, "MWMOTE--Majority Weighted 
Minority Oversampling Technique for Imbalanced Data Set Learning," IEEE 
Transactions on Knowledge and Data Engineering, vol. 26, no. 2, pp. 405-425, 2014. 
[83] H. He, Y. Bai, E. Garcia, and S. Li, "ADASYN: Adaptive synthetic sampling approach 
for imbalanced learning," in Neural Networks, 2008. IJCNN 2008.(IEEE World Congress 
on Computational Intelligence). IEEE International Joint Conference on, 2008, pp. 1322-
1328: IEEE. 
[84] A. Pourhabib, B. K. Mallick, and Y. Ding, "Absent data generating classifier for 
imbalanced class sizes," The Journal of Machine Learning Research, vol. 16, no. 1, pp. 
2695-2724, 2015. 
[85] B. Wang and N. Japkowicz, "Imbalanced data set learning with synthetic samples," in 
Proc. IRIS Machine Learning Workshop, 2004, p. 19. 
[86] C. Elkan, "The foundations of cost-sensitive learning," in International joint conference 
on artificial intelligence, 2001, vol. 17, no. 1, pp. 973-978: LAWRENCE ERLBAUM 
ASSOCIATES LTD. 
[87] R. Longadge and S. Dongre, "Class Imbalance Problem in Data Mining Review," arXiv 
preprint arXiv:1305.1707, 2013. 
[88] M. A. Maloof, "Learning when data sets are imbalanced and when costs are unequal and 
unknown," in ICML-2003 workshop on learning from imbalanced data sets II, 2003, vol. 
2, pp. 2-1. 
[89] Y. Freund and R. E. Schapire, "A desicion-theoretic generalization of on-line learning 
and an application to boosting," in European conference on computational learning 
theory, 1995, pp. 23-37: Springer Berlin Heidelberg. 
[90] Y. Sun, M. S. Kamel, A. K. Wong, and Y. Wang, "Cost-sensitive boosting for 
classification of imbalanced data," Pattern Recognition, vol. 40, no. 12, pp. 3358-3378, 
2007. 
[91] W. Fan, S. J. Stolfo, J. Zhang, and P. K. Chan, "AdaCost: misclassification cost-sensitive 
boosting," in Icml, 1999, pp. 97-105. 
[92] W. Lee, C.-H. Jun, and J.-S. Lee, "Instance categorization by support vector machines to 
adjust weights in AdaBoost for imbalanced data classification," Information Sciences, 
vol. 381, pp. 92-103, 3// 2017. 
[93] C. Drummond and R. C. Holte, "Exploiting the cost (in) sensitivity of decision tree 
splitting criteria," in ICML, 2000, vol. 1, no. 1. 
[94] M. Kukar and I. Kononenko, "Cost-Sensitive Learning with Neural Networks," in ECAI, 
1998, pp. 445-449. 
[95] K. Veropoulos, C. Campbell, and N. Cristianini, "Controlling the sensitivity of support 
vector machines," in Proceedings of the international joint conference on AI, 1999, pp. 
55-60. 
[96] G. Wu and E. Y. Chang, "Class-boundary alignment for imbalanced dataset learning," in 
ICML 2003 workshop on learning from imbalanced data sets II, Washington, DC, 2003, 
pp. 49-56. 
[97] R. Akbani, S. Kwek, and N. Japkowicz, "Applying support vector machines to 
imbalanced datasets," in European conference on machine learning, 2004, pp. 39-50: 
Springer. 
[98] B. Wang and N. Japkowicz, "Boosting support vector machines for imbalanced data 
sets," Knowledge and information systems, vol. 25, no. 1, pp. 1-20, 2010. 
115 
 
[99] J. Mathew, M. Luo, C. K. Pang, and H. L. Chan, "Kernel-based SMOTE for SVM 
classification of imbalanced datasets," in Industrial Electronics Society, IECON 2015-
41st Annual Conference of the IEEE, 2015, pp. 001127-001132: IEEE. 
[100] H. Yu, C. Mu, C. Sun, W. Yang, X. Yang, and X. Zuo, "Support vector machine-based 
optimized decision threshold adjustment strategy for classifying imbalanced data," 
Knowledge-Based Systems, vol. 76, pp. 67-78, 2015. 
[101] Y. Tang and Y.-Q. Zhang, "Granular SVM with repetitive undersampling for highly 
imbalanced protein homology prediction," in 2006 IEEE International Conference on 
Granular Computing, 2006, pp. 457-460: IEEE. 
[102] R. Batuwita and V. Palade, "Efficient resampling methods for training support vector 
machines with imbalanced datasets," in The 2010 International Joint Conference on 
Neural Networks (IJCNN), 2010, pp. 1-8: IEEE. 
[103] M. A. H. Farquad and I. Bose, "Preprocessing unbalanced data using support vector 
machine," Decision Support Systems, vol. 53, no. 1, pp. 226-233, 4// 2012. 
[104] P.-N. Tan, S. Michael, and V. Kumar, "Chapter 6. association analysis: Basic concepts 
and algorithms," Introduction to Data Mining. Addison-Wesley. ISBN, vol. 321321367, 
2005. 
[105] J. D. Piette and E. A. Kerr, "The Impact of Comorbid Chronic Conditions on Diabetes 
Care," Diabetes Care, vol. 29, no. 3, pp. 725-731, 2006. 
[106] J. N. Struijs, C. A. Baan, F. G. Schellevis, G. P. Westert, and G. A. van den Bos, 
"Comorbidity in patients with diabetes mellitus: impact on medical health care 
utilization," BMC Health Services Research, journal article vol. 6, no. 1, p. 84, 2006. 
[107] D. Delen, A. Oztekin, and L. Tomak, "An analytic approach to better understanding and 
management of coronary surgeries," Decision Support Systems, vol. 52, no. 3, pp. 698-
705, 2// 2012. 
[108] H. V. Jagadish et al., "Big data and its technical challenges," Communications of the 
ACM, vol. 57, no. 7, pp. 86-94, 2014. 
[109] M. Kubat, R. C. Holte, and S. Matwin, "Machine learning for the detection of oil spills in 
satellite radar images," Machine learning, vol. 30, no. 2-3, pp. 195-215, 1998. 
[110] R. B. Rao, S. Krishnan, and R. S. Niculescu, "Data mining for improved cardiac care," 
ACM SIGKDD Explorations Newsletter, vol. 8, no. 1, pp. 3-10, 2006. 
[111] P. K. Chan, W. Fan, A. L. Prodromidis, and S. J. Stolfo, "Distributed data mining in 
credit card fraud detection," Intelligent Systems and their Applications, IEEE, vol. 14, no. 
6, pp. 67-74, 1999. 
[112] H. Haibo and E. A. Garcia, "Learning from Imbalanced Data," Knowledge and Data 
Engineering, IEEE Transactions on, vol. 21, no. 9, pp. 1263-1284, 2009. 
[113] D. W. Hosmer Jr and S. Lemeshow, Applied logistic regression. John Wiley & Sons, 
2004. 
[114] P. Hájek, "Municipal credit rating modelling by neural networks," Decision Support 
Systems, vol. 51, no. 1, pp. 108-118, 4// 2011. 
[115] R. Bellazzi and B. Zupan, "Predictive data mining in clinical medicine: Current issues 
and guidelines," International Journal of Medical Informatics, vol. 77, no. 2, pp. 81-97, 
2// 2008. 
[116] M. T. Hagan, H. B. Demuth, M. H. Beale, and O. De Jesús, Neural network design. PWS 
publishing company Boston, 1996. 
[117] S. Lee, "Using data envelopment analysis and decision trees for efficiency analysis and 
recommendation of B2C controls," Decision Support Systems, vol. 49, no. 4, pp. 486-
497, 11// 2010. 
[118] L. Breiman, "Random Forests," (in English), Machine Learning, vol. 45, no. 1, pp. 5-32, 
2001/10/01 2001. 
116 
 
[119] P. Liu, Y. Wang, L. Cai, and L. Zhang, "Classifying skewed data streams based on 
reusing data," in Computer Application and System Modeling (ICCASM), 2010 
International Conference on, 2010, vol. 4, pp. V4-90-V4-93: IEEE. 
[120] V. Ganganwar, "An overview of classification algorithms for imbalanced datasets," 
International Journal of Emerging Technology and Advanced Engineering, vol. 2, no. 4, 
pp. 42-47, 2012. 
[121] L. K. Hansen and P. Salamon, "Neural network ensembles," IEEE transactions on 
pattern analysis and machine intelligence, vol. 12, no. 10, pp. 993-1001, 1990. 
[122] C. Sabanayagam, W. Yip, D. S. Ting, G. Tan, and T. Y. Wong, "Ten Emerging Trends in 
the Epidemiology of Diabetic Retinopathy," Ophthalmic Epidemiology, pp. 1-14, 2016. 
[123] R. Lee, T. Y. Wong, and C. Sabanayagam, "Epidemiology of diabetic retinopathy, 
diabetic macular edema and related vision loss," Eye and Vision, vol. 2, p. 17, 2015. 
[124] P. Liu, Y. Wang, L. Cai, and L. Zhang, "Classifying skewed data streams based on 
reusing data," in 2010 International Conference on Computer Application and System 
Modeling (ICCASM 2010), 2010, vol. 4, pp. V4-90-V4-93: IEEE. 
[125] M. A. Hearst, S. T. Dumais, E. Osman, J. Platt, and B. Scholkopf, "Support vector 
machines," IEEE Intelligent Systems and their Applications, vol. 13, no. 4, pp. 18-28, 
1998. 
[126] A. Anand, G. Pugalenthi, G. B. Fogel, and P. Suganthan, "An approach for classification 
of highly imbalanced data using weighting and undersampling," Amino acids, vol. 39, no. 
5, pp. 1385-1391, 2010. 
[127] C. J. Burges, "A tutorial on support vector machines for pattern recognition," Data 
mining and knowledge discovery, vol. 2, no. 2, pp. 121-167, 1998. 
[128] B. E. Boser, I. M. Guyon, and V. N. Vapnik, "A training algorithm for optimal margin 
classifiers," in Proceedings of the fifth annual workshop on Computational learning 
theory, 1992, pp. 144-152: ACM. 
[129] G. Wu and E. Y. Chang, "Adaptive feature-space conformal transformation for 
imbalanced-data learning," in ICML, 2003, pp. 816-823. 
[130] N. V. Chawla, "Data mining for imbalanced datasets: An overview," in Data mining and 
knowledge discovery handbook: Springer, 2005, pp. 853-867. 
 
117 
 
VITA 
 
Saeed Piri 
 
Candidate for the Degree of 
 
Doctor of Philosophy 
 
Thesis:    DEVELOPING AND DEPLOYING DATA MINING TECHNIQUES IN 
HEALTHCARE  
 
 
Major Field:  Industrial Engineering and Management 
 
Biographical: 
 
Education: 
 
Completed the requirements for the Doctor of Philosophy in Industrial 
Engineering and Management at Oklahoma State University, Stillwater, 
Oklahoma in July, 2017. 
 
Completed the requirements for the Master of Science in Industrial Engineering 
at Sharif University of Technology, Tehran, Iran in 2011. 
  
Completed the requirements for the Bachelor of Science in Industrial and 
System Engineering at Amirkabir University of Technology, Tehran, Iran in 
2008. 
 
Experience:   
 
Research Associate, Center for Health Systems Innovation, Spears School of 
Business, Oklahoma State University, 2014-2017. 
 
Research Associate, School of Industrial Engineering and Management, 
Oklahoma State University, 2013- 2014. 
 
Professional Memberships:  
 
Institute for Operations Research and the Management Sciences (INFROMS) 
 
Institute of Industrial and System Engineering (IISE), 
 
Decision Science Institute (DSI) 
 
Alpha Pi Mu 
